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Abstract
Caliciviruses are a family of single-stranded positive sense RNA viruses with a non­
segmented genome. Feline Calicivirus (FCV) causes respiratory disease in cats and 
noroviruses cause gastroenteritis in humans. More recently, murine norovirus (MNV), a 
murine form of human norovirus, was described. Although human noroviruses (HuNV) 
cannot be cultured in vitro, MNV and FCV can, making them excellent models for HuNV.
Previous studies of calicivirus entry have shown very different pathways for these two 
viruses. FCV enters cells via a clathrin-dependent or macropinocytic pathway, but nothing 
is known about what signalling events are involved in this process, where the virus traffics 
to post-entry or the effects the virus has on cell metabolism. MNV uses a clathrin- and 
caveolae- independent pathway that is dependent on dynamin, lipid rafts and microtubules. 
This project aimed at dissecting the early events in FCV and MNV infection; which 
signalling pathways are involved and what trafficking occurs in the cells. We have used 
pharmacological inhibitors of signalling pathways (genistein, okadaic acid and wortmannin) 
and dominant negative inhibitors of proteins involved in endocytic and signalling pathways 
as well as markers of endosomal compartments for colocalisation studies. We have now 
shown that FCV entry is dependent on dynamin, traffics from early to recycling endosomes 
and is dependent on PI3-kinases for entry and replication. MNV-1 traffics to the recycling 
endosome, possibly from the macropinosome, and is dependent on tyrosine kinases and 
protein phosphatases. We have also begun to investigate the effects of FCV infection on 
the metabolism of host cells using BiOLOG technology. These experiments showed that in 
infected cells there is an overall decrease in metabolism, but an increase in glucose 
uptake. This study has resulted in further elucidation of the early events in infection of both 
of these viruses which could aid in the future development of antiviral therapies.
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Chapter 1 Introduction
1.1 Caliciviruses
The first calicivirus to be described was Vesicular Exanthema of Swine Virus (VESV) 
which caused an epidemic in pigs in 1936. The caliciviruses are so named because of 
the cup-shaped indentations classically found on the surface of the virus (from the Latin 
word calyx meaning goblet; Thiel & Konig, 1999). The viruses within this family are small, 
icosahedral, non-enveloped viruses, with a single-stranded positive-sense RNA genome 
of between -7 .3  -  8 .6 kb in length divided into 2 to 4 open reading frames (ORFs).
Since the first discovery of a calicivirus in 1936, more members of the Caliciviridae family 
have been found and the family divided into five genera (shown in Table 1.1) based on 
their genomic organisation and sequence similarities. These are Lagovirus, Sapovirus, 
Vesivirus (including Feline Calicivirus -  FCV), Norovirus (including the Norwalk Virus -  
NV) and more recently, the Nebovirus genus. As well as these five genera, there are 
several proposed genera including, “Recovirus” (Rhesus Enteric Calicivirus), “Valovirus” 
and chicken caliciviruses (“Bavovirus” and “Nacovirus”), in addition to several 
unclassified caliciviruses (see Section 1.1.5) However, it is viruses within the Norovirus 
and Sapovirus genera which are the primary causative agents of food- and water-borne 
viral gastroenteritis in humans (Green et al., 2001). These infections are not treatable; 
the infected person is merely kept hydrated until the symptoms pass and although 
norovirus is usually a self-limiting disease, it can cause mortality in immuno­
compromised patients (Mattner et al., 2006). The Caliciviridae family includes significant 
human and veterinary pathogens, causing great economic losses to agriculture in 
farming animals as well as to the NHS and businesses in human cases.
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CALICIVIRIDAE TAXONOMY
Genus Species Viruses
Vesivirus
Feline calicivirus Feline calicivirus serotypes
Vesicular exanthema of 
swine virus
Vesicular exanthema of swine virus serotypes, 
bovine calicivirus, cetacean calicivirus, primate 
calicivirus, reptile calicivirus, San Miguel sealion 
virus serotypes
Sapovirus Sapporo virus
Porcine enteric calicivirus, Sapporo virus, 
Houston virus, Manchester virus
Norovirus Norwalk virus
Murine norovirus, Lordsdale norovirus, Norwalk 
virus, Snow Mountain norovirus, Southampton 
norovirus
Lagovirus
European brown hare 
syndrome virus
European brown hare syndrome virus serotypes
Rabbit haemorrhagic 
disease virus
Rabbit haemorrhagic disease virus serotypes
Nebovirus Newbury-1 virus Newbury-1 virus, Nebraska virus
Table 1.1 Taxonomy of the Caliciviridae family (ICTV, 2011; Clarke et al., 2012)
The calicivirus family is comprised of five genera, the most recent being the neboviruses.
1.1.1 Vesiviruses
The Vesivirus genus of the Caliciviridae comprises two species: the founding member of 
the calicivirus family Vesicular exanthema of swine virus (VESV), and Feline calicivirus 
(FCV). The VESV species is made up of many serotypes which infect many different 
animals. These viruses include several serotypes of San Miguel Sea Lion Virus (SMSLV) 
and California Sea Lion Vesivirus as well as bovine, human, skunk, primate, rabbit and 
walrus caliciviruses and several serotypes of VESV. In contrast, FCV is the only serotype 
of the FCV species. Within the Vesivirus genus, there are several unclassified 
vesiviruses: the mink, canine caliciviruses and vesiviruses of unknown origins. 
Importantly, vesiviruses from marine animals have been found to infect humans (Smith et 
al., 1998; Smith et al., 2006), with SMSLV able to infect several animals such as seals, 
swine, rabbits and primates as well as humans, and so is an emerging cause for 
concern. It is suggested that the first source of VESV in the 1930s was when pigs were 
fed SMSLV-infected meat from sea lions (Smith et a!., 1998). Fortunately, VESV can be 
effectively controlled by slaughter of affected animals, and the virus is now considered to 
be extinct (Studdert & Symes, 2008).
1.1.1.1 Feline Calicivirus (FCV)
FCV is a diverse virus species, made up of several antigenic variants or strains 
(reviewed in Radford et al., 2007). FCV is the most widely known member of the 
Vesivirus genus, causing an upper-respiratory infection in cats that is transmitted by 
direct contact (Wardley & Povey, 1977), and also reportedly by fleas (Mencke et al., 
2009). FCV has also been found to survive on fomites for up to 72 h (Clay et al., 2006), 
increasing the likelihood of spread in enclosed areas such as catteries or shelters. 
Symptoms of this infection differ depending on the mode of transmission and the strain of 
virus (Knowles et al., 1990), but include sneezing, conjunctivitis, fever and pneumonia
(Thiel & Kônig, 1999). Although this virus can usually be controlled by vaccination, 
several other strains have recently surfaced which cause a systemic disease, termed 
Virulent Systemic Disease (VSD) and have a mortality rate between 35 & 50% (Schorr- 
Evans et al., 2003; Hurley et al., 2004; Pedersen et al., 2000). These viruses cause more 
severe symptoms, however it appears that these virulent strains of FCV do not 
significantly differ genetically from other FCV strains (Hurley et al., 2004; Foley et al., 
2006). These strains are a cause for concern as they are far more virulent than 
previously circulating FCV strains, and although previously having been isolated to the 
USA, have now also been found in the UK (Coyne et al., 2006). Outbreaks of VSD 
viruses are usually controlled by quarantine and careful biosecurity as the virus is 
extremely contagious. Worryingly, the current FCV-F9 vaccine does not protect cats from 
these strains (Coyne et al., 2006) however, there are new vaccines in development that 
seem to confer better protection against the more virulent strains (Huang et al., 2010; 
Foley et al., 2011).
As human noroviruses cannot be cultured for study in vitro, FCV has long been used as 
a model virus to study norovirus biology.
1.1.2 Lagoviruses
The genus Lagovirus is made up of two viruses; the Rabbit haemorrhagic disease virus 
(RHDV), classified in 1990 (Ohiinger et al., 1990) and the European brown hare 
syndrome virus (EBHSV), first diagnosed in 1980 (Gavier-Widen & Morner, 1991). The 
resultant disease from RHDV and EBHSV is very similar (Fuchs & Weissenbock, 1992); 
however, EBHSV infections result in a lower mortality rate than RHDV.
In 1996, during testing on a nearby island for bio-control use, RHDV was released 
accidentally onto the Australian mainland where it spread rapidly (Kovaliski, 1998). It had 
a dramatic effect on wild rabbit populations, reducing populations by 95% in some areas
(Mutze et al., 1998). More recently, there was a new Lagovirus discovered in several 
apparently healthy Australian rabbits. This virus does not cause clinical infection and has 
been given the proposed name of Rabbit Calicivirus Australia 1 (RCV-A1). It confers 
some protection against RHDV, reducing mortality rates from 90% to 50% (Strive et a!., 
2009). RHDV has also been identified in Canada this year, causing concern over its 
continued spread (Gould, 2012). Likewise, EBHSV has been reported in many European 
countries (reviewed in Mitro & Krauss, 1993), including the UK (Chasey & Duff, 1990; 
Gavier-Widen & Morner, 1991) and is now endemic in Italy (Scicluna et al., 1994) and 
like RHDV, has a high mortality rate (Gavier-Widen, 1994; Fuchs & Weissenbock, 1992).
1.1.3 Noroviruses
The Norovirus genus is made up of only one species, the Norwalk virus which is divided 
into 5 distinct genogroups, GI-GV (Zheng et al., 2006). Of these genogroups, it is Gl, Gil 
and GIV that cause disease in humans, with Gll viruses accounting for most of those 
infections (Siebenga et al., 2009). The Norovirus genus of caliciviruses comprises 
several economically important viruses, including the human pathogen, Norwalk Virus 
(NV) or Human Norovirus (HuNV), also known as the winter vomiting bug. The other 
viruses within this genus have been found in animals and classified as swine viruses in 
Gll, bovine viruses in Gill, canine in GIV and murine forms in GV (Green, 2007). Due to 
the broad host-range of viruses in this genus, noroviruses are of particular interest in 
development of antiviral therapies.
1.1.3.1 Human Noroviruses (HuNV)
The first account of the ‘winter vomiting disease’ in 1929 (Zahorsky, 1929), went on to be
ascribed to the Norwalk virus (NV) following an outbreak of gastroenteritis in Norwalk,
Ohio in 1968 (Adler & ZickI, 1969; Kapikian et al., 1972). Human Noroviruses (HuNV) are
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now known to cause approximately 85% of all non-bacterial outbreaks of gastroenteritis 
(Lopman et al., 2003). Most outbreaks of NV are found in confined spaces, such as 
hospitals, cruise ships or schools where the virus can be passed easily and quickly from 
person to person. Outbreaks also occur more frequently during the winter months 
(Mounts et a!., 2000), as seen in Figure 1.1, when people spend more time in confined 
areas. Infection with NV usually causes a brief (between 24 -  48 h), but acute illness with 
onset of symptoms such as diarrhoea, nausea, abdominal pain and projectile vomiting 
within 24 hours (Dolin et a!., 1971). However, more severe symptoms and even fatalities 
can occur if the patient is immunocompromised or elderly, with the elderly also being 
more susceptible to infection (Gerba et a!., 1996). A study in 2008 showed that up to 80 
deaths among elderly people in England and Wales each year can be attributed to 
infection with NV (Harris et a!., 2008).
NV is highly infectious, with an infectious dose as low as 18 virus particles (Teunis et a!., 
2008). The virus has been found to survive on surfaces for period from a few days to 
over a week (Cheesbrough et a!., 1997) and on refrigerated marinated mussels for up to 
4 weeks (Hewitt & Greening, 2004). It has also been found that cleaning surfaces 
contaminated with norovirus with a detergent or low levels of chlorine did not remove the 
virus (Barker et a!., 2004), nor did repeated vacuuming (Cheesbrough et a!., 1997). 
Added together, it is apparent how this virus can be very easily spread and cause 
disease, in fact it is estimated that there are 650 000 cases per year (Adak et a!., 2002), 
although it is suggested that many more cases occur than are reported (Wheeler et a!., 
1999). All these infections cost the NHS approximately £100 million per year (Lopman et 
a!., 2003).
For most of the population, infection with norovirus only confers protection from further 
infection for approximately 2-3 months (Matsui & Greenberg, 2000). However, it has 
been known for many years that some people have a level of protection against infection 
with norovirus (Parrino et a!., 1977), although the basis for that immunity was not
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Figure 1.1 Graph showing comparisons of seasonal laboratory reports of norovirus in England 
and Wales (from HPA, 2012)
Shown here is the norovirus season as designated by the HPA; starting in July (week 27) and 
running until June (week 26 of the following year). Laboratory reports of norovirus infection for 
each week of the year from 2005 to 2012 show the typical seasonal peakduring the winter 
months.
understood. In recent studies on susceptibility of contracting norovirus, it has been found 
that the histo-blcod group antigens (Tan & Jiang, 2005), particularly secretcr status 
(controlled by the fucosyltransferase 2 gene) play a key role. It is suggested that people 
who are ‘nonsecretors’ are protected from infection with Norwalk virus (GI.1) (Lindesmith 
et al., 2003; Hutson et al., 2005). Although this virus causes such great economic losses 
in hospital ward closures and sick days, study of this virus has been hampered by a lack 
of an efficient tissue culture system (Duizer et al., 2004). The most common models used 
to study norovirus biology are FCV (Section 1.1.1.1) and murine norovirus (MNV, 
Section 1.1.3.2)
1.1.3.2 Murine Norovirus 1 (MNV-1)
The murine form of norovirus, murine norovirus (MNV) was first discovered in laboratory 
mice in 2003 (Karst et al., 2003) and since then has been found in over 20% of 
laboratory mice in the USA (Wobus et al., 2006). Although MNV is able to infect healthy 
mice (Thackray et al., 2007) it doesn’t result in disease. This is in contrast to STAT1 
(signal transducer and activator of transcription-1 ) deficient mice lacking innate immunity, 
where infection with MNV is lethal (Karst et al., 2003; Hsu et al., 2006). MNV is an 
enteric pathogen, and like NV, infects its host via the faecal-oral route, replicating in the 
small intestine (Mumphrey et al., 2007). There are now 15 known MNV strains (Karst et 
al., 2003, Thackray et al., 2007) which are highly diverse in their ability to replicate in 
culture. Along with MNV-Ts tropism for dendritic cells and macrophages in vitro as well 
as in vivo (Wobus et al., 2004; Ward et al., 2006) it can also be cultured in microglial 
cells (Cox et al., 2009) and a small animal model is also available (Karst et al., 2003). 
With the discovery of MNV-1 and the ability to culture it using various methods, came an 
additional and improved model for studying calicivirus biology from what was previously 
available.
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1.1.4 Sapoviruses
Like the noroviruses, the Sapovirus genus contains only one species, Sapporo virus 
(SaV). However, there are several reports indicating that both the detection rates are 
lower and the symptoms of this infection milder than NV (Wolfaardt et a/., 1997; Pang et 
a/., 2000; Sakai at a/., 2001). The sapovirus genus can be divided into 5 genogroups (Gl- 
V); Gl, II, IV & V all infect humans while Gill infects pigs (Farkas et al., 2004). This virus 
was named after the first town it was discovered in, Sapporo, Japan in 1977 (Chiba et 
al., 1979). After its discovery in 1977, SaV was identified in many places around the 
world (Noel et al., 1997; Wolfaardt et al., 1997) including the UK (Liu et al., 1995) and 
has now been shown to have a worldwide distribution (Nakata et al., 1996). There has 
also been an increase in cases in Australia over the last few years (Hansman et al., 
2006). These viruses are mainly connected with relatively mild gastroenteritis in infants 
and young children, often associated with day-care centres. However, there have been 
outbreaks of SaV involving adults; in the USA in 1997 (Noel et al., 1997) and more 
recently in 2005 in a hospital in Sweden which affected 23 adults and medical workers, 
causing a range of symptoms including nausea, vomiting and diarrhoea. (Hugo 
Johansson et al., 2005).
1.1.5 Newer genera of the Caliciviridae
Nebovirus is the most recent genus of the Caliciviridae family, ratified as a member in 
2009 (Carstens, 2010, ICTV 2011). To date, all viruses to be included in this genus are 
bovine enteric viruses. These viruses include several strains of the species Newbury-1 
virus (Oliver et al., 2006) such as the Nebraska virus strain (Smiley et al., 2002).
There are three genera proposed to be included in the calicivirus family; the first is 
Recovirus (Rhesus enteric calicivirus). The first virus to be classified in this genus was 
the Tulane virus. Although originally found in rhesus macaques (Farkas et al., 2008), the
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Tulane virus has been found to possibly infect humans (Farkas et al., 2010), as high 
levels of antibodies have been found in blood samples of animal wardens. More recently, 
another virus isolated from patients in Bangladesh suffering from diarrhoea (called 
Bangladesh/289/2007) was also classified as a Recovirus (Smits at a!., 2012), 
highlighting the viruses within this proposed genus as possible threats to human health. 
Another proposed genus is the Valovirus genus -  the prototype viruses in this genus are 
the porcine St-Valérien-like viruses (L'Homme at a/., 2009; Di Martino at a!., 2012). 
Although closely related to the Tulane virus, it is argued that they differ significantly 
enough to be classified in their own genus.
The final genera to be recently proposed are found to infect poultry. Although there have 
previously been calicivirus-like particles found in chicken faecal materials (Wyeth at a!., 
1981; Cubitt & Barrett, 1985), until recently there was insufficient information to further 
classify the viruses. Recent reports have provided the first detection of chicken 
caliciviruses (Wolf at a/., 2011; Wolf at a/., 2012). Although these viruses may cause an 
asymptomatic infection in chickens, the authors argue that there is enough evidence to 
classify them in novel genera, namely “Bavovirus” and “Nacovirus”.
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1.2 Calicivirus morphology
The classic appearance of cup-shaped indentations on the surface of the caliciviruses 
viewed by electron microscopy is what earned them their name, from the Latin word 
calyx (cup or goblet) (Green et al., 2000). However, not all the viruses within this family 
display this distinctive appearance (Granzow et al., 1996). These non-enveloped viruses 
are ~25-40nm in diameter (Cubitt & Barrett, 1985), with 90 dimers of the major structural 
protein, VP1 arranged in an icosahedral T=3 pattern which forms the capsid (Prasad et 
al., 1994a; Prasad et al., 1994b). The VP1 protein is made up of three domains, the NTA 
(N-terminal arm), S (shell) and P (protrusion) domains (Prasad et al., 1994b; Prasad et 
al., 1999). The S domain creates a contiguous shell surrounding the genome, with a 
flexible hinge connecting it to the P domains which protrude from it and form the 
indentations which are characteristic of this family of viruses. The P domain is divided 
into two subdomains, the stem PI & the head P2, with P2 involved in most of the cellular 
interactions and immune recognition due to it being extended above the viral surface 
(Prasad et al., 1999; Taube et al., 2010). More recently, the three-dimensional structures 
of several caliciviruses have been elucidated (see Figure 1.2), including FCV (Bhella et 
al., 2008), MNV (Katpally et al., 2008) as well as the VLP (virus-like particle) of RHDV 
(Katpally et al., 2010).
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A B
Figure 1.2 Representation of the structure of FCV and MNV-1 by cryo-electron microscopy
(from Katpally et al., 2008 and Bhella et al., 2008)
(A) shows the structure of FCV; (B) shows MNV-1. The cup-shaped indentations characteristic of 
caliciviruses are visible, as the dark pink in A and green in B.
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1.3 Genomic structure of caliciviruses
The Caliciviridae family is made up of several genetically diverse genera, but are 
essentially assigned to the family based on several of the following properties. 
Caliciviruses possess positive-sense, single-stranded RNA genomes between 7.3-8.6 kb 
in length which have a short untranslated region (UTR) at the 5’ end, and are poly- 
adenylated at the 3’ end (Burroughs & Brown, 1978; Carter et al., 1992a; Farkas et al., 
2008). Covalently linked at the 5’ end of the genome, there is a 10-15 kDa protein, called 
VPg (Viral Protein genome-linked) which is believed to play a crucial role in translation 
initiation on calicivirus RNAs (Goodfellow et al., 2005). All genera make a subgenomic 
RNA transcript during replication which is also linked to VPg at the 5’ end (Meyers et al., 
1991; Herbert et al., 1996). The subgenomic RNA is co-terminal with the 3’ end of the 
genomic RNA and encodes the structural proteins (the major and minor capsid proteins; 
Neill & Mengeling, 1988). Abundant amounts of the 2.4 kb subgenomic RNA is produced, 
in addition to the 7.3.-8.6 kb genomic RNA during replication of the virus (Neill & 
Mengeling, 1988). During FCV infection the subgenomic RNA is found packaged into 
viral particles (Neill, 2002). Evidence of subgenomic RNA in NVs has also been found 
after a 2.3kb RNA molecule was recovered from an infected human volunteer (Jiang et 
al., 1993). This subgenomic RNA is a chief differentiating factor between caliciviruses 
and Picornavirales (the closest relatives of caliciviruses; Ehresmann & Schaffer, 1977).
Within the calicivirus family, there are two different clusters of genomic 
organisation based on the structure of their ORFs. The genomes of the lagoviruses, 
sapoviruses and neboviruses are made up of two ORFs, 0RF1 encoding both the non- 
structural proteins and the major structural proteins as one large polyprotein. In contrast, 
vesivirus and norovirus genera are made up of three or four ORFs, respectively, and 
have their non-structural proteins and structural capsid proteins encoded separately on 
ORFs 1 & 2, respectively (Green et al., 2000; Clarke et al., 2012). In some of the viruses
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in this family, the 3’ end of 0RF1 overlaps with the 5’ end of 0RF2, the overlap varying 
among different strains. In contrast, the genome of other caliciviruses include "spacer" 
sequences between ORFs 1&2, such as the canine calicivirus which has a spacer of 3 
nucleotides (nt; Martella et al., 2008) unlike the overlap seen in FCV (Sosnovtsev et al., 
2002). Generally, non-structural proteins are encoded at the 5’ end, and the structural 
proteins at the 3’ end of the genome. The genomes of FCV, MNV and NV, among others, 
have been sequenced (Carter et al., 1992a; Jiang et al., 1993; Karst et al., 2003).
1.3.1 FCV genom e
The genome of FCV is ~7.7kb long (Carter et al., 1992b), with a VPg protein covalently 
linked at the 5’ end (Burroughs & Brown, 1978). The three ORFs contained in the 
genome encode proteins necessary for virus replication; 0RF1 (from nt 20 to 5314 on 
the genomic RNA), encodes a large non-structural polyprotein, made up of a protease, a 
helicase and a polymerase (Neill, 1990). This polyprotein is cleaved to produce individual 
proteins by a virus-encoded cysteine protease (Carter, 1989; Sosnovtseva et al., 1999). 
ORF2 and 0RF3 are encoded by the subgenomic RNA which is linked to VPg at the 5’ 
end (Herbert et al., 1997), although 0RF2 is in fact in the same reading frame as 0RF1, 
not ORF3 (Simmonds et al., 2008). 0RF2 runs from nt 5314 to 7317 at the 5’ end of the 
subgenomic RNA overlapping with 0RF1, resulting in a backward frameshift (-1) with 
regard to ORF1. 0RF2 encodes the virus capsid protein precursor which is cleaved by 
an ORF1-encoded proteinase (Carter et al., 1992b; Sosnovtsev et al., 1998) to form a 60 
kDa mature capsid protein (virion protein 1: VP1) and the 14.3 kDa capsid leader (LC). 
0RF3 (from nt 7317 to 7634, at the 3’ end of the subgenomic RNA) encodes a minor 
structural protein called VP2 (virion protein 2; Sosnovtsev & Green, 2000) which is 
essential for productive infection of the virus, in generating infectious virions (Sosnovtsev 
et al., 2005). The genome structure is shown compared with MNV’s in Figure 1.3
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1.3.2 MNV-1 genom e
The genome of MNV-1 (as compared to the FCV genome in Figure 1.3) is 7.3kb in 
length and split into 4 ORFs. Like FCV, on the 5’ end of the genome is a VPg protein 
(Green et al., 2001) which is essential for translation initiation (Daughenbaugh et a!., 
2006), while the 3’ end is polyadenlyated (Karst et a/., 2003). ORF 1, similarly to FCV, 
encodes a large (187.5 kDa) non-structural polyprotein that is cleaved by the 3C-like 
protease into several non-structural proteins including NTPase, VPg, Protease and 
Polymerase proteins (Blakeney et a!., 2003; Sosnovtsev et a/., 2006). ORFs 2&3, on the 
subgenomic RNA, encode structural proteins and, as in FCV, there is an overlap of 
0RF1 with 0RF2 which varies according to the genogroup of the virus (Simmonds et a/.,
2008). 0RF2 expresses the major capsid protein, VP1 which is made up of the S and P 
domains, with the S domain being more highly conserved than the P domain. The 58.9 
kDa VP1 is able to self-assemble into virus-like particles (VLPs) when expressed in a 
recombinant baculovirus expression system (Karst et ai., 2003). 0RF3, found at the 3’ 
end of the genome, encodes a small (22.1k Da) basic protein, or VP2 (Sosnovtsev et a/.,
2006) which has been shown to play a role in virion stability in Norwalk viruses (Glass et 
a/., 2000) and may show a similar activity in MNV. The role of the protein encoded on the 
newly-discovered fourth ORF was recently shown to be a virulence factor (VF1) which is 
required to delay apoptosis of the infected cells (Thackray et a/., 2007; McFadden et a!., 
2011). While 0RF1 and 0RF3 are in the same reading frame, 0RF2 is in a different 
reading frame (Wobus et a!., 2006), and 0RF4 in a further reading frame (Thackray et 
ai., 2007).
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1.4 Calicivirus ceil attachment
The first stage in the multi-step process of virus cell entry and infection is binding of the 
virus to the cell. For this to occur, the virus must bind to an attachment factor or receptor 
on the cell surface, which differs for each virus and cell type. Some viruses can use two 
or more receptors, such as HIV (Human Immunodeficiency Virus) which uses CD4 
(cluster of differentiation) and a co-receptor CCR5 (C-C chemokine receptor type 5) to 
enter cells (Berger et a!., 1999; Steffens & Hope, 2004). Some studies into the 
attachment factors for caliciviruses have been carried out, including the rabbit vesivirus, 
which attaches to the annexin A2 to enter HEK293T cells (Gonzalez-Reyes et al., 2009) 
and bovine noroviruses which make use of sialic acids and galactosyl residues (Mauroy 
et al., 2011). Due to the importance of human noroviruses, the receptors they make use 
of have also been thoroughly investigated. They have been found to be able to make use 
of several receptors; histo-blood group antigens (Tan & Jiang, 2005), heparan sulphate 
(Tamura et al., 2004) and sialyl-Lewis x (Rydell et al., 2009).
1.4.1 FCV receptor
The receptor for FCV was identified in 2006 as JAM-A (Junctional Adhesion Molecule A,
previously known as JAM-1; Makino et al., 2006), which interacts with the top portion of
the P2 domain of the viral capsid (Ossiboff et al., 2010). The function of JAM-A in
regulating cell to cell interactions and the creation of apical tight junctions is important in
the normal functioning of the immune system, as reviewed in Ebnet et al. (2004). It is
part of a super-family of immunoglobulin-like proteins which are expressed on many cell
types, including endothelial cells, epithelial cells and red blood cells amongst others
(Mandell & Parkos, 2005). Due to this, and the fact that FCV was also shown to be able
to bind to the JAM-A receptor in both permissive cells lines (CRFK cells) as well as in
non-permissive cell lines (Vero, HmLu-1 and 293T cells) that had been transfected with a
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JAM-A expressing plasmid; it was suggested that there must be another factor 
influencing the tropism of FCV for cells of the respiratory tract. It was more recently found 
that FCV can also bind to o2,6-linked sialic acid for entry (Stuart & Brown, 2007). Sialic 
acids are a family of negatively charged sugar molecules found on mammalian cell 
surfaces and have a role in cell to cell interactions (Rosenberg, 1995). They are typically 
attached to glycolipids, glycoproteins and proteoglycans, usually linked at the termini of 
glycans by a2,3 or o2,6 bonds. In human tissues, a study into the location of sialic acids 
found that a2,6-sialic acid is predominantly found expressed on cells in the lungs while 
different sialic acids are found in other tissues in the body (Kitagawa & Paulson, 1994). 
There could be a similar localisation of receptors in feline respiratory cells, explaining 
FCV’s tropism for infection, which is primarily in respiratory cells. Many other viruses use 
sialic acids for binding to host cells, such as arteriviruses (Van Breedam et al., 2010) and 
picornaviruses (enterovirus 70; Alexander & Dimock, 2002) although many also make 
use of other receptors for internalisation. Influenza virus is able to use a2,3-linked sialic 
acid for binding to avian cells as these are expressed in the intestinal tract, while in 
humans Influenza virus binds to o2,6-linked sialic acids found in the respiratory tract 
(Matrosovich et al., 2004) highlighting the importance of adaptation to host cells and 
explaining cell tropism by these viruses.
1.4.2 MNV-1 receptor
Attachment of MNV-1 to cells is facilitated by the P domain of the MNV-1 capsid 
(Katpally et al., 2008; Katpally et al., 2010; Taube et al., 2010). The attachment factor for 
three strains of MNV (MNV-1, WU11, S99) has been found to be the terminal sialic acid 
residues of gangioside molecules (Taube et al., 2009). Of the three types of gangliosides 
tested (GM1, GA1 and GDI a), it was found that all three strains of MNV tested could 
bind efficiently to GDI a. This is thought to be due to the fact that the other gangliosides
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tested (GM1 and GA1) do not possess a terminal sialic acid. Unlike FCV which binds 
only to the 2,6-linked sialic acids, MNV-1 can bind to both o2,3 and o2,6-linked sialic 
acids. A recent investigation into MNV binding to cells found that MNV strains have 
developed several approaches to bind to cells by binding to different glycan receptors 
which possibly contributes to tissue tropism in vivo (Taube et a!., 2012). The ability of the 
virus to bind to different sialic moieties could be an adaptation to bind to the receptor 
displayed in the specific tissue the virus is infecting.
1.5 Calicivirus replication
Viruses are obligate intracellular parasites, meaning they need to be within a living cell to 
replicate and cause infection. After entry into the cell (reviewed in Section 1.2), 
caliciviruses escape into the cytoplasm by an unknown mechanism, following which the 
RNA is translated to produce the non-structural proteins. The positive sense RNA 
genome is then transcribed to produce a full-length reverse complement of the RNA, 
using the RdRp (RNA dependent RNA polymerase) which is encoded in the genome and 
translated from the genome upon cell entry (Clarke & Lambden, 1997). This negative- 
sense strand now acts as a template for synthesising a full-length genomic RNA, 
producing both structural and non-structural proteins.
Typical of positive strand RNA viruses, replication of FCV occurs in the cytoplasm of 
infected cells, particularly on the surfaces of membranous vesicles (Schaad et a!., 1997; 
Green et a/., 2002; Wobus et a/., 2004). Infected cells produce numerous intracellular 
vesicles, which leads to the cell undergoing substantial membrane rearrangements 
(Green et a/., 2002). As the course of infection continues, infected cells become rounded 
in appearance after about 5 - 8  hours, as well as nuclear condensation beginning to be 
observed after 5 hours. Nearing the end of infection ( 8 - 1 4  hours), the rounded cells 
were observed to detach and undergo apoptosis (Sosnovtsev et a/., 2003) through
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activation of caspases, which could result in an increase in viral particles being released 
from the cell (Al-Molawi et al., 2003; Natoni et al., 2006).
As with FCV, the replication of MNV-1 occurs in the cytoplasm, in close proximity to 
intracellular membranes, and has been observed after 12 hours inside or alongside a 
single- or double- membraned vesicles. These vesicles increased in size over time with 
many virus-containing vesicles filling the cell, shifting the nucleus and causing 
widespread reorganisation of intracellular membranes, rearrangement of the 
endoplasmic reticulum (ER) and disruption of the Golgi (Wobus et al., 2004; Wobus et 
al., 2006).
1.6 Calicivirus non-structural proteins (ORF1)
The calicivirus 0RF1 encodes the large non-structural polyprotein (-180-250 kDa) which 
is proteolytically cleaved to produce the viral non-structural proteins (between -13  and 
96 kDa; Sosnovtsev et al., 2002). Proteins encoded in calicivirus genomes are named 
2C- or 3C- “like” due to their sequence homology to picornavirus proteins which are 
named 2C or 3C (Sosnovtseva et al., 1999). These non-structural proteins are: the 2C- 
like NTPase, the VPg, the 3C-like Protease and the 3D RNA-dependent RNA 
polymerase. The 3C-like protease encoded in this ORF mediates the autocatalytic 
cleavage and processing of the large polyprotein at the cleavage sites which are marked 
by either E or Q residues at the PI position (Sosnovtseva et al., 1999). Cleavage of the 
polyprotein at five cleavage sites produces six mature proteins, with this step being 
critical for FCV replication (Sosnovtsev et al., 2002).
The order of encoded proteins in the FCV 0RF1 (from the N-terminus) is as follows: p5.6 
// p32 // NTPase (p39) // p30 // VPg (p i3) // Protease -  Pol (p76). As with the FCV 
genome, similar cleavage occurs in the MNV-1 genome to produce six mature proteins,
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ordered (from the N-terminus) as follows: p38.3 // NTPase (p39.6) // p18 // VPg (p14.3) // 
Pro (p19.2) // Pol (p57.5). (Sosnovtsev et al., 2002; Sosnovtsev et al., 2006; McFadden 
et al., 2011; and illustrated in Figure 1.3)
1.6.1 2C-like NTPase
The 2C-like NTPase section of 0RF1 encodes the 2C-like protein with an NTP-binding 
domain, the 2C protein sharing substantial homology with the picornaviral 2C protein 
(Neill, 1990; Clarke & Lambden, 1997). The role of this protein is still unclear, however it 
is proposed to be involved in replication as it is conserved through all caliciviruses and is 
believed to play a role in formation of viral membrane-bound replication complexes, 
(Meyers et al., 2000; Kaiser et al., 2006).
1.6.2 VPg
Many positive-stranded RNA viruses are known to possess a genome linked protein 
(VPg) at the 5’ end of the genome, such as picornaviruses and potyviruses (Wimmer, 
1982). The presence of a VPg is a characteristic shared by caliciviruses, where both the 
genomic and subgenomic RNAs are VPg-linked, the 10-15 kDa VPg being encoded in 
0RF1 (Clarke & Lambden, 2000; Sosnovtsev et al., 2002). In the RHDV genome, the 
covalent link between VPg and the viral RNA was proposed to be a tyrosine residue; this 
residue has since been found to be conserved in most caliciviruses (Machin et al., 2001). 
When this amino acid was mutated in the FCV genome, the effect on growth and 
replication of the virus proved to be lethal, proving the importance of this link between the 
VPg and the RNA (Mitra et al., 2004).
In eukaryotic cells, initiation of translation is controlled by a cap-dependent mechanism. 
However, in some viruses, a cap-independent mechanism is employed for translation
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initiation. In caliciviruses, the VPg acts as a ‘cap-substitute’. It was first shown that FCV 
required VPg for translation of its RNA into protein (Herbert et al., 1997). Since then, it 
has been shown for FCV that VPg interacts with the cap-binding protein, elF4E 
(eukaryotic Initiation Factor 4E), essential for translation initiation (Goodfellow et al., 
2005; Chaudhry et al., 2006). MNV-1 shows a similar requirement for functional VPg, 
revealed by the binding of VPg to elF3, elF4GI and elF4E, as well as ribosomal proteins 
involved in translation initiation (Chaudhry et al., 2006; Daughenbaugh et al., 2006). As 
well as FCV and MNV-1, the VPg of NV has been shown to interact with elF3 in vitro and 
in mammalian cell lysates (Daughenbaugh et al., 2003). Clearly, from the conservation of 
VPg across the genera of Caliviriridae the function of VPg as a ‘cap-substitute’ for 
recruitment of initiation factors and in viral protein synthesis in a cap-independent 
method is vital for the replication of these viruses.
1.6.3 3C-like Protease
The presence of the calicivirus 3C-like cysteine protease (3Cpro) was first predicted by 
nucleotide sequence analysis of FCV (Neill, 1990). The coding region is located 
immediately upstream of the RdRp at the 3’ end of 0RF1. As shown in RHDV, 3Cpro is 
responsible for cleavage and processing of the calicivirus polyprotein into mature non- 
structural proteins, as well as cleavage of the capsid protein precursor (Boniotti et al., 
1994; Sosnovtseva et al., 1999). In FCV, 3Cpro forms a stable complex with RdRp of 76 
kDa, and this complex was shown to cleave the amino terminus of 0RF1 at five different 
cleavage sites (Sosnovtseva et al., 1999). As well as its role in polyprotein cleavage, 
3Cpro has been reported to be involved in the inhibition of translation of cellular mRNAs 
(messenger RNAs) during calicivirus infection. The 3Cpro has been observed to cleave 
and inactivate the RNA-binding protein, PABP (Poly (A)-binding protein). The 3Cpro of 
FCV is able to cleave both feline and human PABP by removing the C-terminal domain
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of PABP (Kuyumcu-Martinez et al., 2004). The human PABP C-terminal domain 
cleavage site of FCV 3Cpro is not commonly used by other proteases, such as poliovirus 
3C. When investigating the structure of the protease, it was found that four amino acids 
are vital for 3Cpro activity, histidine-39, glutamic acid-60, cysteine-112 and histidine-137. 
This is thought to be due to the positioning of these residues which are found close to the 
inner surface of the potential binding cleft for the 3Cpro substrate (Oka et al., 2007).
1.6.4 RNA-dependent RNA polym erase
The C-terminal protein encoded in 0RF1 is the 3D RdRp which is responsible for 
replication of the calicivirus genomic material, efficiently synthesising RNA from the RNA 
template (Neill, 1990; Vazquez et al., 1998). In FCV, the active form of RdRp is observed 
as a bi-functional protease-polymerase precursor, which does not need to be cleaved 
into two domains for polymerase activity. This 76 kDa precursor protein is accumulated 
to high levels in FCV infected cells in vitro (Wei et al., 2001), as in RHDV infected 
hepatocytes (Konig et al., 1998). In norovirus infection, two active forms of the 
polymerase have been observed in infected cells, the Pro-Pol polyprotein precursor and 
the fully active and cleaved polymerase. As with FCV, the Pro-Pol polyprotein is also 
thought to be bi-functional in acting as both protease and polymerase (Belliot et al., 
2005). Recent investigations into the 3Dpol-mediated RNA synthesis of sapovirus 
showed that it is similar to that of NV, but dissimilar to lagoviruses. This similarity 
between the RdRps of human pathogenic caliciviruses compared with that of the non- 
pathogenic lagoviruses could give an indication of the importance of RdRps in virulence 
and pathogenicity (Fullerton et al., 2007; Zamyatkin et al., 2008).
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1.7 Calicivirus structural proteins (0RF2 & 3)
Calicivirus structural proteins are encoded in ORF 2 and 0RF3 of the RNA genome from 
the bicistronic subgenomic RNA. This is where the differences in genome arrangement 
are found between the genera, as mentioned in Section 1.1.7, In lagoviruses, 
sapoviruses and the new genus, neboviruses, the capsid protein, which is the major 
structural protein, is part of the large polyprotein encoded by 0RF1 and is in the same 
frame as the non-structural protein coding region. For these viruses, the capsid protein is 
matured then released by proteolytic cleavage of 0RF1 by the viral protease (Wirblich et 
al., 1995; Clarke et al., 2012). The norovirus and vesivirus genome organisation differs 
slightly in that 0RF2 is in a different reading frame with respect to 0RF1. This is 
overcome by the use of the bicistronic subgenomic RNA (encoding both 0RF2 and 
0RF3) and TURBS (termination upstream ribosomal binding site) which ensure 
reinitiation of translation and adequate production of the capsid protein (Carter et al., 
1992a; Meyers, 2007; Poyry et al., 2007).
0RF3 is a small open reading frame sited at the 3’ end of the genomic and subgenomic 
RNA, encoding virion protein 2 (VP2), the minor structural protein (Sosnovtsev et al.,
2005). This reading frame is frame-shifted with respect to 0RF2 (Clarke & Lambden, 
2000) and it is due to this frame-shift that the levels of VP2 expressed in infected cells is 
-10%  of the level o fV P I (Herbert et a i, 1996; Belliot et a i, 2005).
1.7.1 FCV capsid protein
0RF2 of the FCV genome encodes the capsid protein VP1 (virion protein 1), the
precursor of which was first detected by Carter et al (Carter et a i, 1992a). The capsid
protein precursor is post-translationally cleaved by the 3Cpro from a 76 kDa precursor
into a 62 kDa mature capsid protein (VP1 ; Carter et a i, 1992b; Sosnovtsev et a i, 1998).
Maturation takes place by the removal of a 14 kDa fragment from the 5’ end of the capsid
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protein (called the leader capsid) which can be readily detected in FCV-infected cells, but 
not in mature FCV virions (Tohya et al., 1999; Chang et al., 2008). The FCV VP1 can 
also be cleaved later in infection, mediated by caspases-2 and -6, when a fragment of 40 
kDa is produced (Carter, 1989; Al-Molawi et al., 2003). The role of caspases in this event 
is unclear, but it is suggested that the virus-induced apoptosis could play a role in 
productive FCV infection, possibly for the release of virions from the cell (Natoni et al.,
2006).
1.7.2 Norovirus capsid protein
The first identification of the 58 kDa norovirus capsid protein was in 1981, when it was 
isolated and identified from a stool sample of a volunteer with norovirus (Greenberg et 
al., 1981). The ORF2-encoded VP1 can self-assemble into VLPs which are 
morphologically and antigenically identical to the native NV or MNV-1 capsid protein, and 
is similar to other calicivirus VLPs which are also expressed in baculovirus expression 
systems. Due to the strong virus-specific serum antibody response elicited by these 
particles, they could be valuable tools in the development of a norovirus vaccine (Jiang 
et al., 1992; Clarke & Lambden, 1997; Wobus et al., 2006). It has been shown that a 
single amino acid substitution in the MNV-1 capsid is enough to decrease viral infectivity 
(Bailey et al., 2008).
1.7.2 M inor structural protein (VP-2)
To date, all members of the Caliciviridae family have been found to possess a small 3' 
terminal ORF which encodes a small basic protein called VP2, with one of two copies 
found in each mature virion (Sosnovtsev & Green, 2000). In lagoviruses, sapoviruses 
and neboviruses, VP2 is produced from 0RF2, whereas in vesiviruses and noroviruses,
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it is expressed from 0RF3 (Clarke & Lambden, 2000; Clarke et al., 2012). The size of 
VP2 differs between the genera, but ranges from between 8.5 and 23 kDa, with the 
sequence being highly homologous between the strains of each virus, such as in FCV 
and NV (Herbert et al., 1996; Glass et al., 2003). The exact role of VP2 is not yet clear, 
however, there are several suggestions regarding its interactions with VP1 (in NV; Glass 
et al., 2003) or with the ProPol (for FCV; Kaiser et al., 2006). Although it has an uncertain 
role, deletion of 0RF3 was lethal for FCV, and although the replication machinery could 
tolerate 3’ deletions and point mutations in 0RF3, the viruses produced were not 
infectious. This led to the theory that although 0RF3 is not necessary for formation of 
VLPs, it is required for viability of the virus, and so could play a role in virus replication 
(Sosnovtsev et al., 2005).
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1.8 Endocytosis
For cells to survive there needs to be an efficient transport system of necessary 
extracellular substances into the cell, and unnecessary intracellular substances out of the 
cell. The process whereby different extracellular particles enter the cell is termed 
endocytosis, which also enables the cell to connect to the extracellular environment via 
signalling. Endocytosis generally occurs by invagination of the plasma membrane (or 
protrusions) followed by the trafficking of that particle to its destination within the cell. 
Once within the cell, the pathways that these particles use are called endocytic 
pathways. There are many endocytic pathways that are used to enter a cell which 
depend on the size of the particle to be taken up, and the final destination within the cell. 
Although endocytosis is normally used for internalisation of substances necessary for cell 
survival, viruses and other pathogens have developed many ways of subverting these 
entry pathways to gain entry into cells and cause disease. To date, there have been 
numerous endocytic pathways found, and there are pathways being constantly 
discovered (such as the undefined pathway used by Human Papillomavirus 16 (HPV16; 
Schelhaas et al., 2012) and re-classified (as reviewed in Doherty & McMahon, 2009 and 
shown in Figure 1.4). As well as these new pathways, there are growing incidences of 
viruses being able to use adaptations of characterised. To add a further level of 
complexity, many viruses, including herpes simplex virus (HSV; Nicola et al., 2003) and 
equine herpesvirus-1 (Hasebe et al., 2009) are able to use different entry pathways in 
different cell types. It is these many pathways that are studied, in the hope that if we can 
discover how pathogens are entering cells, we can prevent this step. However, in the 
study of the entry mechanisms of these pathogens, much of what is now known about 
endocytosis has been elucidated. This has aided in constantly increasing our knowledge 
of the complex cell biology involved in cellular endocytosis.
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1.8.1 C lathrin-m ediated endocytosis
The best characterised pathway and one of the most commonly used for cellular cargo is 
the clathrin-mediated pathway (reviewed in Marsh & Helenius, 2006). This quick and 
efficient method of internalisation is commonly used by the cell for many cargoes, 
particularly for smaller particles (Marsh & Helenius, 1989) and can internalise a particle 
in 60 s (Merrifield et al., 2002; Taylor et a!., 2011). Clathrin-coated vesicle formation can 
be broken down into five steps following particle binding; initiation, cargo selection, 
assembly of the coat, vesicle scission and uncoating (McMahon & Boucrot, 2011). There 
are many proteins involved in this process (as shown in Figure 1.6), but the participation 
of some is variable. However the crucial component is clathrin which coats the pit, acting 
as a scaffold (Brodsky, 1988). When a particle binds to its cellular receptor, a pit is 
formed beneath it -  this action induces trans-membrane signalling which promotes 
uptake. This pit formation has been very recently re-characterised by recent studies in 
mammalian cells and yeast, with the indication now being that a putative ‘nucléation 
module’ is formed on the plasma membrane and it is this that marks out where the pit will 
form (Stimpson et a!., 2009; Henne et a!., 2010). This module is made up of several 
proteins, including FCHo (Fer/Cip4 homology domain-only) proteins, epsIS (EGFR 
(Epidermal growth factor) pathway substrate clone-15) proteins which act as scaffolding 
for AP2, (adaptor protein 2) and intersectins which also act as scaffolding. All of these 
proteins are thought to be necessary for clathrin-coated pit formation by commencing 
membrane curvature before clathrin is recruited (Reider et a!., 2009; Stimpson et a/., 
2009; Henne et a/., 2010). It is proposed that these proteins then bring in AP2 which is 
the second-most abundant protein involved in this pathway after clathrin (Blondeau et a/.,
2004) and works jointly with other cargo-specific adaptor proteins to mediate cargo 
selection. AP2 binds to both the cargo and the accessory adaptor proteins and as such is 
the core adaptor protein (Schmid et a/., 2006). In fact it has been found that without AP2,
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the nucléation module is still formed, but clathrin is not recruited and therefore the vesicle
is not formed (Motley et al., 2003). Following the selected cargo being bound either by
AP2 or one of the many cargo-specific adaptor proteins, clathrin-coat assembly begins.
AP2 and accessory proteins such as AP180 recruit clathrin triskelia from the cytoplasm
to the plasma membrane where polymerisation of clathrin stabilises the curvature of the
structure (Reider & Wendland, 2011). At this point, other cargo accessory adaptor
proteins and curvature effectors such as epsin, 1(3-arrestin and eps15 are drawn to the
rim of the forming vesicle (Tebar et al., 1996; Saffarian et al., 2009), and it is this direct
interaction between the curvature effectors and the membrane that is thought to sculpt
the vesicle (McMahon & Boucrot, 2011). The clathrin triskelia form a structure
surrounding the pit which led early investigators to describe them as a “vesicle in a
basket” (Kanaseki & Kadota, 1969). For the budding clathrin-coated vesicle to be
detached from the membrane, the mechanochemical enzyme dynamin (Sweitzer &
Hinshaw, 1998) is recruited to the neck by proteins such as sorting nexin-9 (SNX9) or
amphiphysin (Ferguson et al., 2009). Dynamin proteins self-assemble into rings or
‘collars’ around the neck of the vesicle and following GTP hydrolysis, constrict to
separate the vesicle from the cell membrane, forming vesicles of between 80-120nm in
diameter (Bashkirov et al., 2008). Following detachment from the cell membrane, auxillin
binds to the clathrin triskelia and recruits HSC70 (heat shock cognate 70) to the vesicle
to trigger the uncoating of the clathrin cages (reviewed in Taylor et al., 2011). This
releases the clathrin machinery back into the cytoplasm to await recruitment for the next
coated pit formation, and allows the uncoated vesicle to travel to its target endosome and
fuse with it. The subsequent trafficking and fusion of vesicles with endosomes is highly
dependent on small GTPases, particularly from the Rab subfamily, which act as
molecular switches to control trafficking actions (Zerial & McBride, 2001; Jordens et al.,
2005). The first endosome a primary vesicle is trafficked to is the early endosome. Of the
several proteins necessary for early endosomal function and trafficking, Rab5, PI3-
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kinase (Phosphoinositide 3-kinase) and its product Ptdlns3P (phosphatidylinositoi-3-
phosphate) are vitally important in its function (Lawe et al., 2002). The acidic
environment within the early endosome acts to dissociate receptors from their ligands,
allowing the receptors to be recycled to the surface. An example of this is transferrin,
where, following binding and internalisation of transferrin with its receptor, dissociation
takes place in the acidic early endosome, from where the receptor is released to be
recycled back to the plasma membrane (Hinrichsen et al., 2003; Maxfield & McGraw,
2004). However, this acidic environment can also act as a trigger for a virus to un-coat or
become ‘penetration-ready’, as is the case in Severe Acute Respiratory Syndrome
coronavirus (SARS-CoV), where the proteases which trigger this change in the virus are
acid-dependent (Simmons et al., 2005). The fast recycling route back to the plasma
membrane taken by receptors, once free from their ligand, is controlled by Rab4 and
Rab35, which have both been implicated in the trafficking of transferrin (van der Sluijs et
al., 1992; Maxfield & McGraw, 2004; Kouranti et al., 2006). One alternative to this
pathway is the so called ‘slow recycling’ route, which involves the maturation of the early
endosome, when it extends tubules which become the recycling complex, losing Rab5
proteins and gaining R a b ll (Sonnichsen et al., 2000), while the main portion of the early
endosome becomes the late endosome or multi-vesicular endosome (Maxfield &
McGraw, 2004). Some cargoes, such as receptors that should not be recycled to the
membrane, undergo endo-lysosomal traffic and remain in the early endosome, which
matures to form the late endosome, a process which is usually marked by the
replacement of Rab5 proteins with Rab7 (Poteryaev et al., 2010) and is also marked by
LAMPS (lysosomal-associated membrane proteins; Gruenberg & Stenmark, 2004). This
transport from early to lysosomal compartments is also dependent on PI3-kinases for
regulation of sorting as well as in the endosomal structure (Shpetner et al., 1996).
Transport from the late endosome is essentially one-directional, since when the late
endosome fuses with a lysosome, its contents are degraded. Cargoes are marked for
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this degradative pathway by the addition of ubiquitin by ubiquitin ligases (Hicke & Dunn, 
2003), which is recognised by Mrs and ESCRTs (endosomal sorting complexes required 
for transport) which sort these cargoes to be degraded (Hurley, 2008). Other trafficking 
pathways associated with clathrin-mediated entry include traffic from the late endosome 
to the TON (trans-golgi network) mediated by Rab9 (Barbero et al., 2002).
Due to this pathway being the most-studied and best-characterised, there are many 
viruses which are known to hijack this pathway for entry into host cells. Semliki Forest 
virus (SFV; Marsh & Helenius, 1980; Vonderheit & Helenius, 2005) and vesicular 
stomatitis virus (VSV; Johannsdottir et al., 2009) are well-established clathrin-mediated 
cargoes. However, more recently it has been found that VSV can enter via vesicles that 
are not entirely coated with clathrin (Cureton et al., 2009), and entry is not dependent on 
the classical adaptor protein AP2, casting doubt on what pathway this virus is actually 
using (Johannsdottir et al., 2009). A recent study into filoviral entry confirmed that Ebola 
virus glycoprotein enters via a classical clathrin-mediated pathway, dependent on AP2 
and eps15, whereas the other member of this virus family, Marburg virus glycoprotein 
utilises a different form of clathrin-mediated entry, one independent of eps15 and AP2 
pathways, but dependent on 1(3-arrestin (Bhattacharyya et al., 2010; Bhattacharyya et 
al., 2011). Adenoviruses type 2 and 5 both enter cells via a clathrin- and dynamin- 
dependent pathway, however from there they escape out of the typical early to late 
endosomal pathway, and instead are found in trans-Golgi compartments (Gastaldelli et 
al., 2008). In contrast, Echovirus 7 follows the classical endocytic pathway associated 
with clathrin-mediated entry, and is observed to traffic from the plasma membrane 
through early endosomes to late endosomes (Kim & Bergelson, 2012). As seen from 
these few examples, when it comes to virus entry, a ‘classical’ clathrin-mediated entry 
pathway does not truly exist.
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1.8.2 Lipid raft entry
Lipid rafts are condensed areas (‘islands’) on the cell membrane consisting of plentiful 
saturated glycosphingolipids, sphingomyelin and cholesterol (reviewed in Simons & 
Ikonen, 1997). Although lipid rafts were first associated with endocytosis as platforms for 
caveolae formation, they in fact also serve as vital signalling platforms (reviewed in 
Simons & Toomre, 2000), providing a base for much of the signalling that occurs in the 
cell. They have been shown to internalise particles independently of caveolae, such as in 
murine polyomavirus entry (Gilbert & Benjamin, 2000) as well as Coxsackievirus B4 
entry (Triantafilou & Triantafilou, 2003), and more recently in the well-studied entry of 
HIV (Carter et al., 2009). As well as caveolar entry, there are several other pathways 
that originate at lipid rafts, some dependent on, and some independent of, dynamin. This 
varying requirement for dynamin could be attributed to the splicing of the dynamin gene 
in mammals which could result in different splice variants being involved in different entry 
routes (McNiven et al., 2000).
1.8.2.1 Caveolae-dependent entry
Caveolae were first identified in the 1950s; the unique flask-shaped invaginations were 
described as small ‘caves’ in the membrane surface (Yamada, 1955) and have since 
been found to play roles in endocytosis, lipid metabolism and signalling. In contrast to 
clathrin-mediated entry, caveolar entry is not constitutive, the caveolae are instead a 
stable structure on the membrane which are stimulated to internalise particles (Thomsen 
et al., 2002), a process that occurs at a much slower rate than clathrin-coated pit 
invagination. There are even suggestions that caveolae are largely not involved in 
endocytosis, except when stimulated (Hommelgaard et al., 2005; Lajoie & Nabi, 2007). 
Caveolae form at areas on the plasma membrane termed lipid rafts, due to their 
abundance in lipids, and are made up of several proteins, with caveolin proteins forming
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the central structure. Caveolins are small membrane proteins (21kDa) with 100-200
molecules lining caveolar pits to form a spike-like coat (Rothberg et al., 1992; Pelkmans
& Zerial, 2005). There are three caveolin proteins found in mammals, the most abundant
and important being caveolin-1 (Fra et a!., 1995); cells deficient in caveolin 1 have been
found to possess no visible caveolae (Rothberg et a!., 1992; Drab et a!., 2001), as in
cells deficient in caveolin-3 (Galbiati et a!., 2001). Caveolins 1 and 2 are mostly found in
non-muscle cells, whereas caveolin-3 is found in smooth and skeletal muscle cells
(Ration & Simons, 2007). Caveolin-1 binds to filamins A and B (Stahlhut & van Deurs,
2000) which in turn organise the actin cytoskeleton and so are important regulators of
caveolae-mediated entry and trafficking (Sverdlov et a!., 2009). This tight connection
between caveolin and actin implies a role for the cytoskeleton in caveolar entry, but that
role has not yet been fully characterised (Morone et a!., 2006; Richter et a!., 2008). As in
clathrin-mediated endocytosis, caveolar endocytosis is greatly dependent on the
presence of dynamin proteins at the opening to caveolae (Oh et a!., 1998) as they are
necessary for internalisation of caveolar vesicles (Yao et a/., 2005) by cutting the vesicle
from the plasma membrane. As well as dynamin, Intersectin is also necessary for
separating the budding caveolae from the membrane (Predescu et a!., 2003). The
binding of a ligand initiates the disruption of the actin cytoskeleton and the recruitment of
dynamin II to the location of internalisation (Pelkmans et a!., 2002; Sharma et a!., 2004).
A report in 2001 looking into the entry of SV40 (Simian Virus 40; Pelkmans et a/., 2001)
identified a previously unknown organelle used in caveolar transport, and termed it a
caveosome. This neutral pH organelle was described as immobile within the cell, without
early endosomal markers and was where the group suggested caveolar cargo (including
SV40) was transported to. Although subsequently other viruses (such as HPV 31; Smith
et a!., 2007) were found to traffic through caveolae to early endosomes, it was in 2010
that the same group discounted the existence of these organelles (Mayer et a!., 2010).
This was based on further research using pH-dependent fluorophores, which allowed for
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improved visualisation of virus trafficking. This was followed by further investigation of 
the prototype caveolar-dependent virus, SV40, showing that this virus actually travels to 
early then late endosomes (Engel et al., 2011). As the existence of caveosomes has 
been placed into such doubt, the proposed model of caveolar entry is now the 
internalisation of particles into caveolae and subsequent transport to early endosomes. 
This is the pathway followed by a classical marker of this pathway. Cholera Toxin B 
(ChTxB), which is internalised by caveolae (Parton et al., 1994; Pelkmans & Zerial,
2005), passes to early endosomes before reaching the Golgi (Tran et al., 1987; Girod et 
al., 1999); however ChTxB is also able to use other endocytic pathways.
Several viruses are known to use caveolar endocytosis to enter cells, such as Echovirus- 
1 (Marjomaki et al., 2002; Pietiainen et al., 2004) and HPV 16 (Laniosz et al., 2009) 
which enters via clathrin-mediated entry but subsequently requires caveolin-dependent 
trafficking. However, the most well-known viral cargo of this pathway is SV40 which is 
often used as a marker of caveolae-dependent entry (although it’s intracellular trafficking 
has only recently been confirmed). The recent report on SV40 entry has shown that the 
virus is transported through a succession of endocytic vesicles, from early to maturing to 
late endosomes and possibly to endolysosomes (Engel et al., 2011). However, as a 
further complication in the endocytic pathway of SV40, it is able to enter cells using two 
distinct pathways. As well as entering through caveolar pathway, which is dynamin- 
dependent and slow (Pelkmans et al., 2001; Pelkmans et al., 2002), in cells devoid of 
caveolin, SV40 is also able to enter using a clathrin- and caveolae- independent pathway 
that is dynamin-independent and quicker (Damm et al., 2005).
1.8.2.2 Flotiliin pathway
Flotillin (or reggie) proteins were first identified in 1997 as constituents of detergent- 
resistant membrane fractions that were found to float in density gradients, hence the
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name (Eisenberg et al., 1959). These membrane-associated proteins have been found to 
have wide-ranging functions in signalling, interactions with the cytoskeleton and 
endocytosis. In some cell types devoid of caveolae, flotillins have been found in the place 
of caveolins (Lang et al., 1998). The two flotillin proteins, flotillin-1 (reggie-2) and flotilIin-2 
(reggie-1) can differ in their distribution and functions in membrane traffic (Langhorst et 
al., 2008) but when co-assembled, have been found to induce curvature of the 
membrane, forming invaginations in the membrane that are morphologically similar to 
caveolae (Frick et al., 2007). In a similar way to caveolin proteins, flotillin proteins 
assemble in lipid rafts, where flotillin-1 and flotillin-2 bind to each other, forming specific 
microdomains, although these are separate from caveolae (Lang et al., 1998; Frick et al.,
2007). Flotillins differ from caveolins in that the microdomains they form are laterally 
mobile in the membrane, and are able to bud into the cell (Glebov et al., 2006; Frick et 
al., 2007). Although they are very similar in topology to caveolin proteins, they are 
unrelated in sequence (Bauer & Pelkmans, 2006). Flotillins have been found to be 
expressed in all mammalian tissues studied and are expected to be expressed 
universally implying they are important in cell function, however the role of flotillin 
proteins has not yet been fully characterised (; Eisenberg et al., 1959; Volonté et al., 
1999; Stuermer, 2010). They are proposed to offer a scaffolding function for membrane 
rafts (Stuermer, 2011), or alternatively acting as a regulator of membrane components, 
or, as increasing evidence suggests, as part of an endocytic pathway (Hansen & Nichols,
2009). As well as the observation that parts of the membrane microdomains bud into the 
cell, flotillins have been found to colocalise with endocytic cargoes (Glebov et al., 2006). 
Flotillins have also been found in several endocytic vesicles; the recycling endosomes, 
lysosomes, multivesicular bodies and in phagosomes in macrophages (Dermine et al., 
2001; Browman et al., 2007; Payne et al., 2007).
Cargoes that have been found to use a flotillin-dependent, but dynamin-independent
pathway include ChTxB and the glucose phosphate isomerase (GPI)-linked protein
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CD59 (Glebov et al., 2006; Frick et al., 2007). There has also been a flotillin-dependent 
pathway found that is dependent on dynamin for the entry of cell-surface proteoglycans 
in which they bypass early endosomal antigen-1 (EEAI)-positive early endosomes and 
fuse with Rab9-positive late endosomes (Payne et al., 2007). Clearly, the characteristics 
of flotillin-dependent endocytosis are not simple, and additionally, there has also been 
some overlap found between the flotillin and CLIC/GEEC pathways (see Section 
1.2.2.3), where flotillin was found in the membranes of early CLIC/GEEC vesicles 
(Lundmark et al., 2008). Flotillin has also been suggested as a specialised adaptor for 
other endocytic pathways (Schneider et al., 2008), which seems to be supported by the 
fact that to date, there are no known viruses that enter cells via a purely flotillin- 
dependent pathway. Although there have been several studies into flotillin, the 
differences in requirements for the endocytic pathway, as well as other roles it could be 
playing in the cell could all differ depending on the cell type, with much still needing to be 
clarified (Stuermer, 2011).
1.8.2.3 CLIC-GEEC
Although GPI-APs were first thought to enter cells via a caveolae-dependent pathway, a 
different, constitutive entry pathway was later discovered that was clathrin- and 
caveolae-independent (Sabharanjak et al., 2002). The entry of GPI-APs was 
characterised by their internalisation into specialised tubulovesicular compartments (-30- 
40nm in diameter) of acidic pH called CLICs (dathrin-independent carriers; Kalia et al.,
2006). CLICs bud directly from the plasma membrane, and mature and fuse to form 
GEECs (GPI-AP-enriched early endosomal compartments) following which they merge 
with Rab5 and EEA-1 positive early endosomes (Kalia et al., 2006). From the early 
endosomes, the next destination for cargoes of this pathway can be lysosomal and 
recycling vesicles, but these seem to vary, depending on cell type (Fivaz et al., 2002;
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Sabharanjak et al., 2002). The whole process of internalisation and traffic through the 
endocytic network happens very quickly, (suggested to be 5 min), this quick motion 
being highly dependent on maintenance of the actin structure of the cell (Chadda et al.,
2007). As well as being highly dependent on the cholesterol found in the lipid
rafts (Cheng et al., 2006), there are several key proteins involved in the structure and 
functioning of this pathway. The structure of the characteristic tubular-shaped vesicle is 
maintained by the GRAF1 protein (GTP (guanosine triphosphate)ase regulator 
associated with focal adhesion kinase-1) which is important in synchronising signalling 
and membrane remodelling for GEEC internalisation (Lundmark et al., 2008). The Rho 
GTPase, Cdc42 is essential for formation of GEECs in its role of regulating actin 
polymerisation and signalling pathways. This was shown by the inhibition of Cdc42 by 
Clostridium difficile Toxin B (a toxin that inactivates Rho family GTPases) where the 
normal fluid-phase uptake seen in this pathway was decreased (Sabharanjak et al., 
2002). The action of Cdc42 is controlled by A rfi; when activated at specific locations on 
the plasma membrane, it induces the recruitment of Rho GTPase Activating Protein 10 
(ARHGAP10) to the cell surface (Chadda et al., 2007). Together, A rfi and Cdc42 
regulate endocytosis of CLIC-GEEC at the plasma membrane (Kumari & Mayor, 2008). 
The membrane scission protein, dynamin was shown to be unnecessary for this pathway 
(Sabharanjak et al., 2002; Kirkham et al., 2005), however the interactions observed 
between GRAF1 (which is vital in CLIC-GEEC endocytosis) and dynamini have placed 
doubt on this matter (Lundmark et al., 2008).
As well as GPI-APs (Glycophosphatidyl-lnositol Anchored Proteins), several other
cargoes for this pleomorphic pathway have been found; ChTxB is able to make use of
this pathway and once within the cells has been shown to travel to the golgi (Kirkham et
al., 2005; Lundmark et al., 2008). As mentioned, large amounts of fluid phase is taken up
by this pathway, indicated in the uptake of macropinocytic markers such as dextran
(Sabharanjak et al., 2002; Kirkham et al., 2005). MFICII (major histocompatibility complex
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Il) also enters via this pathway, and was observed to co-internalise with ChTxB (Knorr et 
al., 2009). Until recently, there were no known viral cargoes of this pathway, however last 
year it was found that Adeno-associated virus-2 (AAV2) uses a dynamin-independent 
form of CLIC-GEEC for entry into host cells (Nonnenmacher & Weber, 2011 ).
1.8.2.4 IL-2 receptor entry
While studying the (3-chain of the Interleukin-2 receptor subunit-(3 (IL-2R-(3), a novel 
pathway was discovered that was independent of clathrin and caveolin. The so-called IL- 
2R pathway was described as being dependent on the small GTPase RhoA and on 
dynamin-2 (Lamaze et al., 2001). In that report, studies conducted in lymphocytes 
showed the dathrin-independent endocytosis pathway of IL-2Rs was a constitutive one, 
probably due to their position on lipid rafts which form a constant base for internalisation. 
As well as IL-2, this pathway has also been found to internalise other proteins in both 
immune cells and fibroblasts, for example yc-cytokine receptor (R; Sauvonnet et al., 
2005) and IgE R (Immunoglobulin E receptor; Fattakhova et al., 2006). The IL-2 receptor 
pathway is found partitioned only in detergent-resistant membranes implicating lipid rafts 
as the base for this pathway (Lamaze et al., 2001). While other pathways depend on 
Cdc42 for regulation of actin, this pathway makes use of RhoA (Garred et al., 2001). 
RhoA is known to play a role in regulating actin dynamics (Jaffe & Hall, 2005) and it is 
thought to be playing this role in IL-2R endocytosis, rather than that of ligand sorting 
(Garred et al., 2001). More recently, a role for R ad  was also discovered to be vital in 
stimulating the serine/threonine kinases Paki and Pak2 to initiate dathrin-independent 
endocytosis (Grassart et al., 2008). The Paks are essential in actin polymerisation 
(Ridley, 2006). Part of the role of the Pak signalling is the activation of the downstream 
target, cortactin which has several domains for interactions with other proteins. Cortactin 
is necessary for the endocytosis of IL-2R-P and yc-cytokine R, in its connection with actin
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as well as dynamin-2 which regulate the assembly of actin apparatus (Schafer et al., 
2002). As well as it’s interaction with dynamin and actin, cortactin associates with Arp2/3, 
a vital initiator of actin nucléation essential in this pathway (Sauvonnet et al., 2005). 
Although there are no known viruses entering cells using this pathway, there are several 
that may enter via an IL-2R-like pathway or a subtype of this pathway. Feline Infectious 
Peritonitis virus (FIPV) enters cells via a clathrin- and caveolae-independent pathway 
that is dynamin-2 & cholesterol dependent, but independent of RhoA (Van Hamme et al.,
2008). Similarly, SARS-CoV enters via a novel pathway, but is also independent of RhoA 
(Wang et al., 2008). HSV VP22 uses a dynamin-and Arf6-dependent pathway that is also 
independent of RhoA. This pathway takes the virus to early endosomes, lysosomes and 
possibly on to recycling endosomes. As this trafficking pathway has not yet been verified 
for entry through an IL-2 pathway, this may indicate HSV VP22 is using another pathway, 
possibly the Arf-6 dependent pathway (Nishi & Saigo, 2007).
1.8.3 M acropinocytosis
For cells to take in large amounts of fluid and small particles, they use a process called 
macropinocytosis which was first described in 1931 (Lewis, 1931). Although similar to 
phagocytosis, macropinocytosis is less specific and typically involves engulfment of fluid 
and cell membrane to form large vacuoles (Watts & Marsh, 1992). In some cells, such as 
immature dendritic cells and macrophages, macropinocytosis is constitutive, used for the 
uptake of fluid and antigens from the extracellular surroundings in their role as antigen 
presenting cells. In other cells, the process of macropinocytosis is induced, usually by an 
interaction between a ligand and its receptor, such as the Receptor Tyrosine Kinase 
(RTK) epidermal growth factor (EGF) binding to its receptor (EGFR) which induces its 
internalisation and subsequent transport to lysosomes (Kornilova et al., 1996).
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The binding of a ligand induces a complex signalling response which in turn leads to 
alterations in the cell, including actin rearrangements which cause ruffling on the plasma 
membrane and formation of macrcpincscmes, summarised in Figure 1.7.
As well as the RTKs which are involved in binding of ligands, another important signalling 
molecule in macropinocytosis is the serine/threonine kinase PAK1 (p21 activated kinase- 
1) which controls cytoskeletal changes and motility and alone is sufficient to induce 
macropinocytosis (Dharmawardhane et al., 2000). The Rho GTPase R a d  activates 
PAK1 (Knaus et a!., 1998) which is then transferred to the plasma membrane, from 
where it triggers several effectors that are required for membrane blebbing and ruffling, 
as well as macropinosome formation (Dharmawardhane et a!., 1997; Sanders et a!., 
1999; Liberali et a!., 2008). As part of the signalling pathway of macropinocytosis, Arf6 
and R a d  play key roles in triggering lamellopodial ruffles, circular ruffles & blebs through 
interactions with other kinases (Ridley et a/., 1992; Johannes & Lamaze, 2002; Mercer & 
Helenius, 2008). Although PI3-kinase is activated by R a d , it can also be activated by 
other signalling molecules such as Src kinase (Am ye re et a!., 2000). The pathway 
initiated by PI3-kinase is involved in several phases of macropinocytosis, such as 
membrane projection, macropinosome trafficking, and mostly in activation of Rab34 for 
the closure of the macropinosome (Araki et a/., 1996; Amyere et a/., 2000; Lindmo & 
Stenmark, 2005; Swanson, 2008).
As can be seen from the brief outline of the roles of signalling molecules, the next stage
in macropinocytosis is the activation of membrane modifications. Currently, the
membrane projections that occur after activation are divided into four different types, all
of which are highly dependent on actin rearrangements -  lamellopodial ruffles, circular
ruffles, filopodial protrusions and blebs. These different protrusions are produced
depending on which ligand is bound to the cell surface (Mercer et a!., 2010). While
stimulation with EGF or Adenovirus (Meier et a!., 2002) causes large, flat lamellopodial
ruffles, circular ruffles produce ‘crown-like’ projections on the cell surface in response to
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PDGF (Araki et al., 2000). There have been some instances of long finger-like 
protrusions being observed during the endocytosis of Vaccina Virus Mature Virions (W  
MVs; Locker et al., 2000; Mercer et al., 2010) as well as Nipah virus (Pernet et al., 2009). 
In contrast to filopodial protrusions, blebs are irregular lumps that occur on the plasma 
membrane. These lumps are caused by a destabilisation of the actin network, and have 
been shown to rapidly internalise KSHV (Kaposi’s sarcoma-associated herpesvirus; 
Valiya Veettil et al., 2010).
Although most ruffles dissolve back into the plasma membrane, some fold back and
enclose within them the fluid for uptake, forming the macropinosome, a large vacuole, up
to 10pm in diameter which is then detached from the membrane (Swanson, 2008). Due
to the uptake of fluid instead of a particle to give it structure, and the lack of any coat
proteins, these vacuoles are large and of irregular shape and size.
Macropinocytosis is mostly associated with fluid uptake, but due to its lack of any distinct
features or molecular markers, is not able to be accurately characterised. It is known to
be dependent on cholesterol, with membrane ruffling and macropinosome formation
inhibited by the elimination of cholesterol (Grimmer et al., 2002). The role of Cdc42 is
vital in the first stages of macropinocytosis, in activating Rac and Rho (Nobes & Hall,
1995; Chen et al., 1996) as are the roles of Arf6 and Rab5 in trafficking of the
macropinosome (Lanzetti et al., 2004). NaVH^ exchangers are membrane proteins which
control intracellular pH to allow Cdc42 and R a d  signalling to take place, hence why the
inhibition of macropinosome formation is seen when cells are treated with inhibitors of
NaVH^ exchangers, such as amiloride (Koivusalo et al., 2010). Different macropinocytic
protrusions have also been found to have different requirements for macropinosome
closure; circular ruffles require dynamin for fission of the macropinosome from the
membrane (Liu et al., 2008), as seen in the entry of BTV1 (bluetongue virus; Gold et al.,
2010) and HIV-1 entry (Carter et al., 2011). In contrast, lamellopodial ruffles make use of
CtBPI / BARS (C-terminal-binding protein 1 / brefeldin A-ribosylated substrate) for this
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function (Liberali et al., 2008), and while blebs are also dynamin-independent, the 
mechanism of their closure remains a mystery (Mercer & Helenius, 2008). Once formed, 
the macropinosome can recycle back to the plasma membrane, fuse with endosomes or 
lysosomes, and has also been seen to acidify before fusion with lysosomes (Racoosin & 
Swanson, 1993; Schelhaas et a i, 2012).
Although it is typically a ligand-induced method for the cell to take up fluid, 
macropinocytosis has increasingly been found to be the entry pathway for many viruses 
(reviewed in Mercer & Helenius, 2012) such as African Swine Fever Virus and 
Filamentous Influenza virus (Rossman et a i, 2012; Sanchez et a i, 2012). This is thought 
to be due to the fact that this pathway is non-specific, so does not require binding to a 
particular receptor for internalisation to occur. A classical virus to use this pathway is W  
which mimics apoptotic bodies to gain entry (Mercer & Helenius, 2008) by binding to 
glycosaminoglycans (Carter et a i, 2005) and is delivered to the acidic early endosome 
(Townsley et a i, 2006). W  internalisation is dependent on actin, Rho GTPases, PAKI 
and cholesterol, and entry of the two forms of W  (MVs and extracellular virions, EVs) 
sees the formation of either filopodial protrusions or blebs (Locker et a i, 2000; Mercer & 
Helenius, 2008; Mercer et a i, 2010). As well as viruses that use the classical 
macropinocytosis pathway, some use modified an as yet uncharacterised 
macropinocytosis-like pathway, such as HPV16 which was shown to use similar 
signalling pathways to macropinocytosis, with differences in vesicle size and GTPase 
requirements (Schelhaas et a i, 2012). This indicates there is still much to be understood 
about this pathway.
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1.8.4 A rf6-dependent pathway
Although the GTPase Arf6  can be involved in clathrin-dependent entry (Houndolo et al.,
2005) and is also an integral part of macropinocytosis (Schafer et al., 2000), it was also 
found to form an endocytic pathway in its own right in HeLa and COS-7 cells 
(Radhakrishna & Donaldson, 1997). Arf6  plays a crucial part in membrane trafficking by 
activating phosphatidylinositol 4-phosphate-5-kinase which stimulates phosphatidyl- 
inositol 4,5-bispohosphate to initiate actin remodelling, as well as a possible role in 
directing endosomal dynamics (D'Souza-Schorey & Chavrier, 2006). Cargo internalised 
through the Arf6  pathway can either be recycled back to the plasma membrane via 
tubular-shaped Arf6 -positive compartments (Radhakrishna & Donaldson, 1997), or to 
Rab5- or EEA1-positive early endosomes, through to late endosomes and lysosomes to 
be degraded (Naslavsky et al., 2003).
Although this pathway has been shown to be either dynamin-dependent or dynamin-
independent, most cargoes depend on dynamin involvement in this process. The Arf6
pathway has been definitively shown to be independent of clathrin and caveolae, and
possibly dependent on lipid rafts (Naslavsky et al., 2004). The original description of this
pathway was as a dynamin-independent pathway, but more recently HSV VP22 has
been found to use an Arf6 -, lipid raft- and dynamin-dependent pathway (Nishi & Saigo,
2007). As well as HSV VP22 using this pathway, several other cargoes internalise using
this pathway; some of these include the plasma membrane protein IL-2R subunit-a and
MHC Class I (MHC I; Radhakrishna & Donaldson, 1997), B1-integrin (Brown et al.,
2001), peripheral myelin protein, Pmp22 (Donaldson, 2003) and some GPI-APs, for
example CD59 (Naslavsky et al., 2004). Dependence on lipids also appears
questionable, possibly differing between the cell-types tested; although entry of MHC I
and CD59 were both found to require cholesterol (Naslavsky et al., 2004). Although in
the past there has been some suggestion that the Arf6  and CLIC/GEEC pathways are
variations of the same pathway, this has now generally been discounted due to the fact
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that inhibition of GRAF1, which is vital in CLIC/GEEC entry, inhibited fluid phase entry 
but had no effect on MHC I endocytosis (Lundmark et al., 2008).
Better definition of the Arf6  pathway has proved elusive since in some cell lines it seems 
completely absent while in others it does not constitute an endocytic pathway, but rather 
a recycling pathway (Brown et al., 2001; Naslavsky et al., 2004). Additionally, in cell 
types where it is found, although hyper-activating it caused increased endocytosis of 
MHC I, inhibition of Arf6  did not inhibit endocytosis (Naslavsky et al., 2003). It has been 
suggested that the role for this pathway under normal cell conditions is regulation of 
membrane availability or to recycle activated small GTPases to the plasma membrane 
(Santy & Casanova, 2001)
1.8.5 C ircular Dorsal Ruffles
Although it was found long ago that stimulation by epidermal growth factors could induce 
internalisation of EGFRs by dathrin-independent pathways (Haigler et al., 1979), only 
relatively recently have the structures involved in this process been characterised. These 
structures are called circular dorsal ruffles (CDR), or dorsal waves, due to their dynamic 
movement across the plasma membrane and are differentiated from invapodia and 
podosomes on the basis of their location on the cell surface, their function and half-life 
(Buccione et al., 2004; Orth et al., 2006). These actin-based structures form in the dorsal 
membrane of several epithelial and mesenchymal cells and are very transient (Orth & 
McNiven, 2006). They form upon stimulation by RTK growth factors, such as EGF, 
platelet-derived growth factor (PDGF) and hepatocyte growth factor (HGF) (reviewed in 
Buccione et al., 2004). Although these structures had been observed for several years, 
only recently have they been successfully imaged; a few minutes post-stimulation, the 
CDRs were arranged on the dorsal cell membrane, following which they constricted and
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disappeared again, all within 20 min (Hedberg et al., 1993; Dharmawardhane et al., 
1997). This motion of the membrane is highly dependent on the interaction of dynamin 
and cortactin in the organisation of the actin network (Krueger et al., 2003; McNiven et 
al., 2004). As well as dynamin and cortactin, there have been several other proteins 
identified in this process, such as Arp2/3, PI3-kinase, Rab5, Arf6 , Rac and Ras, most of 
which play a role in actin dynamics in the cell (Haigler et al., 1979; Buccione et al., 2004; 
Goicoechea et al., 2006). Even though these structures have been steadily better 
characterised, their specific purpose is as yet unknown; it is widely accepted that they 
are central in establishing motile cell polarity as well as in cytoplasmic remodelling 
(Krueger et al., 2003). Although CDRs have been thought in the past to be a mediator of 
macropinocytosis, due to their apparent relationship to macropinosome formation 
(Dowrick et al., 1993) this view has been contested due to a significant difference in the 
proteins necessary for each process. Experimental studies in embryonic fibroblasts 
showed that CDR formation required the N-WASP-related protein (neural Wiskott-Aldrich 
Syndrome Protein) WAVE1, while WAVE2 was necessary for macropinosome formation 
(Suetsugu et al., 2003). The circular dorsal ruffle pathway is proving to be a novel and 
effective method for cells to internalise many RTKs from the dorsal plasma membrane 
especially rapidly. To date, there are no definitive viral vectors of this pathway.
1.8.6 Phagocytosis
Professional phagocytic cells, such as amoeba, monocytes, macrophages and 
neutrophils, are able to internalise opsonised particles and other large particulate matter 
using phagocytosis. This cargo-triggered form of internalisation is important as a host 
defence mechanism and in tissue repair with two different forms characterised; the Fc- 
receptor (FcR) mediated form and the C3bi receptor (CR3) mediated form. When the
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FcRs are activated by the strong interaction with IgG-coated targets, the phagocyte 
produces filopodial extensions around the particle, with macrophages seen to attempt to 
ingest a glass coverslip coated in IgG (Wright & Silverstein, 1984). This form of 
phagocytosis is characterised by the formation of membrane ruffles and invaginations 
shaped around the cargo in order to internalise it. All the membrane required for the 
formation of the cup around the particle means that some membranous material is 
required from intracellular organelles, such as late endosomes, lysosomes and recycling 
endosomes (Huynh et al., 2007). This whole process is highly dependent on small 
GTPase proteins such as Cdc42 for producing the filopodial extensions and R a d  for 
regulating actin (Massol et al., 1998; Castellano et al., 2000; Chimini & Chavrier, 2000; 
Hoppe & Swanson, 2004). Cdc42 and R a d  recruit more proteins to the membrane 
which are necessary for phagocytosis, namely N-WASP for signal transduction, actin and 
the Arp2/3 complex which nucleates and polymerises new actin fibres (May et al., 2000). 
IQGAP1 (the IQ motif containing GTPase activating protein 1) interacts with several 
components of the cytoskeleton; one of these is D ia l, a formin which also acts to 
polymerise actin, and is vital in the formation of the phagosome cup (Brandt et al., 2007).
The alternative form of phagocytosis is initiated by binding of C3bi (a complement
fragment which coats complement-opsonised targets) to its receptor CR3. In contrast to
FcR-mediated phagocytosis, there are no extensions of the membrane, rather the
particle sinks into the cell membrane with few protrusions, involving microfilaments in this
process (Kaplan, 1977). While the membrane protrusions of FcR-mediated phagocytosis
are controlled by Cdc42 and R a d , the reorganisation of the actin structure seen in CR3-
mediated phagocytosis is mediated by RhoA and its effector Rho kinase and is taken into
membranes lined with actin (Caron & Hall, 1998; Olazabal et al., 2002). Similar to FcR-
mediated phagocytosis, the Arp2/3 complex is also implicated in CR3-mediated
phagocytosis, however not in the membrane protrusions characteristic of that pathway
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(May et al., 2000). Also vital in both forms of phagocytosis in macrophages is the 
dynamin-2 protein, as well as it’s recruitment by PI3-kinase (Gold et al., 1999).
Although not a well-used entry route for viruses, to date two are known to utilise 
phagocytosis to enter their host cells. HSV1 is able to be taken up into non-professional 
phagocytic cells. Protrusions of the membrane which envelop the virus are reminiscent of 
the FcR-mediated phagocytosis pathway; however, dependence on RhoA could indicate 
a different form of phagocytosis. Entry of HSV1 is also dependent on dynamin-2 and 
actin (Clement et al., 2006).
Mimivirus {Acanthamoeba polyphaga mimivirus or APMV) is an amoebal pathogen that 
infects macrophages by phagocytosis. (Ghigo et al., 2008). Entry into macrophages was 
found to be clathrin- and caveolae-independent, however, membrane protrusions were 
observed, which were later proven not to be macropinocytic. Dependence of APMV entry 
on actin, PI3-kinases and dynamin further convinced the group that the virus was using 
phagocytosis to enter macrophages; however, this has not yet been proven in amoebae. 
When entry into non-phagocytic cells was analysed, APMV was not able to internalise. It 
is therefore thought that this large DNA virus (750nm, Xiao et al., 2005) could have 
developed its phagocytosis in order to enter amoeba (which are phagocytic cells), 
possibly the only pathway that would be capable of internalising a virus of that size.
1.8.7 Entosis
Entosis is not a well-characterised pathway; it bears some resemblance to phagocytosis, 
but is not used for the intake of opsonised particles or dead cells, rather for invasion of a 
living cell into the cytoplasm of another (Overholtzer et al., 2007). Unlike dying cells 
taken up by phagocytosis, internalised cells taken up by this process are still alive and 
have even been seen to undergo cell division. It was shown that when cells detached
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from the matrix upon which they were growing, although cell death is usually triggered, a 
cell that is still living can be taken up into another cell. This process is dependent on 
actin and driven by RhoA, ROCK, myosin II and also requires cadherin-mediated 
adhesion for initiation of this process (Overholtzer et al., 2007). Internalised cells are 
either released from the internalising cell, or they are degraded via the lysosomal 
pathway. This presence of one cell within another (cell-in-cell) has been observed 
previously in human cancers, with entosis being a possible explanation for this 
phenomenon. This process has only been observed in tumour cells, and is thought to 
prevent the formation of tumours where detached cells are internalised by other cells (Le 
Bot, 2007).
1.9 Entry of caliciviruses into cells
The entry pathways of several caliciviruses have been investigated so far.
Early research into FCV cell entry found that the entry of FCV into CRFK cells was 
sensitive to chloroquine. Chloroquine inhibits endosomal acidification, which suggested 
that FCV required acidification of the endosome for effective infection (Kreutz & Seal,
1995). More recently, Stuart and Brown showed that FCV enters cells via a clathrin- 
mediated pathway (Stuart & Brown, 2006), also requiring Rab5 for trafficking within the 
cell and uses macropinocytosis, possibly as a secondary pathway. The receptor for FCV 
has also recently been identified as JAM-A (Makino et al., 2006). More detail of FCV 
entry pathways is found in Chapter 3
Until relatively recently, there was nothing known about MNV-1 entry. However, work in 
our laboratory (Gerondopoulos et al., 2010) as well as by Perry et al (2010) using several 
pharmacological inhibitors as well as dominant negative proteins, has elucidated much
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about MNV pathways of entry. It was shown that MNV-1 entry into RAW 264.7 cells 
requires cholesterol, dynamin and microtubules for entry, but is independent of clathrin, 
caveolin, flotillin, phagocytosis or CLIC/GEEC entry, nor does it require actin. MNV-1 
infection was also shown to increase when macropinocytosis was inhibited 
(Gerondopoulos et al., 2010; Perry & Wobus, 2010). This could have been explained by 
the cell compensating by up-regulating another pathway, or possibly that the virus which 
was normally entering via macropinocytosis was being degraded, so when this pathway 
was inhibited, infection was more productive. More detail of the entry pathway used by 
MNV-1 can be found in Chapter 4. The cellular receptor for MNV-1 has also recently 
been identified as sialic acid (Taube et al., 2009).
Recently, the binding and entry of G ill.2 bovine noroviruses has been studied (Mauroy et 
al., 2011). The model virus (VLP) used in this study was found to bind to cells using the 
galatosyl and sialic acid residues, and internalised using either cholesterol-dependent 
mechanisms or via macropinocytosis. Although this pathway appears similar to MNV-1 
entry, not enough is known about its entry to say so definitively. It can be seen however, 
that viruses within the same family quite often use completely different endocytic 
mechanisms to enter host cells.
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1.10 Cell metabolism
In the normal metabolically active cell, there are many processes that take place; among 
them is endocytosis, replication of the genome and the process which is fundamental to 
keeping the cells running, metabolism. Metabolism is required for organisms to respire, 
grow and reproduce, as well as to be able to respond to their environment, and for 
maintenance of the cellular structure. The process of metabolism is characterised as an 
ordered set of chemical reactions that occur in sequence, where one molecule is 
chemically altered to form another molecule, providing the cell with substrates necessary 
for survival (Garrett & Grisham, 2010).
There are two types of metabolism; catabolism which breaks down substances, for 
example to produce energy, while anabolism is the use of energy to produce substances 
needed in the cell, such as nucleic acids and proteins. Metabolism is tightly controlled by 
hormones, regulatory ‘signals’ triggered by the concentration of cellular metabolites, 
along with enzymes which act at every step in transforming the molecule to proceed to 
the next step. As well as their role in catalysing these reactions, enzymes are also vital 
because they themselves can be regulated depending on the state of the cell thus 
enabling the cell to respond to its environment and maintain homeostasis (Garrett & 
Grisham, 2010; Berg etal., 2012).
There are several pathways of metabolism, which the cell uses dependent on what is 
required. The five main paths of metabolism are glycolysis, the Krebs cycle (also called 
the citric acid cycle), the Pentose Phosphate Pathway (PPP), fatty acid synthesis and (3- 
oxidation (Berg et al., 2012).
Many other pathways are used, for example, for the storage of glycogen as a source of 
energy, glycogenesis takes place and to break down that glycogen, glycogenolysis
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occurs, forming glucose-6 -phosphate for use by the cell. Most of these pathways form 
substrates that then feed into the main metabolic pathways described later, however one 
of the most common and important fuels for metabolism is the monosaccharide glucose, 
which is used by almost all organisms. Because glucose is such a valuable fuel, many 
metabolic products (for example lactate and pyruvate) are reclaimed in order to 
resynthesize glucose by gluconeogenesis.
1.10.1 The effects of viral infection on host cell m etabolism
Viruses are obligate intracellular parasites, and as such require a host cell within which 
they can survive and replicate. When a virus invades a host cell, one of the cellular 
processes affected is metabolism (Koppelman & Evans, 1959). The effect of virus 
infection on cell metabolism is not only based on a need for more energy to produce viral 
proteins and genetic material, but can also affect lipid synthesis through the forced 
production of viral lipid envelope such as in Human Cytomegalovirus (HCMV) infection 
(Munger et al., 2006). There have been several studies into the relationship between 
viruses and cell metabolism, including influenza virus and HCMV where it was found that 
upon entry into the cell, the viruses establish their own metabolic program, overriding 
that of the cells’ (Munger et al., 2006; Ritter et al., 2010; Yu et al., 2011a). The main 
pathways of energy production for mammalian cells are glycolysis, the RPR, the Krebs 
cycle, fatty acid synthesis and (3-oxidation which are briefly described below (Berg et al., 
2012).
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1.10.2 G lycolysis
This metabolic pathway is able to convert glucose into pyruvate, which is then in turn 
converted into Acetyl-coA (Acetyl-coenzymeA) to be used in the Kreb s cycle. Glycolysis 
occurs in the cytoplasm of the cell, not requiring oxygen for occurrence of this pathway. 
From one glucose molecule entering this pathway, two pyruvate molecules are produced 
from this pathway. However, only two or three ATP (adenosine triphosphate) molecules 
are able to be produced. Although this yield of ATP is not as efficient as in the Krebs 
cycle (Section 1.4.3), the advantage to the cell of glycolysis is the ability to produce ATP 
rapidly, as the cells is using it up, as is the case in muscle cells. Glycogen or glucose can 
be used in this pathway, providing either two ATP molecules, from glucose, or three ATP 
molecules, from glycogen.
1.10.3 Pentose Phosphate Pathw ay (PPP)
The Pentose Phosphate Pathway (PPP) takes place in the cytoplasm of cells, (in 
mammals this is mostly in liver cells) and is involved in the production of several ATP 
molecules. The PPP is considered as an alternative to the glycolysis pathway, in that it 
also involves the breakdown of glucose-6 -phosphate, however instead of forming 
pyruvate, ribose-5-phosphate is formed, which is used in the synthesis of nucleotides 
and nucleic acids. This pathway is essential not only in nucleotide synthesis but also in 
the formation of amino acids. This metabolic pathway also provides the cell with many 
NADPH (Nicotinamide adenine dinucleotide phosphate, reduced) molecules which are 
can be used by the cell to prevent oxidative stress by beginning the process which 
converts H2 O2 to H2 O. Although this pathway involves the breakdown of glucose, it is 
considered to be primarily anabolic due to the resulting formation of nucleotides.
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1.10.4 Krebs cycle
The Krebs cycle depends on oxygen, and is therefore classed as aerobic metabolism 
(Krebs & Johnson, 1937). This process is used by all organisms for the production of 
energy; in eukaryotic cells, it takes place in the matrix of mitochondria, however since 
bacteria do not possess mitochondria, this process occurs in the cytoplasm. Pyruvate 
molecules are converted into Acetyl-coA and fed into a cycle of chemical reactions; for 
every two pyruvate molecules fed into this cycle, one glucose molecule is produced. This 
pathway is also known as the citric acid cycle due to the production of citrate which is 
first fed into the cycle, through a series of chemical reactions and is then reformed before 
the cycle continues. The cyclic nature of this pathway means that production of ATP by 
the Krebs cycle is not rapid. However, it is very efficient, producing in excess of thirty 
ATP molecules. Not only used for the production of energy; the Krebs cycle is also vital 
as a source of the components of important biomolecules, produced depending on the 
cell’s energy requirements. The regulatory ‘signals’ the Krebs cycle responds to are the 
concentrations of metabolites in the cell, responses which are tightly controlled at several 
sites; namely pyruvate dehydrogenase, citrate synthase, isocitrate dehydrogenase and 
a-ketoglutarate dehydrogenase (Garrett & Grisham, 2010).
1.10.5 Fatty acid synthesis and p-oxidation
Acetyl-coA is a vital component of cellular metabolism, used in many biochemical 
reactions. It is vital in the Krebs cycle to produce energy, where it is Acetyl-coA which 
feeds the cycle. (3- oxidation is the process by which fatty acids within the cell are broken 
down within the mitochondria to form Acetyl-coA. Fatty acids are activated and 
transported from the cytoplasm to the mitochondria to be transformed into Acetyl-coA. In 
opposition to this pathway is fatty acid synthesis which creates fatty acids from Acetyl- 
coA, converting them first to Malonyl-coA by the action of Acetyl-coA carboxylase (Abu-
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Elheiga et al., 2001), the remaining reactions are catalysed by the fatty acid synthase 
enzymes. Fatty acid synthesis occurs in the cytoplasm and results in storage of energy 
as fat, mostly occurring in liver and adipose cells.
1.10.6 Studying m etabolism  using Biolog Phenotypic M icroarrays
Understanding the metabolism of a host cell during infection can relate a great deal of 
information about the processes which lead to a productive infection. The Biolog 
Phenotype Microarray™ (PM) technology was developed for use in high-throughput 
screening of substrate utilisation, including carbon, nitrogen substrates, differing pH 
conditions, and chemical sensitivity such as to antibiotics (Armon et al., 1990; Miller et 
al., 1993; Bochner et al., 2001). The technology is based on the efficient and rapid 
plating of samples into pre-prepared 96 well plates which have individual substrates 
immobilised on the bottom of each well. The assay measures the use of the substrates 
by the cells from the change in NADH (Nicotinamide adenine dinucleotide, reduced) 
levels, which is in turn measured from the reduction of a reporter dye (tétrazolium dye). 
The addition of tétrazolium dye facilitates the monitoring and quantification of the cell’s 
respiration in response to varying conditions or substrates by spectrophotometry at 
590nm. Among many discoveries, this technology has aided in the characterisation of 
membrane transport genes of Pseudomonas aeruginosa (Johnson et al., 2008) and in 
the discovery of a strain of Pseudomonas that is able to degrade nicotine, potentially 
useful in bioremediation of tobacco-contaminated environments (Ruan et al., 2005). 
Furthermore, the Biolog system has been employed to study Legionella pneumophila, in 
discovering that fatty acids trigger the differentiation of this bacteria (Edwards et al., 
2009), and in the biochemical identification of Legionella species (Armon et al., 1990).
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More recently, the Biolog technology has been adapted for use in mammalian cells, 
facilitating the study of metabolic characterisation of mammalian cells (Bochner et al., 
2011). This further development includes the addition of several mammalian cell-specific 
dyes and plates to test other carbon and energy sources as well as nitrogen sources, 
hormones and ions. To date, this technology has been used mostly for the study of 
cancer cells, such as in the possible identification of androgen-regulated metabolism 
markers as a biomarker of prostate cancer (Putluri et al., 2011). However, to date there 
have not been any published studies describing the use of the Biolog system to study 
metabolism during the interactions of viruses with mammalian cells. Here, for the first 
time we describe studies (detailed in Chapter 5) to investigate the metabolic effects of 
FCV-F9 infection of CRFK cells.
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1.11 Project aims
The importance of noroviruses as human and livestock pathogens is clear from the first 
sections of this report. As such, the investigation of how these viruses enter cells and 
affect them is vitally important. Until such time that human noroviruses can be cultured 
successfully in vitro, we can use MNV-1 and FCV as models for these viruses to begin to 
understand their entry mechanisms.
i) Previous work on FCV entry showed that it uses clathrin-mediated entry and 
macropinocytosis to enter CRFK cells. Flowever, the signalling involved in this process, 
and the endosomal route taken by the virus once inside the cell had not been 
investigated. We sought to reveal what signalling pathways were being utilised by FCV 
upon entry into the cell using signalling inhibitor drugs, as well as track its progress 
through the cell using colocalisation with endosomal markers.
ii) Work on MNV-1 entry has only recently begun, and although there is now more known 
about the pathways of entry, not much is known about the signalling involved in virus 
entry and replication, and the possible involvement of macropinocytosis in MNV-1 entry 
remained to be determined. We sought to answer this question about macropinocytosis 
using colocalisation with dextran, as well as probing the signalling involved in MNV-1 
entry using signalling inhibitor drugs.
iii) Nothing is known about the effects of FCV infection on CRFK cell metabolism. 
Consequently, we investigated the effect that infection of CRFK cells with FCV has on 
CRFK cell metabolism using Biolog phenotypic microarray technology™.
Increased understanding of cell entry and the effects on cell metabolism by these viruses 
could aid in designing new antiviral agents against both human and animal caliciviruses.
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Chapter 2 General Materials and Methods
2.1 Maintenance of cells
2.1.1 M aintenance of Crandell Rees feline kidney cells (CRFK)
CRFK cells were obtained from the European Collection of Cell Cultures (ECACC) and 
grown in Eagle’s Minimum Essential Medium (MEM) with Earle’s salts, supplemented 
with 10% heat inactivated FBS (foetal bovine serum), 1% penicillin/streptomycin and 1% 
non-essential amino acids. Preparation of confluent monolayers was achieved as 
follows; the media was removed and the cells washed with 3 ml 1% trypsin/versene to 
remove remaining serum. After removing the trypsin/versene solution, cells were 
detached from the flask with 5 ml of trypsin/versene. 5 ml of 10% FBS-Eagle’s MEM was 
added and the cells centrifuged at 2500 rpm for 3 min. The medium was removed and 
the cell pellet resuspended in 10 ml of 10% FBS-Eagle’s MEM. 2 ml of the cell 
suspension was removed to a 75 cm^ flask containing 15 ml 10% FBS-Eagle’s MEM and 
grown at 37°C with 5% C02 (Incubator Galaxy S, Wolf Laboratories).
2.1.2 M ouse leukaem ic m onocyte-m acrophage cells (RAW  264.7)
RAW 264.7 cells were obtained from Dr Ian Goodfellow, Imperial College UK. RAW cells 
were grown in Dulbecco’s Minimum Essential Medium (DMEM) with Earle’s salts, 
supplemented with 1 % non essential amino acids, 1 % penicillin/streptomycin and 1 0 % 
heat inactivated foetal bovine serum (FBS). Tissue culture reagents were all purchased 
from GibcoBRL. Confluent monolayers of cells were prepared as follows; cells were 
scraped off the surface of the flask and centrifuged at 2500 rpm for 3 min. The 
supernatant was removed and the cell pellet resuspended in 10 ml of 10% FBS DMEM.
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Cells (1.5 ml) were placed in a 75 cm^ flask containing 15 ml 10% FBS DMEM and 
grown at 37°C with 5% CO2 (Incubator Galaxy S, Wolf Laboratories).
2.2 Production of virus stock
2.2.1 Feline Calicivirus F9 stock
A 75 cm^ flask containing a confluent monolayer of CRFK cells in 4 ml 2% FBS-Eagle’s 
MEM was infected with 400 pi of FCV F9 seed stock (Dr Mike Carter, University of 
Surrey). The cells were rocked for 1 h and the medium removed and replaced with 8  ml 
10% FBS-Eagle’s MEM. Cells were incubated for 5 h or until the cytopathic effect was 
apparent. The cells were subjected to 2 freeze/thaw cycles before the cell suspension 
was centrifuged, filtered, aliquoted and stored at -80°C. Viral titre was measured by 
TCID5 0 (tissue culture infectious dose titration).
2.2.2 M urine Norovirus-1 stock
A 75 cm^ flask containing a confluent monolayer of RAW cells in 4 ml 2% FBS DMEM 
was infected with 400 pi of MNV-1 seed stock (gift from Prof H Virgin, Washington 
University, St Louis, USA). Cells were rocked for 1 h, after which the medium was 
removed and replaced with 8  ml of 10% FBS DMEM. The cells were incubated for 18 h 
or until the cytopathic effect was visible. Cells were subjected to 2 freeze/thaw cycles 
before the cell suspension was centrifuged, filtered, aliquoted and stored at -80°C. Viral 
titre was measured by TCID5 0 .
61
2.3 Tissue culture infectious doseso (TCID 5 0) assay
2.3.1 FCV
Ten fold serial dilutions of virus stock or sample preparations as in Section 3.2.2 were 
prepared in serum free MEM and 50 pi of each dilution was added to 6  wells of a 96 well 
plate. The last row in the plate served as a negative control with only serum free MEM 
added to each well. Cells were seeded at 2 x 10^ cells per well to reach approximately 
80% confluency overnight. The cells were incubated at 37°C and 5% CO2 then scored 
the following day as uninfected or infected according to the amount of cpe (cytopathic 
effect). The titre of the virus was calculated and expressed as TCID50 units per ml. The 
formula used was;
Viral titre =  f(% of wells infected at dilution above 50%) - 50%1_________
[(% of wells infected above 50%) -  (% of wells infected below 50%)]
2.3.2 MNV-1
Ten fold serial dilutions of virus stock or sample preparations (as described in Section 
4.3.2) were prepared in serum free DMEM. 50 pi of each dilution was added to 6  wells in 
a 96 well plate, the last row in the plate serving as a negative control with only serum 
free DMEM added to each well. Cells were counted and seeded at 1.8 x 10^ cells per 
well to reach approximately 80% confluency. The cells were incubated at 37°C and 5% 
CO2 and scored 2 days later for MNV as uninfected or infected in relation to the amount 
of cpe. The titre of the virus was calculated as in Section 2.3.1 above and expressed as 
TCID5 0 units per ml.
62
2.4 Pharmacological Inhibitors
Dynasore (Sigma Aldrich), Wortmannin (Calbiochem), Okadaic acid (Calbiochem), and 
Genistein (Sigma Aldrich) were reconstituted in DMSG (Sigma Aldrich) to the required 
concentration as shown in Table 2.1 and stored at -20°C. As these drugs are 
photosensitive, all experiments carried out with these drugs were performed in the dark.
2.5 Cytotoxicity test
Dynasore, genistein, okadaic acid and wortmannin were all tested for cell cytotoxicity by 
seeding cells in a 96 well plate to ~80% confluency (CRFKs were seeded a t 4 x 1 0 ^  cells 
per well, RAWs were seeded at 3 x 1 0 ^  cells per well). Cells were treated with the drug 
(12 h for RAW cells, 6  h for CRFK cells), the supernatant was removed and tested for 
cell death using the Roche Applied Science Cytotoxicity Detection Kit^‘‘^^ (LDH). A low 
and high control were also included in the testing -  the low control was from untreated 
cells, the high control was from cells treated with 0.1% Triton x 100 in PBS for 10 min 
before harvesting. The CDs of the resulting samples were read in an ELISA plate reader 
(Bio-Tek Instruments Inc) at 490 nm. The percentage of dead cells was calculated as 
follows;
% cytotoxicity = test sample -  low control
high control -  low control x 1 0 0
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Drug
Working
concentration
(FCV)
Working
concentration
(MNV-1)
Drug effects
Wortmannin
(Calbiochem)
50 & 100 nM 50, 100 & 500 nM
Phosphoinositide 3-kinase 
(PI3-kinase) inhibitor
Okadaic acid 
(Calbiochem)
50 & 100 nM 50 & 100 nM
General protein 
phosphatase inhibitor
Genistein 
(Sigma Aldrich)
20 & 50 pM 20 & 50 pM Tyrosine kinase inhibitor
Dvnasore 
(Sigma Aldrich)
25, 50 & 75 pM ---- Dynamin inhibitor
Table 2.1 Pharmacological inhibitors of endocytosis and cellular signalling
Summary of various pharmacological inhibitors used in FCV and MNV experiments
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2.6 Preparation of competent JM109s for use in transformations
JM109 bacteria were scraped from frozen stock and spread onto an LB agar (see 
Appendix) plate (without antibiotics) and grown overnight. Colonies were picked to 5ml 
LB medium (without antibiotics) and grown overnight at 37°C in an orbital incubator. 0.5 
ml was diluted into 50 ml of LB medium and grown at 37°C in an orbital incubator until 
the OD600 nm nearest 0.2 was reached. The culture was chilled on ice for 10 min and 
spun down at 3000 rpm for 10 min at 4°C. The medium was discarded and the bacterial 
pellet resuspended in 15 ml of CaCl2/Tris solution (see Appendix). This was chilled on 
ice for 15 min and centrifuged at 3000rpm for lOmin at 4°C. The supernatant was 
discarded, the pellet resuspended in 2  ml of CaCl2/Tris and dispensed into 2 0 0 pl 
aliquots. These were left on ice for 2 h before being used for transformation of plasmids 
as in Section 2.7.2 below.
2.7 Transformations for plasmid midiprep
2.7.1 Transform ations o f Rab5, Rab7 & ArfS plasm ids w ith com petent E.coli 
DH5a
DH5a E.coli were thawed slowly from liquid nitrogen before being mixed with 1 pg of 
plasmid DNA in a cold eppendorf. This was incubated on ice for 30 min then heat- 
shocked in a 42°C waterbath for 45 sec. The cells were returned to ice for 5 min, 200 pi 
of LB medium was added and incubated for 1 h at 37°C. This mixture was spread on LB 
agar plates containing antibiotics (kanamycin, 40 pg/ml) and grown overnight at 37°C 
(Laboratory Thermal Equipment Ltd). The next day, colonies were picked and inoculated 
in 5 ml of LB medium with antibiotic and grown in an orbital shaker (Gallenkamp) at 37°C
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for 8  h. After this, the medium was transferred to 50 ml LB medium with antibiotics and 
returned to the orbital shaker for 16-18 h.
The next day, the culture was transferred to a falcon tube and centrifuged at 3000 rpm 
for 15 min. The supernatant was discarded and the pellet frozen down until ready for 
preparation with QIAGEN MidiPrep (Qiagen). The plasmids were isolated following the 
manufacturer's protocol exactly and the DNA quantified by nanodrop (Labtech). To 
further concentrate the DNA, it was precipitated following this protocol: 0.1 volumes of 
2M NaAc (Appendix) was added and vortexed. Two volumes of 100% EtOH was added, 
mixed and left at -20°C overnight. This was centrifuged at 14 000 rpm for 15 min and the 
supernatant removed. The tube was half-filled with 70% EtOH and centrifuged for 5 min 
at 14 000 rpm. The supernatant was removed and the tube left open to evaporate the 
last of the EtOH. The DNA pellet was dissolved in water to reach a desired concentration 
and the DNA quantified by nanodrop.
2.7.2 Transform ations of Rab11 plasm ids w ith com petent JM 109s
2pl of miniprep DNA was added to each aliquot of JM109s, mixed and stood on ice for 
30 min. The bacteria were heat-shocked at 42°C for 2 min and stood on ice for 5 min. 
1ml of LB media was added, the solution mixed and incubated at 37°C for 1 h. lOOpI 
aliquots were plated out onto LB agar plates containing 40pg/ml Kanamycin and 
incubated overnight at 37°C, the following day a colony picked to 5ml of LB media with 
Kanamycin and grown for 8 h, then transferred to an overnight 50ml culture. The next 
day, this culture was spun down at 3000 rpm for 15 min, the supernatant removed and 
the pellet frozen until preparation with QIAGEN MidiPrep (Qiagen) and quantified as in 
Section 2.7.1 (DH5a).
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2.8 SDS-PAGE and Western Blot analysis
Samples were prepared with equal amounts of protein added to MilliQ H2 O (MQ), 3xSDS 
sample buffer (New England Biolabs) and DTT (New England Biolabs) to a final volume 
of 30pl. These were boiled at 100°C for 5 min and loaded into the gel (see Appendix) 
alongside a pre-stained protein marker (broad range, 6  -  175kDa, New England 
Biolabs). The gel was run in running buffer (see Appendix) at 100V, 0.2A for 90 min. 
Proteins were transferred onto a PVDF membrane (Immobilon, Milipore) by running at 
100V, 0.4A for 90 min in transfer buffer (see Appendix). The membrane was blocked in 
5% blocking buffer (Appendix) overnight then incubated in primary antibody for 1 h at 
room temperature. The membrane was washed in 1x TBS TWEEN (Appendix) for 2x 30 
second washes and 2 x 1 0  min washes then incubated in the appropriate secondary 
antibody (horse radish peroxidase (HRP) conjugated) for 1 h at RT. The membrane was 
washed as before and SuperSignal West-Pico chemiluminescent substrate (Pierce, 
Thermo Scientific) was used to detect proteins. An X-Ray film (Fuji) was exposed to the 
membrane then developed and fixed.
2.9 Statistical analysis
Experiments were carried out in triplicate with two samples each time, except where 
specified. Graphpad Prism 6  was used for statistical testing using one-way AN OVA and 
Dunnets post-hoc testing to compare more than 2 samples or t-tests for comparing two 
samples.
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Chapter 3 
Early events and signalling in FCV infection
3.1 Introduction
The process of endocytosis, whereby extracellular particles are internalised into the cell,
is normally used for transporting necessary substances into the cell. However,
pathogens have found many ways to hijack these pathways for their own use, in cell
entry. The entry pathways of many viruses have been studied and there have been
various tools developed for studying these pathways such as electron microscopy and
siRNA screening. Among these is the use of dominant negative (DN) forms of proteins
involved in different entry pathways, the use of inhibitor drugs as well as colocalisation
studies. All three of these methods were employed in our study of FCV entry.
Previous work investigating FCV-F9 entry into CRFK cells showed that the virus enters
cells via a clathrin-mediated pathway, also making use of macropinocytosis (Stuart &
Brown, 2006). These pathways were methodically investigated using several drugs and
DN proteins. The role of clathrin-mediated entry for FCV was studied using
chlorpromazine and DN eps15, which disrupt the formation and stability of clathrin-
coated pits. The next stage of clathrin-mediated entry is transport from the cell
membrane to acidic early endosomal compartments. This stage of FCV entry was
investigated using chloroquine, bafilomycin A1 and DN Rab5. Chloroquine and
bafilomycin A1 both inhibit the acidification of endosomes, while DN Rab5 inhibits the
normal function of Rab5 in trafficking to early endosomes. When inhibiting both clathrin
coat formation and early endosomal function, FCV infection was inhibited, demonstrating
the reliance of FCV on this pathway (Stuart & Brown, 2006). Two further pathways were
tested; lipid raft/caveolae pathways using nystatin (a sterol-binding drug which interferes
with caveolae formation), as well as macropinocytosis, using amiloride, El PA (5-(N-ethyl-
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N-isopropyl) amiloride) and benzamil which all inhibit the NaVH^ exchangers integral for 
macropinocytosis (Stuart & Brown, 2006). Using these inhibitors, macropinocytosis was 
also discovered to be vital for FCV entry. Following this, the trafficking within the cell was 
investigated using nocodazole and cytochalasin D which interfere with the microtubules 
and actin respectively. While there was no effect on FCV infection under nocodazole 
treatment, cytochalasin D inhibited infection, indicating a role for actin in FCV entry. As 
well as this, a brief investigation into kinases was undertaken, with the use of PP2 which 
inhibits Src tyrosine kinases. Inhibition of these tyrosine kinases had no effect on FCV 
infection (Stuart & Brown, 2006).
In this chapter, we sought to confirm Stuart and Brown (2006) results and then take the 
work on FCV entry and trafficking further. To do so, we first looked at dynamin, a protein 
integral in clathrin-coated entry. Following on from Stuart & Brown’s work showing FCV 
enters via clathrin-mediated entry, we scrutinised the role of dynamin in the entry of FCV. 
Due to clathrin-mediated endocytosis being dependent on dynamin, we hypothesised 
that FCV would be dependent on functional dynamin within the cell. In order to analyse 
this aspect of entry, we used the reversible dynamin inhibitor, dynasore (Macia et al.,
2006).
After internalisation through the clathrin-mediated pathway (as well as others), the first
cellular compartment an endocytosed particle is trafficked to for sorting is the early
endosome (Trowbridge at a i, 1993). From Stuart & Browns’ investigations, we knew that
FCV trafficked to early endosomes. We sought to confirm and expand this result using
colocalisation studies, as well as following the virus further along the endocytic pathway.
To do so, we utilised several classic endocytic markers; transferrin, dextran, EEA1 (Early
Endosomal Antigen-1) and LAM PI (Lysosomal Associated Membrane Protein),
examining colocalisation with labelled virus at early time points in viral infection. EEA1 is
central to early endosome creation in fusion of the endosome (Mills et al., 1998) and is
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commonly used as a marker for early endosomes (Mu et al., 1995); as such we looked 
for colocalisation of EEA1 with FCV.
Although this previous study had found that FCV trafficked to early endosomes (Stuart & 
Brown, 2006), there was no examination into the role of late endosomes to discover 
whether these endosomes are part of FCV’s route through the cell. Transferrin is 
commonly used as a marker for the clathrin-mediated endocytic pathway; it is known to 
traffic from early to late to recycling endosomes and out of the cell (Dautry-Varsat et al., 
1983). In this study, transferrin was used to track FCV’s pathway through the cell.
Rab7 is a small GTPase involved in the sorting and fusion of late/sorting endosomes and 
lysosomes (Bucci et al., 2000). In order to analyse the effect on FCV infection of 
disturbing Rab7 activity in the cell, a DN form of Rab7 was transfected into cells prior to 
infection with FCV, giving an indication of dependence on late endosomes.
In addition to this, colocalisation studies using LAMP1 [a trans-membrane glycoprotein 
used as a marker of late endosomes (reviewed in Fukuda, 1991)] were carried out. 
Another small GTPase implicated in endocytic pathways, Rabi 1, is involved in trafficking 
and recycling within the cell (Ullrich et al., 1996; Green et al., 1997). A DN form of Rabi 1 
was transfected into these cells prior to infection to examine the effect on FCV infection 
of the disruption of normal Rabi 1-dependent recycling activity within the cell.
As well as tracking the virus through the cell, we were also interested in knowing more 
about its ability to utilise both clathrin-mediated as well as macropinocytic entry 
pathways. To do so, we made use of dextran, a widely used marker of 
macropinocytosis/fluid-phase endocytosis (Kerr & Teasdale, 2009) to colocalise with 
labelled FCV.
The process of endocytosis is controlled to a large extent by signalling within the cell 
(reviewed in Sorkin & Von Zastrow, 2009; Platta & Stenmark, 2011).
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Phosphoinositide-3-kinases (PI3-kinases) are involved in several processes within the 
cell (reviewed in Cantley, 2002) including cell growth, migration and survival as well as 
their role in signalling in endocytosis. PI3-kinases play a key role in several endocytic 
pathways, most notably macropinocytosis and clathrin-mediated entry (Shpetner et al.,
1996) where it is used to activate Rab5 activity (Li et al., 1995). We used the irreversible 
inhibitor of PI3-kinases, wortmannin in order to analyse the dependence of FCV on 
functional PI3-kinases for entry and infection of CRFK cells.
Protein kinases are widely-used signalling molecules within the cell acting as ‘molecular 
switches'. It is when these kinases are stuck in the ‘on’ position that cancer often occurs 
due to over-proliferation of cells, and so these are now a target for cancer therapies 
(Krause & Van Etten, 2005). Tyrosine kinases are so named because they 
phosphorylate proteins on the tyrosine residue which activates them, causing several 
different actions such as relocating proteins within cells (Sun & Tonks, 1994), molecular 
interactions and enzyme activity (Krebs & Beavo, 1979), as well as a key involvement in 
endocytosis. The tyrosine kinase-specific inhibitor, genistein (Akiyama et al., 1987) was 
used in this study to determine FCV’s dependence on tyrosine kinases for entry and 
infection of CRFK cells .
Protein phosphatases are most commonly connected with lipid raft/caveolar entry 
(Parton et a!., 1994). As the ‘reverse’ of kinases, phosphatases are used to remove 
phosphate groups from proteins, with phosphatases often acting in opposition to kinases 
as molecular ‘switches’ to switch proteins off.
Okadaic acid is an inhibitor of protein phosphatases, specifically phosphatases 1 & 2a 
(Cohen et al., 1990), inhibiting endocytosis by lipid rafts and macropinocytosis, and was 
used in this study to investigate the role of protein phosphatases in FCV entry.
Using these tools, we further investigated the route FCV uses when entering CRFK cells 
as well as the intracellular trafficking of the virus and the cellular signalling it depends on 
for productive infection of these cells.
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Materials and Methods
3.2 Effect of endocytic inhibitors on FCV infection of CRFK cells
3.2.1 Analysis of the effect o f drug on FCV entry by confocal m icroscopy
The MOI (multiplicity of infection) of the virus was first determined empirically using 
confocal microscopy to calculate the percentage of infected cells compared to the total 
number of cells.
CRFK cells were grown on coverslips in a 24 well plate overnight at 37°C in 5% CO2 to 
reach -70%  confluency. Differing concentrations of drugs which inhibit different 
signalling pathways (shown in Table 2.1) or DMSO control were mixed in serum-free 
MEM and added to the cells for 30 min. FCV-F9 at an MOI of 0.8 was added for 1 h in 
the presence of the drug. After this time, the cells were washed and replaced with serum- 
free MEM, DMSO control or inhibitor for 5 h (reversible drugs were present throughout 
the 5 h incubation, irreversible drugs were replaced with serum-free MEM for the 
remaining 5 h). A transferrin, dextran or Cholera Toxin B (ChTxB) control was included 
as described in Section 3.4. After incubation, the cells were washed and fixed in 800 pi 
4% paraformaldehyde/ 0.2% glutaraldehyde (Appendix) for 45 min on ice. Cells were 
maintained in PBS (Appendix) at 4°C until staining as in Section 3.9 Analysis of drug 
effect on virus entry was calculated by counting at least 1 0 0  infected cells per 
experiment, (unless otherwise stated) and comparing the drug-treated to the mock- 
treated control.
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3.2.2 Analysis o f the effect o f drug on FCV infection by TCID50
CRFK cells were grown overnight in 24 well plates until -80%  confluent then treated with 
pharnnacological inhibitors in 3 ways; i) drug treatment for 30 min then virus for 1 h, 
replaced with drug or media for the remainder of the infection time; ii) cells were infected 
for 1 h and after removing virus, drug was added for the rest of the infection time; iii) cells 
were infected for 1 h, after removal of the virus, serum-free medium was added for 1 h, 
followed by addition of the drug. This aimed to find the point at which the drug was 
having an effect on virus infection: at entry, in early or in later events in infection. After 
incubation for a total of 6  h, cells were scraped from the wells, transferred to a 
microcentrifuge tube and centrifuged at 14000 rpm at 4°C for 15 min. The supernatant 
was aliquoted and frozen at -2 0 °C until use in TCID50 assays (Section 2.3.1)
3.3 Internalisation of endocytic markers
Before assessing the effect of any inhibitor on FCV entry, the effect of that inhibitor on 
the different entry pathways into the cell was first investigated. To do so, we used three 
endocytic controls in these experiments: transferrin, ChTxB and dextran.
3.3.1 Transferrin binding and internalisation
Transferrin is habitually used as a control for clathrin-mediated entry (Hinrichsen et al., 
2003) and was used in our studies to investigate the effect of a specific drug on clathrin- 
mediated endocytosis. Cells were treated as in Section 3.2.1 without infection, but 
instead Alexa Fluor® 568-conjugated transferrin (80pg/ml; Molecular Probes, Invitrogen) 
was added for 15 min following drug treatment. Cells were rinsed and fixed in 4% 
paraformaldehyde/ 0.2% glutaraldehyde for 45 min on ice. This was replaced with PBS
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and kept at 4°C until staining for confocal microscopy. Cells were stained with nuclear 
stain as in Section 3.9 and mounted on glass slides.
3.3.2 Cholera toxin B binding and internalisation
ChTxB is most commonly used as a control for lipid raft or caveolar entry (Sandvig & van 
Deurs, 2002; Parton et al., 1994), and in our study was used to confirm the role of 
particular inhibitors on lipid raft entry into cells.. It was added to cells after treatment as in 
Section 3.2.1 (without infection). Alexa-Fluor® 594-linked ChTxB (20pg/ml; Molecular 
Probes, Invitrogen) was added to cells for 30 min, rinsed with acid wash (Appendix) and 
the cells fixed in 4% paraformaldehyde for 45 min on ice. These samples were stained 
with nuclear stain as in Section 3.9 and mounted on glass slides.
3.3.3 Dextran binding and internalisation
Dextran is characteristically used as a control for fluid phase/macropinocytic entry 
(Dharmawardhane et al., 2000) and in our study was used to examine the effect of 
specific inhibitors on macropinocytic entry into cells. Dextran was added to cells after 
treatment as laid out in Section 3.2.1 Alexa-Fluor 555-linked Dextran (500pg/ml, 
Molecular Probes, Invitrogen) was added to the cells for 30 min, rinsed off and the cells 
fixed in 4% paraformaldehyde for 45 min on ice. The samples were stained with nuclear 
stain as in Section 3.9 and mounted on glass slides for visualisation by confocal 
microscopy.
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3.4 Purification of FCV F9
T175 (x21) flasks containing CRFK cells at approximately 80% confluency were infected 
with FCV-F9 at an MOI of -0.1 and incubated overnight until cpe was apparent. Cells 
and medium were harvested and stored at -80°C until completely frozen. The media was 
thawed at room temperature (RT) then spun down at 4000 rpm for 30 min (Beckman J2- 
21 M/E centrifuge) to pellet cellular debris. The supernatant was filtered through a 
0.45pm vacuum filter unit (Nalgen) and NaCI (Fisher Scientific) added to a final 
concentration of 0.2M whilst stirring at 4°C. PEG 3350 (Sigma Aldrich) was added to 
10% final volume and stirred at 4°C overnight to allow precipitation to occur. The virus 
preparation was centrifuged at 14000 rpm for 45 min at 4°C (Beckman J2-21M/E 
centrifuge, JA16 rotor) and all supernatant removed. Pellets were resuspended in boric 
acid buffer (Appendix) using a blunt needle (left on ice to aid resuspension). The 
suspension was pelleted again at 14000 rpm for 25 min at 4°C (Beckman J2-21M/E 
centrifuge) and the supernatant removed and kept on ice. The pellets were resuspended 
as before in boric acid buffer and pelleted at 14000 rpm for 20 min at 4°C (Beckman J2- 
21 M/E centrifuge) and the supernatant pooled with the previous supernatant and 
incubated on ice for several hours. A 30% sucrose solution (see Appendix) in a tube 
suitable for SW28 rotor was carefully overlaid with the virus solution then centrifuged at 
25000 rpm overnight at 4°C (Beckman L8-70M ultracentrifuge, SW28 rotor). The next 
day, the liquid was removed and the inside of the tubes dried to remove traces of 
sucrose. The pellets were resuspended in boric acid buffer with a blunt needle then 
incubated on ice for several hours before being centrifuged at 15 000 rpm for 10 min at 
4°C (Hettich MIKRO 22R). The supernatant was transferred to a microcentrifuge tube 
and kept on ice while the pellet was resuspended in boric acid buffer and spun down as 
before. The supernatant was transferred to a microcentrifuge tube and incubated on ice 
while a 2x caesium chloride solution was prepared in PBS (Appendix). An equal amount
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of caesium chloride solution was added to each supernatant and mixed well before 
transferring to 2 tubes suitable for use in an SW55Ti rotor. Samples were centrifuged at 
40000 rpm for 20 h at 4°C in tubes suitable for SW55Ti rotor (Beckman L8-70M, SW55Ti 
rotor). The following day, these tubes were removed and placed in a clamp stand. A 
narrow beam of light was used to visualise the band containing the virus preparation and 
this band was removed from the gradient using a needle. The samples were pooled and 
dialysed overnight at 4°C against 2L of PBS using a Slide-a-Lyser cassette (Pierce, 
Thermo Scientific) with MWCO (molecular weight cut-off) of 10000. The following day, 
samples were centrifuged in a 30000 MWCO Vivaspin Centrifugal Concentrator (GE 
Healthcare; Hettich MIKRO 22R centrifuge) then transferred to a siliconised tube and 
spun down at 15000 rpm for 15 min at 4°C and the supernatant aliquoted and stored at - 
80°C. The concentration of the purified virus preparation was estimated using a BCA 
assay (Pierce, Thermo Scientific) and the virus preparation analysed by SDS-PAGE 
(Section 2.8) to evaluate its purity. The virus preparation was also tested for infectivity 
by plaque assay as in Section 3.8
3.5 Labelling of purified FCV-F9 with DyLight
For the effective visualisation of purified FCV by confocal microscopy, the FCV prep was 
directly labelled with a fluorophore instead of staining. Purified virus (see Section 3.6) 
was thawed and mixed with 20x borate buffer (Pierce, Thermo Scientific) before adding 
DyLight 488 NHS Ester (Pierce, Thermo Scientific) at ~5 pg virus to 1 pi dye. This 
reaction was incubated at RT for 1 h in the dark before being centrifuged in Dye Removal 
Columns (Pierce, Thermo Scientific; Hettich MIKRO 22R) as per the manufacturer’s 
instructions. This solution was then stored at -20°C or used immediately as set out in 
Section 3.7
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3.6 Plaque assay
CRFK cells were seeded onto 6 well plates at 9 x 10"^  per well and incubated overnight to 
reach confluency. Virus was diluted in serum-free MEM to concentrations of 10'^ to 10'® 
and 400pl inoculated onto each well along with an uninfected control. The plates were 
incubated for an hour with rocking, the virus removed and replaced with a mixture of 2x 
media (Appendix) and 0.8% agar (Appendix). This was allowed to set and returned to 
the incubator for 36 h. After this time, the cells were fixed in 2ml formal saline solution for 
20 min. 0.5 ml crystal violet stain (Appendix) was added to each well for 15 min. After 
this time, the stain was washed out of each well, the cell monolayers rinsed in d.H2 0 , 
allowed to dry and the plaques counted. The pfu/ml was calculated using the following 
equation:
Number of plaques 
Dilution factor x 0.4ml
3.7 Colocalisation studies
Labelled FCV was mixed with serum-free MEM to a concentration of -0 .6  pg/pl and 
inoculated onto a cell monolayer on a coverslip in a 24 well plate. Virus was incubated on 
cells with specific markers of endosomes within the cell as indicated in each experiment; 
the cells were then fixed and stained with ToPro3 as in Section 3.9 in preparation for 
confocal microscopy.
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3.8 Effect of DN and CA Rab proteins on FCV-F9 infection
CRFK cells were seeded onto coverslips in a 24 well plate at 4.8 x 10^ cells per well for 
transfections with plasmids encoding Rab7 proteins or 3.5 x 10"^  cells per well for 
transfections with plasmids encoding Rab11 or Arf6 proteins and incubated overnight at 
37°C to reach -70%  confluency. The following day, the media was replaced with 300pl of 
serum-free MEM. For each well to be transfected, 100 pi of OptiMEM (GibcoBRL) was 
mixed with 1.5 pi Fugene HD (Roche Applied Science) and 0.5 pg DNA (plasmids 
expressing green fluorescent protein (GFP)-tagged wt Rab5, DN Rab5 S34N, wt Rab7, 
DN Rab7 T22N, wt Rabi 1, DN Rabi 1 S25N or CA [constitutively active] Rabi 1 Q70L; 
kindly supplied by Prof Stephen Ferguson, Roberts Research Institute, Ontario, Canada). 
The mixtures were incubated at RT for 15 min then 100 pi of the transfection mixture was 
added drop-by-drop to each well and the cells rocked to ensure even coverage. The cells 
were incubated at 37°C for 18 h (for rabi 1 & arf6, the medium on the cells was changed 
after 3 h to 10% MEM and incubation continued for 15 h). After this time, cells were 
infected with FCV-F9 at an MOI of 0.8 for 1 h. The cells were washed and incubated in 
serum free MEM for a further 5 h. Cells were fixed in 800 pi 4% paraformaldehyde/ 0.2% 
gluteraldehyde on ice for 45 min, then maintained in PBS at 4°C until staining as in 
Section 3.9
3.9 Immunofluorescence labelling of CRFK cells
Following drug treatment and infection, and for some colocalisation studies, CRFK cells
were permeabilised in 0.1% Triton x 100 (Appendix) for 15 min, rinsed in PBS and
blocked in 0.5% PBS/BSA (Appendix) for 30 min. Primary antibody (200 pi) was added
to each well and incubated at RT for 1 h. After washing in PBS ( 3 x 5  minute washes),
200 pi secondary antibody was incubated on the cells for 1 h. After washing as before,
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ToProS nuclear stain (1:10 000 in PBS; Molecular Probes, Invitrogen) was applied for 10 
min. For experiments using labelled markers or transfection of GFP-tagged plasmids 
only, ToProS staining only was carried out. The coverslips were removed, rinsed in MQ 
water and placed cell-side down on a glass slide with Vectashield (Vector Laboratories) 
then sealed with clear nail varnish. A Zeiss LSM 510 META confocal laser microscope 
was used to count infected cells in the treated and mock treated samples to find 
percentage infection rates for each cell treatment, or to image colocalisation studies.
3.9.1 Staining for FCV-capsid protein
To visualise FCV infection in CRFK cells, cells were stained with anti FCV capsid IG9 
primary antibody (1:10 000; Carter et al., 1989); Alexa-Fluor®-labelled anti-mouse 
secondary antibody (1:400; Molecular Probes, Invitrogen) and ToProS staining of nuclei.
3.9.2 Staining for endosom al proteins
To visualise EEA1 proteins in these cells, cells were stained with anti EEA1 primary 
antibody (5pg/ml, Abeam); Alexa-Fluor® 555 labelled anti-rabbit secondary and ToProS. 
For the staining of LAMP1, cells were permeabilised in 0.5% saponin (Appendix) for 15 
min, and antibody dilutions were prepared in 0.1% saponin; primary antibody LAMP1 
diluted 1:20 (LAMP 4A1, kind gift from Prof Jean Gruenberg, Dept of Biochemistry, 
University of Geneva), Alexa-Fluor® 555 labelled anti-mouse secondary to 1:400, 
followed by ToProS staining of the nuclei.
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Results
3.10 Purification of FCV-F9
In order to visualise FCV entry effectively by confocal microscopy, we labelled virus 
directly using a fluorophore, DyLight. Virus was prepared and purified using a sucrose 
cushion and a caesium chloride gradient before concentrating (Section 3.4). The 
resultant virus was analysed by SDS-PAGE and Western blot with anti-IG9 FCV capsid 
antibody. As seen in Figure 3.1, the virus prep is of higher concentration than the 
original virus stock. The infectivity of the virus was also tested to ensure that by adding 
the fluorophore, the virus was not becoming any less efficient at infecting cells. Labelled 
virus was prepared and inoculated onto a cell monolayer in 6 well plates, and titres 
determined by plaque assay (Section 3.6). The titre of the labelled virus was 5.28x10^ 
pfu/ml (compared to the original virus stock titre of 2.5x10® pfu/ml).
3.11 Effect of dynamin inhibition on FCV infection
Dynamin is a GTPase protein found at the membrane of cells which is crucial in clathrin 
mediated entry (Praefcke & McMahon, 2004), acting as a molecular motor (McNiven, 
1998), to pinch off the invaginated vesicle from the membrane and allow it to internalise. 
Dynasore is a recognised inhibitor of dynamin proteins (dynamin-1, -2 and the 
mitochondrial dynamin D rp l; Macia et al., 2006) which is involved in several cellular 
entry pathways, as well as trafficking within the cell. As such, the inhibition of dynamin by 
dynasore affects several dynamin-dependent pathways, such as clathrin-, caveolae- and 
other dynamin-dependent pathways. Due to FCV’s dependence on clathrin for entry, we 
hypothesised that FCV would also be dependent on dynamin for entry.
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BFigure 3.1 Western blot analysis of the purified virus sample
Samples were analysed by SDS PAGE (10%), and Western blot membranes were probed with 
anti-IG9 capsid (1:2000) followed by anti-mouse HRP conjugated secondary antibody. 
Chemiluminescent substrate was added to the blot which was exposed to film and developed. 
(A) shows the purified virus capsid protein (62kDa), (B) the stock virus solution.
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3.11.1 Dynasore is not cytotoxic to CRFK cells
As dynamin is such an integral part of regular cell function, disrupting it can produce 
detrimental effects to the cell. Cell viability under different concentrations of dynasore 
was therefore tested. Cells were treated with dynasore for 6 h, the supernatant harvested 
and tested for LDH activity. The results shown in Figure 3.2 indicated that at the 
concentrations used in our studies (25, 50 and 75 pM); there was negligible cell death. 
These concentrations were deemed suitable for use in subsequent experiments.
3.11.2 FCV entry is dependent on functional dynam in proteins
In order to confirm the effect of dynasore on dynamin in CRFK cells, the effect of 
dynamin inhibition was investigated using endocytic markers as controls (described in 
Section 3.3) Cells were treated with dynasore 30 min before the addition of transferrin, 
dextran or ChTxB, then fixed and stained in preparation for confocal microscopy. As 
shown in Figure 3.3 A&B, dynasore affects the clathrin mediated pathway as seen in the 
reduction of transferrin entry into CRFK cells. Interestingly, in these cells, dynasore also 
reduced macropinocytic entry as shown by the effect on dextran entry in Figure 3.3 
C&D. Reports of dynamin involvement in macropinocytosis are varied, and are 
discussed further in Section 3.21 Treatment of cells with dynasore decreased ChTxB 
entry into CRFK cells (as shown previously; Macia et al., 2006) indicating dynamin is 
involved in lipid raft entry (Figure 3.3 E&F) To study the effect of dynasore on FCV 
entry, cells were treated with dynasore for 30 min before addition of the virus for 6 h, in 
the presence of dynasore. Cells were fixed, and stained as in Section 3.9.1 Inhibition of 
dynamin in CRFK cells was shown to have a significant effect on FCV infection, reducing 
infection by 35% at the highest concentration of dynasore used (Figure 3.4). Together 
with the effect seen on transferrin and dextran entry, this indicates that the role of 
dynamin in FCV entry is partly in clathrin-mediated entry but also in macropinocytic entry.
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Figure 3.2 Increasing concentrations of dynasore do not affect CRFK cell viability
CRFK cells were treated with increasing concentrations of dynasore and incubated for 6 h. After 
this time, the supernatant was removed and tested for LDH activity as an indication of cell death. 
A high control (Triton X-100 treated cells) and low control (media only) are included. Results 
show the mean +/-  SE of 3 replicates, as a percentage of the high control as calculated in Section 
2.7.
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Figure 3.3 Effect of dynasore treatment on the entry pathways of CRFK cells
CRFK cells were mock-treated (A,C&E) or treated with 75 pM dynasore (B,D&F) for 30 min then 
incubated with Alexa-555 transferrin (A&B) for 15 min, Alexa-555 dextran (C&D) or Alexa-555 
ChTxB (E&F) for 30 min at 37°C. ToPro3 stained nuclei are shown in blue. Cells were visualised 
using a ZEISS LSM META confocal laser microscope with 543 nm laser to detect the markers (red) 
and 633 nm laser to detect nuclei (blue). The bar indicates a size of 10 pm.
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Figure 3.4 Dynamin proteins are required for FCV entry into cells
CRFK cells were treated with increasing concentrations of dynasore for 30 min before infection 
for 6 h (control cells were treated with DMSO-containing MEM). Cells were fixed and stained 
using anti-FCV capsid antibody followed by Alexa-555 secondary antibody and ToProS to stain 
the nuclei for confocal microscopy. Results shown are the numbers of cells infected in each 
treatment compared to the control. Results shown are the numbers of cells counted as infected 
in each treatment compared to the control, and are the mean of three independent experiments 
(+/-SE; * is P <0.05).
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3.11.3 FCV replication is reliant upon dynam in
As seen in Section 3.11.2, inhibition of dynamin in CRFK cells inhibited FCV entry. The 
effect of dynasore on FCV replication was also tested by addition of the drug at various 
times before and after infection; the supernatant was collected and virus titres analysed 
by TCID50. As expected, when dynasore was added 30 min before infection, there was a 
significant inhibition of FCV infection. This indicated that the virus yield was significantly 
reduced as the ability of the virus to enter the cells was inhibited. When dynasore was 
added simultaneously with the virus, a similar, but more severe inhibition of infection was 
seen, suggesting that the early events of virus replication also require functional dynamin 
proteins. When dynasore was added 1 h after infection, there was still a significant 
inhibition of virus replication. These results (Figure 3.5) suggest that FCV uses dynamin 
proteins for cell entry, but also in early and later events in replication within the cell.
3.11.4 FCV utilises dynam in in m acropinocytosis & clathrin-m ediated entry
Given that inhibiting dynamin proteins seemed to affect both clathrin-mediated 
endocytosis as well as macropinocytosis in these cells, we studied the effect of dynasore 
on the entry of labelled FCV and transferrin, a marker of clathrin-mediated entry. Since 
we knew that FCV uses clathrin-mediated entry, we expected to see transferrin and FCV 
trapped together on the cell surface when cells were treated with dynasore. After 
treatment of cells with dynasore for 30 min, cells were incubated for 15 min with labelled 
FCV and Alexa-labelled transferrin, fixed and nuclear stained for confocal microscopy. 
As can be seen in Figure 3.6, FCV and transferrin are not trapped on the membrane as 
expected. However, it appears that dynasore treatment affects FCV entry more than 
transferrin entry as shown by the greater reduction in FCV entry compared to that of 
transferrin. This result could indicate a greater-than-expected role for macropinocytosis 
in FCV entry.
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Figure 3.5 FCV depends on dynamin for entry, early and late stages of replication
CRFK cells were treated with dynasore either i) 30 min before infection, ii) simultaneously with 
infection or iii) 30 min after infection with FCV-F9. Control cells were treated with DMSO- 
containing MEM. Infection was carried out for 6 h a t 37°C, the cells were lysed and the viral titre 
of the resultant supernatant analysed by TCID50. The results were calculated as a percentage of 
the untreated control and are shown as the mean of three independent experiments (+/- SE; ** 
is P <0.01; * * *  is P< 0.001).
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Figure 3.6 Dynasore inhibits the entry of both transferrin and FCV
CRFK cells were treated with dynasore (D,E&F) or mock-treated (A,B&C) for 30 min followed by 
incubation with Alexa-555 transferrin (red, A&D) and labelled FCV (green, B&E) for 15 min at 
37°C then fixed. ToPro3 stained nuclei are shown in blue. Cells were visualised using a ZEISS LSM 
META confocal laser microscope with 543 nm laser to detect transferrin (red, A&D), 488 nm laser 
for labelled FCV (green, B&E) and 633 nm laser to detect nuclei (blue). Shown are two replicates; 
panels C&F are overlays of A&B and D&E respectively. The bar indicates a size of 10 pm.
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3.12 FCV partially colocalises with transferrin
The plasma glycoprotein transferrin, binds iron in the blood stream and transports it into 
cells by binding to the transferrin receptor on the cell membrane (Crichton & 
Charloteaux-Wauters, 1987). The iron-bound transferrin is transported to the early 
endosome where the low pH instigates the release of the iron. From the early endosome, 
the transferrin, still bound to its receptor, is moved to the late endosome, then the 
recycling endosome and back out of the cell to be reused for iron transport (Dautry- 
Varsat et al., 1983). Since this pathway of transferrin trafficking is so well-established, we 
attempted to colocalise FCV with transferrin to track its progress through the cell. 
Labelled virus and Alexa-labelled transferrin were allowed to co-internalise into CRFK 
cells for 10, 20 and 30 min, the cells were fixed and stained for visualisation by confocal 
microscopy. Although after 10 min (Figure 3.7), only a relatively small amount of virus 
has been internalised, there was partial colocalisation between transferrin and FCV, 
reinforcing the previous results that FCV travels to early endosomes. After 20 min there 
was less colocalisation, indicating that FCV might not be cycling to late endosomes 
(Figure 3.8) However, after 30 min, there appears to be an increase in colocalisation 
(Figure 3.9). At this time, we would expect transferrin to be in recycling endosomes, and 
as there was increased colocalisation, this points to FCV also being trafficked to 
recycling endosomes. The partial colocalisation seen here suggests that some FCV is 
trafficking from early to recycling endosomes, however to confirm this hypothesis, we 
looked at specific endosomal markers to confirm which endosomes FCV is trafficking to. 
The partial colocalisation seen here could also point to more FCV entering via 
macropinocytosis rather than clathrin-mediated entry.
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Figure 3.7 FCV and transferrin are partially colocalised 10 min post-infection
CRFK cells were incubated with DyLight labelled FCV (green, B&E) and Alexa-555 transferrin (red, 
A&D) for 10 min at 37°C, then fixed. ToPro3 stained nuclei are shown in blue. Cells were 
visualised using a ZEISS LSM META confocal laser microscope with 543 nm laser to detect 
transferrin (red, A&D), 488 nm laser for labelled FCV (green, B&E) and 633 nm laser to detect 
nuclei (blue). Shown are two replicates; panels C&F are overlays of A&B and D&E respectively. 
The bar indicates a size of 10 pm.
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Figure 3.8 Reduced colocalisation between FCV and transferrin 20 min post-infection
CRFK cells were incubated with DyLight labelled FCV (green, B&E) and Alexa-555 transferrin (red, 
A&D) for 20 min at 37°C, then fixed. ToPro3 stained nuclei are shown in blue. Cells were 
visualised using a ZEISS LSM META confocal laser microscope with 543 nm laser to detect 
transferrin (red, A&D), 488 nm laser for labelled FCV (green, B&E) and 633 nm laser to detect 
nuclei (blue). Shown are two replicates; panels C&F are overlays of A&B and D&E respectively. 
The bar indicates a size of 10 pm.
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Figure 3.9 Partial colocalisation between FCV and transferrin 30 min post-infection
CRFK cells were incubated with DyLight labelled FCV (green, B&E) and Alexa-555 transferrin (red, 
A&D) for 30 min at 37°C, and then fixed. ToPro3 stained nuclei are shown in blue. Cells were 
visualised using a ZEISS LSM META confocal laser microscope with 543 nm laser to detect 
transferrin (red, A&D), 488 nm laser for labelled FCV (green, B&E) and 633 nm laser to detect 
nuclei (blue). Shown here are two replicates; panels C&F are overlays of A&B and D&E 
respectively. The bar indicates a size of 10 pm.
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3.13 FCV is trafficked to early endosomes
To confirm the presence of FCV in early endosomes as established by Stuart and Brown 
(2006), colocalisation of labelled FCV with EEA1, a marker of early endosomes, was 
undertaken. EEA1 is commonly used as a marker of early endosomes (Mu et al., 1995) 
as it is known to interact with PI3-kinases, an interaction required for endosomal fusion 
(Patki et al., 1997; Mills et a i, 1998).
CRFK cells were incubated for 10,15 and 30 min with labelled FCV and fixed. They were 
then stained for cellular EEA1 proteins using an anti-EEAl primary antibody and Alexa- 
labelled secondary antibody (as in Section 3.9.2) and processed for confocal 
microscopy. It can be seen in Figure 3.10 & 3.11, after 10 and 15 min, there is 
colocalisation of FCV particles with EEA1, confirming the previous result obtained by 
Stuart and Brown (2006) that FCV traffics to early endosomes. After 30 min, (Figure 
3.12) there is still a small percentage of colocalisation, although by this time we would 
expect FCV to have been cycled out of early endosomes. This could be an indication that 
FCV is using an entry pathway that is slower than clathrin-mediated entry which could 
also explain the lack of complete colocalisation with transferrin.
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Figure 3.10 Colocalisation of FCV with EEAl 10 min post-infection
CRFK cells were infected with DyLight labelled FCV (green, B&E) for 10 min at 37°C before being 
fixed and stained with anti-EEAl antibody followed by Alexa-555 secondary antibody (red, A&D). 
ToPro3 stained nuclei are shown in blue. Cells were visualised using a ZEISS LSM META confocal 
laser microscope with 543 nm laser to detect EEAl (red, A&D), 488 nm laser for labelled FCV 
(green, B&E) and 633 nm laser to detect nuclei (blue). Shown are two replicates; panels C&F are 
overlays of A&B and D&E respectively. The bar indicates a size of 10 pm.
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Figure 3,11 Colocalisation of FCV with EEAl 15 min post-infection
CRFK cells were Infected with DyLight labelled FCV (green, B&E) for 15 min at 37°C before being 
fixed and stained with anti-EEAl antibody followed by Alexa-555 secondary antibody (red, A&D). 
ToPro3 stained nuclei are shown in blue. Cells were visualised using a ZEISS LSM META confocal 
laser microscope with 543 nm laser to detect EEAl (red, A&D), 488 nm laser for labelled FCV 
(green, B&E) and 633 nm laser to detect nuclei (blue). Shown are two replicates; panels C&F are 
overlays of A&B and D&E respectively. The bar indicates a size of 10 pm.
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Figure 3.12 Reduced colocalisation between FCV and EEAl 30 min post-infection
CRFK cells were infected with Dylight labelled FCV (green, B&E) for 30 min at 37°C before being 
fixed and stained with anti-EEAl antibody followed by Alexa-555 secondary antibody (red, A&D). 
ToPro3 stained nuclei are shown in blue. Cells were visualised using a ZEISS LSM META confocal 
laser microscope with 543 nm laser to detect EEAl (red, A&D), 488 nm laser for labelled FCV 
(green, B&E) and 633 nm laser to detect nuclei (blue). Shown are two replicates; panels C&F are 
overlays of A&B and D&E respectively. The bar indicates a size of 10 pm.
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3.14 FCV colocalises with dextran, a marker for fluid-phase entry
Stuart and Brown (2006) investigated the role of macropinocytosis in FCV entry and 
found that FCV was utilising this pathway as well as clathrin-mediated entry for entry into 
CRFK cells. We sought to explore this ability of the virus to use both pathways using 
dextran, which is a well-established marker for macropinocytosis/fluid-phase endocytosis 
(Dharmawardhane et al., 2000). In order to assess to what extent the virus was making 
use of the macropinocytic entry route, we looked for colocalisation of labelled FCV with 
dextran at different timepoints post-infection. DyLight labelled virus and Alexa-labelled 
dextran were allowed to co-internalise for 15, 30 and 60 min, the cells fixed and 
subjected to nuclear staining. Although there is a limited amount of virus and dextran 
internalised after 15 min (Figure 3.13), dextran and FCV particles colocalised 
increasingly over time (Figures 3.13, 3.14 & 3.15). Along with the limited colocalisation 
with transferrin (Section 3.12), this result indicates that this route of endocytosis could 
be a main route for FCV entry into CRFK cells.
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Figure 3.13 Colocalisation of labelled FCV and dextran 15 min post-infection
CRFK cells were incubated with Dylight labelled FCV (green, B&E) and Alexa-555 dextran (red, 
A&D) for 15 min at 37°C, and fixed. ToPro3 stained nuclei are shown in blue. Cells were 
visualised using a ZEISS LSM META confocal laser microscope with 543 nm laser to detect 
dextran (red, A&D), 488 nm laser for labelled FCV (green, B&E) and 633 nm laser to detect nuclei 
(blue). Shown are two replicates; panels C&F are overlays of A&B and D&E respectively. The bar 
indicates a size of 10 pm.
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Figure 3.14 Colocalisation between labelled FCV and dextran 30 min post-infection
CRFK cells were incubated with DyLight labelled FCV (green, B&E) and Alexa-555 dextran (red, 
A&D) for 30 min at 37°C, and fixed. ToPro3 stained nuclei are shown in blue. Cells were 
visualised using a ZEISS LSM META confocal laser microscope with 543 nm laser to detect 
dextran (red, A&D), 488 nm laser for labelled FCV (green, B&E) and 633 nm laser to detect nuclei 
(blue). Shown are two replicates; panels C&F are overlays of A&B and D&E respectively. The bar 
indicates a size of 10 pm.
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Figure 3.15 Colocalisation of labelled FCV and dextran 60 min post-infection
CRFK cells were incubated with DyLight labelled FCV (green, B&E) and Alexa-555 dextran (red, 
A&D) for 60 min at 37°C, and fixed. ToPro3 stained nuclei are shown in blue. Cells were 
visualised using a ZEISS LSM META confocal laser microscope with 543 nm laser to detect 
dextran (red, A&D), 488 nm laser for labelled FCV (green, B&E) and 633 nm laser to detect nuclei 
(blue). Shown are two replicates; panels C&F are overlays of A&B and D&E respectively. The bar 
indicates a size of 10 pm.
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3.15. FCV infection is not affected by a dominant negative Rab7
After confirming that FCV traffics to early endosomes as seen previously (Stuart & 
Brown, 2006; Section 3.13), we wished to study the subsequent trafficking of FCV in 
CRFK cells since nothing was known about this. In order to answer this question, we 
investigated the role of Rab7 in FCV entry.
Rab7 GTPase is utilised within the cell for as endosomes mature from early endosomes 
to late endosomes/lysosomes, gradually taking over the role of Rab5 (a marker of early 
endosomes) as the endosome is transported through the cell (Rink et al., 2005). Rab7 
and LAMP1 are known to localise to late endosomes as they mature into lysosomes 
(Humphries et al., 2011). Results in a previous section (Section 3.12) indicated that FCV 
is not being transported to late endosomes and in order to confirm these results we used 
a DN form of the Rab7 GTPase protein to interfere with the transport of early to late 
endosomes.
CRFK cells were transfected with plasmids expressing GFP-tagged forms of either the 
wild-type (wt) or DN Rab7 protein for 18 h, followed by infection with FCV for 6 h. The 
level of infection was observed by confocal microscopy as seen in Figure 3.16 and the 
results in Figure 3.17 calculated by counting the number of transfected cells and 
scoring them as infected or uninfected. The DN Rab7 had no effect on FCV infection, as 
compared to addition of the wt Rab7 protein (Figure 3.17). This suggests that FCV does 
not require Rab7 for infection of CRFK cells. Since Rab7 is mostly associated with 
transport from early to late endosomes, this result again indicates FCV does not traffic 
via this pathway, but avoids the late endosome. To further support this result, we looked 
for colocalisation between FCV and the late endosomal marker, LAMP1 (Section 3.16).
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Figure 3.16 FCV infection of CRFK cells is independent of Rab7
CRFK cells were transfected with plasmids expressing GFP-tagged wt or DN form of Rab7 for 18 h 
then infected with FCV for 6 h, before being fixed and stained for FCV infection using anti-IG9 
antibody followed by Alexa-555 secondary antibody (red). ToProS stained nuclei are shown in 
blue. Cells were visualised using a ZEISS LSM META confocal laser microscope with 543 nm laser 
to detect the virus (red), 488 nm laser for transfected protein (green) and 633 nm laser to detect 
nuclei (blue). The bar indicates a size of 10 pm.
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Figure 3.17 FCV does not require functional Rab7 for infection of CRFK cells
CRFK cells were transfected with plasmids expressing GFP-tagged wt  and DN forms of Rab7 for 
18 h, before infection with FCV for 6 h. Cells were fixed and stained with anti-FCV capsid 
antibody followed by Alexa-555 secondary antibody. ToProS was used to stain the nuclei. Cells 
were visualised using a ZEISS LSM META confocal laser microscope and the transfected cells 
scored as infected or uninfected. Results shown are the numbers of cells infected (red) in the 
DN-transfected cells compared to the wt (green), and are the mean of three independent 
experiments (+/-SE).
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3.16 FCV is not present in late endosomes
As shown in Section 3.15, there was no effect on FCV infection observed when cells 
were transfected with DN form of Rab7. To confirm this result, we looked for 
colocalisation of virus with LAMP-1 (lysosome-associated membrane protein-1) again 
using labelled FCV. LAMP-1 is a trans-membrane protein which is an integral component 
of late endosomes and lysosomes, associated with Rab7 during late endosome 
maturation (Fukuda, 1991 ; Szymanski etal., 2011).
CRFK cells were infected with labelled FCV for 15, 25 and 30 min, fixed, and stained for 
cellular LAMP-1 proteins using an anti-LAMP primary antibody and Alexa-labelled 
secondary antibody (as in Section 3.9.2) and visualised using confocal microscopy. 
Although we studied potential colocalisation at several time points, there was no 
colocalisation between FCV and LAMP-1 at any time point (Figures 3.18, 3.19 & 3.20) 
This result confirms that FCV bypasses late endosomes (as seen in Rab7 experiments. 
Section 3.15) and possibly the entire lysosomal pathway, which could indicate it is 
trafficking via the recycling endosomes.
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Figure 3.18 Lack of colocalisation between FCV and LAMP-115 min post-infection
CRFK cells were infected with Dylight labelled FCV (green, B&E) for 15 min at 37°C before being 
fixed and stained with anti-LAMP 4A1 antibody followed by Alexa-555 secondary antibody (red, 
A&D), ToPro3 stained nuclei are shown in blue. Cells were visualised using a ZEISS LSM META 
confocal laser microscope with 543 nm laser to detect LAMP-1 (red, A&D), 488 nm laser for 
labelled FCV (green, B&E) and 633 nm laser to detect nuclei (blue). Shown are two replicates; 
panels C&F are overlays of A&B and D&E respectively. The bar indicates a size of 10 pm.
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Figure 3.19 Lack of colocalisation between FCV and LAMP-1 25 min post-infection
CRFK cells were infected with Dylight labelled FCV (green, B&E) for 25 min at 37°C before being 
fixed and stained with anti-LAMP 4A1 antibody followed by Alexa-555 secondary antibody (red, 
A&D). ToPro3 stained nuclei are shown in blue. Cells were visualised using a ZEISS LSM META 
confocal laser microscope with 543 nm laser to detect LAMP-1 (red, A&D), 488 nm laser for 
labelled FCV (green, B&E) and 633 nm laser to detect nuclei (blue). Shown are two replicates; 
panels C&F are overlays of A&B and D&E respectively. The bar indicates a size of 10 pm.
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Figure 3.20 Lack of colocalisation between FCV and LAMP-1 30 min post-infection
CRFK cells were infected with Dylight labelled FCV (green, B&E) for 30 min at 37°C before being 
fixed and stained with anti-LAMP 4A1 antibody followed by Alexa-555 secondary antibody (red, 
A&D). ToPro3 stained nuclei are shown in blue. Cells were visualised using a ZEISS LSM META 
confocal laser microscope with 543 nm laser to detect LAMP-1 (red, A&D), 488 nm laser for 
labelled FCV (green, B&E) and 633 nm laser to detect nuclei (blue). Shown are two replicates; 
panels C&F are overlays of A&B and D&E respectively. The bar indicates a size of 10 pm.
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3.17 FCV infection is inhibited by a dominant negative R ab ll
Rab11 is used within the cell at the recycling endosome for trafficking of substances out 
of the cell (Ullrich et al., 1996; Green et al., 1997) as well as from the trans-Golgi network 
(TGN) out of the cell (Chen et al., 1998). Since our previous results showed that FCV 
was not trafficking to Rab7-associated late endosomes or lysosomes (Section 3.15 and 
3.16), we next investigated whether FCV was trafficking to Rabi 1-positive recycling 
endosomes in the recycling pathway using a DN R a b ll protein. Rabi 1-positive vesicles 
are bound for recycling endosomes, so by disrupting normal R a b ll function, the 
trafficking to recycling endosomes is disrupted.
CRFK cells were transfected with plasmids expressing the wt, DN and CA forms of 
Rabi 1 for 18 h and the cells infected with FCV for 6 h, before being fixed and stained for 
confocal microscopy (Figure 3.21) The level of infection was observed by confocal 
microscopy as seen in Figure 3.21 and the results in Figure 3.22 were calculated by 
counting the number of transfected cells and scoring them as either infected or 
uninfected. When comparing the level of infection in DN plasmid-transfected cells to the 
wt Rabi 1 transfected cells, we saw a significant decrease of 40% in infection in DN 
R a b ll transfected cells (shown in Figure 3.22) As R a b ll is a known marker of 
recycling endosomes, this result is the first indication that FCV could be trafficking via 
recycling endosomes in CRFK cells.
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Figure 3.21 FCV infection of CRFK cells requires Rabll
CRFK cells were transfected with a GFP-tagged wt, DN or CA form of R ab ll for 18 h then 
infected with FCV for 6 h, before being fixed and stained for FCV infection using anti-IG9 
antibody followed by Alexa-555 secondary antibody. ToProS stained nuclei are shown in blue. 
Cells were visualised using a ZEISS LSM META confocal laser microscope with 543 nm laser to 
detect the virus (red), 488 nm laser for transfected protein (green) and 633 nm laser to detect 
nuclei (blue). The bar indicates a size of 10 pm.
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Figure 3.22 FCV infection of CRFK cells is inhibited by a DN R abll protein
CRFK cells were transfected with plasmids expressing GFP-tagged wt, DN and CA forms of R ab ll 
for 18 h, the media changed to 10% FBS media after 3 h. Cells were infected with FCV for 6 h 
then fixed and stained with anti-FCV capsid antibody followed by Alexa-555 secondary antibody 
and ToProB to stain the nuclei. Cells were visualised using a Zeiss LSM 510 META confocal laser 
microscope and the transfected cells scored as infected or uninfected. Results shown are the 
numbers of cells infected (red) in the DN- or CA-transfected cells compared to the wt (green), 
and are the mean of three independent experiments (+/-SE; **  is P^<0.01).
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3.18 Effect of PI3-kinase inhibition on FCV infection
PI3-kinases are involved in many functions within the cell, including cell migration, 
growth and survival, in addition to cell signalling (reviewed in Cantley, 2002). However, it 
was the function of PI3-kinases in endocytic regulation in particular that we wanted to 
examine, to discover whether FCV infection of CRFK cells utilised PI3-kinases. We 
sought to answer this question using the irreversible class I and III PI3-kinase inhibitor, 
wortmannin (Okada et al., 1994). Although it has been shown to inhibit PI4-kinases at 
higher concentrations, the concentrations of wortmannin used in this study are specific 
for PI3-kinases (Domin et a!., 1997; Wipf & Halter, 2005). The action of wortmannin 
inhibits the fusion of endosomes (Jones et a/., 1998) and interferes with
macropinocytosis-induced membrane ruffling (Dharmawardhane et a!., 2000).
Wortmannin has been used to study the entry of several viruses such as adenoviruses 
(Li et a/., 1998, Sanlioglu et a/., 2000), human rhinovirus-2 (Brabec et a/., 2006) and 
HPV16 (Schelhaas et a/., 2012) and so was used in this study to investigate the role of 
PI3-kinases in the entry and trafficking of FCV. Since FCV uses both clathrin-mediated 
endocytosis as well as macropinocytosis to enter these cells, we hypothesised that PI3- 
kinases would be involved in FCV entry.
3.18.1 Effect o f wortm annin treatm ent on CRFK cell cytotoxicity
Due to the involvement of PI3-kinases in so many aspects of cell survival as mentioned
above, we first looked at the effect of wortmannin on cell viability. CRFK cells were
incubated in the presence of wortmannin for 6 h, before the media was removed and
tested for LDH activity as an indicator of cell death. As shown in Figure 3.23, although
the effect on CRFK cells was a -20%  death rate, it was not possible to reduce this
further. Additionally, after visual observation of the cells under wortmannin treatment,
these concentrations of drug were deemed suitable for use in subsequent experiments.
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Figure 3.23 Wortmannin treatment causes mild cytotoxicity to CRFK cells
CRFK cells were treated with increasing concentrations of wortmannin for 6 h, the supernatant 
harvested and tested for LDH activity as an indication of cell death. A high control (Triton X-100 
treated cells) and low control (media only) are included. Results are presented as cell death for 
each treatment as a percentage of the high control (as calculated in Section 2.7), showing the 
mean +/-SE of 3 replicates.
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3.18.2 FCV entry depends on functional P I3-kinases
Before infection of CRFK cells treated with wortmannin, the effect of wortmannin on the 
endocytosis pathways of these cells was explored. To do so, we employed endocytic 
markers as controls (Section 3.3), where cells were treated with wortmannin before 
incubation with transferrin, ChTxB or dextran. It has been described previously, that 
wortmannin does not inhibit entry of transferrin, but prevents its trafficking beyond early 
endosomes (Spiro et al., 1996). We observed accumulations of transferrin in early 
endosomes consistent with these observations (Figure 3.24 A&B) As shown in Figure 
3.24 C&D, wortmannin treatment of CRFK cells greatly decreased the entry of dextran, 
pointing to a key role of PI3-kinases in macropinocytic entry in these cells. Entry of 
ChTxB was not affected by wortmannin treatment; however, in some cases, there were 
accumulations visible similar to those that were seen with transferrin (Figure 3.24 E&F) 
indicating that ChTxB also traffics to early endosomes in these cells as in others (Nichols 
et al., 2001; Richards et al., 2002).
The role of PI3-kinases in FCV entry into CRFK cells was then studied. Cells were 
treated with wortmannin 30 min before infection with FCV for 6 h; cells were fixed and 
stained for confocal analysis. As shown in Figure 3.25, there was a small but significant 
effect on FCV infection, showing that to some extent, functional PI3-kinases are required 
in the cell in order for FCV to enter. This supports previous findings (Stuart & Brown,
2006) that FCV enters through macropinocytosis and clathrin-mediated endocytosis. This 
is the first report of PI3-kinase involvement in FCV infection of CRFK cells.
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Figure 3.24 Effect of wortmannin treatment on the entry pathways of CRFK cells
CRFK cells were mock-treated (A,C&E) or treated with lOOnM wortmannin (B,D&F) for 30 min 
then incubated with Alexa-555 transferrin (A&B) for 15 min, Alexa-555 dextran (C&D) or Alexa- 
555 ChTxB (E&F) for 30 min at 37°C. ToPro3 stained nuclei are shown in blue. Cells were 
visualised using a ZEISS LSM META confocal laser microscope with 543 nm laser to detect the 
markers (red) and 633 nm laser to detect nuclei (blue). The bar indicates a size of 10 pm.
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Figure 3.25 PI3-kinases are required for entry of FCV into CRFK cells
CRFK cells were treated with wortmannin for 30 min and infected for 6 h before being fixed. 
Control cells were treated with MEM containing DMSO. Cells were then stained for confocal 
microscopy using anti-FCV capsid antibody followed by Alexa-555 secondary antibody and 
ToPro3 to stain the nuclei. Results were calculated by counting the number of infected cells in 
each treatment and expressing them as a percentage of the control. Results shown are the mean 
of three independent experiments (+/- SE; * is P ^0.05; **  is P < 0.01).
115
3.18.3 P I3-kinases are essential in FCV replication
The results in above, led us to enquire whether PI3-kinases were involved in FCV 
replication or only in entry. This was achieved by adding the drug at different times 
before and after infection, following which, the media was collected and virus titres 
analysed by TCID50. When wortmannin was added 30 min before the cells were infected 
with FCV, there was a decrease in infection of -70%, indicating that the function of PI3- 
kinases within the cell is essential for virus entry (Figure 3.26) When cells were infected 
at the same time as the addition of wortmannin, there was a significant inhibition of 
infection, which could indicate a role of PI3-kinases in early FCV replication events. 
When wortmannin was added 1 h after cells were infected, significant inhibition of 
infection was observed, suggesting that PI3-kinases are essential for FCV replication, in 
both early and later events. These results point to a role for PI3-kinases not only in entry, 
but also subsequent replication mechanisms as discussed in Section 3.21
3.18.4 FCV depends on PI3-kinases for m acropinocytic entry
Since wortmannin was shown to affect macropinocytosis as well as the clathrin mediated 
pathway from early endosomes to late endosomes (Section 3.18.2), we sought to 
discover exactly where PI3-kinases were involved in FCV infection -  in entry or in 
intracellular events such as trafficking. In order to do so, we treated cells with 
wortmannin before co-internalising fluorescently labelled FCV with Alexa-labelled 
transferrin or dextran for 15 min. Cells were fixed and nuclear stained in preparation for 
imaging by confocal microscopy. As seen from Figure 3.27, treatment with wortmannin 
impeded transferrin entry only at the early endosomes while the entry of FCV was 
completely blocked. In Figure 3.28, it can be seen that wortmannin prevented the entry 
of FCV as well as dextran. The similarity of FCV entry to dextran entry (rather than to 
transferrin entry) again implicates a greater role for macropinocytosis in FCV entry.
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Figure 3.26 FCV depends on PI3-kinases for entry, early and late stages of infection
CRFK cells were treated with different concentrations of wortmannin either i) 30 min before 
infection with FCV (early), ii) at the same time as infection (simultaneous) or iii) 30 min after 
infection (late). Control cells were treated with DMSO-containing MEM. Infection was carried 
out for 6 ha t 37°C, the cells lysed and the virus titres of the supernatant analysed by TCID50. The 
results were calculated as a percentage of the untreated control and are shown as the mean of 
three independent experiments (+/- SE; ** is P ^0.01; * * *  is P < 0.001).
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Figure 3.27 Wortmannin interferes with the trafficking of transferrin and the entry of FCV
CRFK cells were treated with wortmannin (D,E&F) or mock-treated (A,B&C) for 30 min followed 
by incubation with Alexa-555 transferrin (red, A&D) and labelled FCV (green, B&E) for 15 min at 
37°C. ToPro3 stained nuclei are shown in blue. Panels C&F are overlays of A&B and D&E 
respectively. Cells were visualised using a ZEISS LSM META confocal laser microscope with a 488 
nm laser to detect the virus (green), 543 nm laser to detect transferrin (red) and 633 nm laser to 
detect nuclei (blue). The bar indicates a size of 10 pm.
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Figure 3.28 Wortmannin inhibits the entry of both FCV & dextran
CRFK cells were treated with wortmannin (D,E&F) or mock-treated (A,B&C) for 30 min followed 
by incubation with Alexa-555 dextran (red, A&D) and labelled FCV (green, B&E) for 15 min at 
37°C. ToPro3 stained nuclei are shown in blue. Panels C&F are overlays of A&B and D&E 
respectively. Cells were visualised using a ZEISS LSM META confocal laser microscope with a 488 
nm laser to detect the virus (green), 543 nm laser to detect dextran (red) and 633 nm laser to 
detect nuclei (blue). The bar indicates a size of 10 pm.
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3.19 Effect of tyrosine kinase inhibition on FCV infection
Tyrosine kinases are signalling molecules widely used in many cellular processes; their 
function as kinase enzymes is to modify proteins within the cell by adding phosphate 
groups to them. This action can cause a change in the action or location of that protein 
and its interaction with other proteins, initiating a communication signal. As such, these 
kinases are used as ‘molecular switches’ within signalling cascades, usually to switch 
them ‘on’. The relationship between lipid rafts and tyrosine kinases is well-established 
(reviewed in Hunter, 2000; Pike, 2003), where tyrosine kinases play a crucial role in 
initiating other signal transduction pathways from their position in the lipid raft. Tyrosine 
kinases have also been implicated in macropinocytosis, performing a similar function of 
activating signalling cascades (Ridley, 1994), and the Src-family tyrosine kinases play an 
important role in the formation and trafficking of macropinosomes (Kasahara et al.,
2007). Genistein is an isofiavone compound originally extracted from Pseudomonas sp 
and is a reversible inhibitor of tyrosine kinases (Akiyama et al., 1987) used in many 
investigations into viral entry, such as SV40 (Chen & Norkin, 1999) and AAV2 (Qing et 
al., 1997). Since, in the previous report on FCV entry, Src-tyrosine kinases were found 
not to be involved (Stuart & Brown, 2006), we were interested in discovering whether the 
wider tyrosine kinase family was involved, especially in macropinocytosis.
3.19.1 G enistein is not cytotoxic to CRFK cells
Due to the essential role of kinases in normal cell function and survival, the cytotoxicity of
genistein was tested on CRFK cells to ensure the damaging effects on the cell were
limited. Cells were treated with different concentrations of genistein for 6 h, following
which the supernatant was collected and tested for LDH activity. As seen in Figure 3.29,
at the concentrations used (20 pM & 50 pM), genistein was found to have minimal
cytotoxicity and so was considered appropriate for subsequent experiments.
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Figure 3.29 Genistein treatment does not affect the viability of CRFK cells
CRFK cells were treated with varying concentrations of genistein for 6 h, the supernatant 
removed to be tested for LDH activity as an indication of cell death. A high control (Triton X-100 
treated cells) and low control (media only) are included. Results are presented as cell death for 
each treatment as a percentage of the high control (as calculated in Section 2.7), showing the 
mean +/-SE of 3 replicates.
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3.19.2 FCV entry does not depend on tyrosine kinases
Before infection of genistein-treated CRFK cells, the effect of genistein on the entry 
pathways of these cells was explored using endocytic markers as controls (Section 3.3). 
CRFK cells were treated with genistein for 30 min, followed by incubation with transferrin, 
ChTxB or dextran. Cells were fixed and nuclei stained for confocal microscopy. As seen 
in Figure 3.30 A&B, genistein had no effect on transferrin entry, indicating that the drug 
did not non-specifically block clathrin-mediated entry. Although we expected to see a 
decrease in dextran entry which would indicate inhibition of macropinocytosis, we saw no 
effect on dextran entry (Figure 3.30 C&D) showing that genistein did not affect the 
macropinocytic pathway in these cells. There was a slight decrease in ChTxB entry 
under genistein treatment, seen in Figure 3.30 E&F, pointing to a greater role for 
tyrosine kinases in lipid raft/caveolar entry in these cells than in macropinocytosis or less 
of an effect of genistein on tyrosine kinases in these cells (Mercer & Helenius, 2012).
Following these control studies, the effect of tyrosine kinase inhibition on FCV 
entry was analysed. Cells were treated with genistein for 30 min, prior to infection with 
FCV for 6  h (in the presence of genistein), then fixed and nuclear stained in preparation 
for confocal microscopy. Comparing the numbers of infected cells in each treatment, 
showed that inhibition of tyrosine kinases had no effect on FCV entry into CRFK cells 
(Figure 3.31) confirming the lack of involvement of caveolar/lipid raft in FCV entry.
3.19.3 FCV replication is not dependent on tyrosine kinases
Although FCV entry appeared to be independent of tyrosine kinases, the possibility that 
FCV infection and replication could have been affected remained. To explore this matter, 
cells were treated with genistein for 30 min and, in the presence of genistein, infected 
with FCV for 6  h. The viral titre of the supernatant was analysed by TCID5 0 . Inhibition of 
tyrosine kinases by genistein showed no effect on FCV replication (Figure 3.32)
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Figure 3.30 Effect of genistein treatment on the entry pathways in CRFK cells
CRFK cells were mock-treated (A,C&E) or treated with 50pM genistein (B,D&F) for 30 min then 
incubated with Alexa-555 transferrin (A&B) for 15 min, Alexa-555 dextran (C&D) or Alexa-555 
ChTxB (E&F) for 30 min at 37“C. ToPro3 stained nuclei are shown in blue. Cells were visualised 
using a ZEISS LSM META confocal laser microscope with 543 nm laser to detect the markers (red) 
and 633 nm laser to detect nuclei (blue). The bar indicates a size of 10 pm.
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Figure 3.31 Tyrosine kinase inhibition has no effect on FCV entry into CRFK cells
CRFK Cells were treated with genistein 30 min before 6 h infection then fixed and stained for 
confocal microscopy using anti-FCV capsid antibody followed by Alexa-555 secondary antibody. 
ToPro3 was used to stain nuclei and cells were visualised using a ZEISS LSM META confocal laser 
microscope. Results shown are the numbers of cells infected in each treatment compared to the 
control, and are the mean of three independent experiments (+/-SE).
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Figure 3.32 Tyrosine kinases are not required for FCV replication
CRFK cells were treated with genistein 30 min before infection with FCV for 6 h, control cells 
were treated with DMSO-containing MEM. Cells were lysed and the viral titre of the supernatant 
analysed by TCID50. The results were calculated as a percentage of the untreated control and 
expressed as the mean of three independent experiments (+/- SE).
125
3.20 Effect of protein phosphatase inhibition on FCV infection
Protein phosphatases are widely used within the cell in opposition to protein kinases as a 
sort of switch, activating or deactivating many cellular functions. Okadaic acid is a 
general protein phosphatase inhibitor (Cohen, 1990), affecting many phosphatases in the 
cell shown and has been shown to prevent fusion of endosomes (Woodman et al., 1992). 
Okadaic acid treatment has been shown to induce the internalisation of caveolae (Parton 
et al., 1994), also causing an increase in SV40 entry (Pelkmans et al., 2002). Several 
other studies have found another effect of okadaic acid, in that it caused a decrease in 
clathrin-mediated entry as well as fluid-phase entry (Lucocq et al., 1991; Parton et al., 
1994). The potential roles of protein phosphatases in macropinocytosis and intracellular 
trafficking caused us to investigate the role of protein phosphatases in FCV entry and 
infection of CRFK cells.
3.20.1 O kadaic acid is not cytotoxic to CRFK cells
Due to the diverse roles of protein phosphatases within the cell, the toxicity of the 
inhibitor drug, okadaic acid, was tested on CRFK cells. Cells were treated with okadaic 
acid for 6 h and the supernatant harvested and analysed by LDH assay as described in 
Section 2.7. No toxicity to the cells was seen (Figure 3.33) at the concentrations used 
(50 & 100 nM) for further experiments.
3.20.2 FCV entry is independent o f protein phosphatases
Before investigating the effect of okadaic acid on FCV infection of CRFK cells, its effect 
on the endocytic pathways of these cells was investigated using endocytic markers as 
controls (Section 3.3) CRFK cells were treated with okadaic acid for 30 min, then 
incubated with transferrin, ChTxB or dextran, fixed and nuclear stained in preparation for
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Figure 3.33 Different concentrations of okadaic acid do not affect CRFK cell viability
CRFK cells were treated with increasing concentrations of okadaic acid and incubated for 6 h. 
After this time, the supernatant was removed and tested for LDH activity as an indication of cell 
death. A high control (Triton X-100 treated cells) and low control (media only) are included. 
Results are presented as cell death for each treatment as a percentage of the high control as 
calculated in Section 2.7, showing the mean +/- SE of 3 replicates.
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confocal microscopy. There was a slight decrease in the entry of transferrin under 
okadaic acid treatment (Figure 3.34 A&B), indicating that okadaic acid does have an 
inhibitory effect on clathrin-mediated entry in these cells (as seen previously, Parton et 
al., 1994), although not to a significant level. As expected, there was no effect on dextran 
entry (Figure 3.34 C&D), indicating that okadaic acid does not inhibit macropinocytosis 
in these cells (Parton et al., 1994). There was also a slight increase in ChTxB entry after 
treatment with okadaic acid (as reported in several papers such as Parton et al., 1994) 
as seen in Figure 3.34 E&F, implicating a role for protein phosphatases in lipid 
raft/caveolar entry.
In these cells, protein phosphatases appear to be involved to some extent in both lipid 
raft/caveolar entry, and clathrin-mediated entry, but not in macropinocytosis.
Subsequent to control analyses, the role of protein phosphatases in FCV entry was 
studied. CRFK cells were treated with okadaic acid for 30 min before infection with FCV 
for 6  h (in the presence of okadaic acid); cells were then fixed and nuclear stained for 
confocal microscopy. As expected, there was no significant effect on FCV entry (Figure 
3.35), indicative of the minimal effect of the drug on clathrin-mediated entry described 
above. It is possible that the virus was able to utilise a macropinocytic pathway instead 
when clathrin-mediated entry was inhibited under these conditions.
3.20.3 FCV replication does not depend on protein phosphatases
Due to the role of protein phosphatases in endocytic function, we were interested in 
further exploring the role of these enzymes in FCV infection of these cells, possibly in 
replication instead of entry. Cells were treated with okadaic acid for 30 min, infected with 
FCV for 6  h in the presence of okadaic acid then the supernatant collected for analysis of 
viral titre by TCID5 0 . There was no effect on FCV replication when cells were treated with 
okadaic acid (Figure 3.36)
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Figure 3.34 Effect of okadaic acid treatment on the entry pathways in CRFK cells
CRFK cells were mock-treated (A,C&E) or treated with IOOnM okadaic acid (B,D&F) for 30 min 
then incubated with Alexa-555 transferrin (A&B) for 15 min, Alexa-555 dextran (C&D) or Alexa- 
555 ChTxB (E&F) for 30 min at 37“C. ToPro3 stained nuclei are shown in blue. Cells were 
visualised using a ZEISS LSM META confocal laser microscope with 543 nm laser to detect the 
markers (red) and 633 nm laser to detect nuclei (blue). The bar indicates a size of 10 pm.
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Figure 3.35 Protein phosphatase inhibition has no effect on FCV entry into CRFK cells
CRFK cells were treated with okadaic acid for 30 min prior to FCV infection for 6 h. Cells were 
fixed and stained for confocal microscopy using anti-FCV capsid antibody followed by Alexa-555 
secondary antibody and ToPro3 for nuclear staining and cells were visualised using a ZEISS LSM 
META confocal laser microscope. Results shown are the numbers of cells infected in each 
treatment compared to the control, and are the mean of three independent experiments (+/- 
SE).
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Figure 3.36 Protein phosphatases are not required for FCV replication
CRFK cells were treated with okadaic acid 30 min before infection with FCV for 6 h and control 
cells were treated with DMSO-containing MEM. Cells were lysed and the viral titre of the 
supernatant was analysed by TCID50. The results were calculated as a percentage of the 
untreated control and expressed as the mean of three independent experiments (+/- SE).
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3.21 Discussion
The complexity of cellular endocytic pathways is best illustrated by the numerous 
methods viruses can employ to gain entry into cells. Once a virus binds to a cell surface, 
they are able to use many different cellular signalling and endocytic pathways in order to 
hijack the cell. This chapter focuses on the study of these pathways in the mechanism of 
entry of FCV.
Previously, it was reported that FCV used both clathrin-mediated entry as well as 
macropinocytosis for entry into CRFK cells. In continuing this work, we looked at the 
involvement of dynamin, which is known to be integral in the entry of many viruses using 
clathrin-mediated pathway to enter cells, such as Adenovirus Type 2 (Gastaldelli et al.,
2008) and echovirus 7 (Kim & Bergelson, 2012). There are also pathways that are 
clathrin and caveolin-independent but still dynamin-dependent, with viruses such as HIV- 
1 able to use such a pathway to enter macrophages (Carter et al., 2011). Through the 
use of the dynamin-specific inhibitor, dynasore (Macia et al., 2006), we showed that FCV 
infection of CRFK cells requires dynamin not only for entry into the cells, but also for 
subsequent replication steps. There has been some debate over whether or not dynamin 
plays a role in intracellular trafficking, but it has been shown to be involved in the 
recycling pathway, possibly in the scission of budding vesicles from the endosome 
(Nicoziani et al., 2000). More recently dynasore was also shown to inhibit recycling and 
degradative traffic in HeLa cells where it played a role in separating tubular elements of 
early endosomes to form recycling endosomes (Mesaki et al., 2011). This result supports 
our hypothesis of FCV trafficking via the recycling endosomal network, but it is apparent 
that whatever role dynamin is playing in the intracellular trafficking in CRFK cells, 
replication of FCV is highly dependent on this role, and requires further investigation.
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Stuart and Brown (2006) had also shown that FCV enters cells and travels to early 
endosomes. To begin our colocalisation studies, we sought to confirm this result using 
transferrin, which traffics from early endosomes through the recycling network. Although 
we saw colocalisation of FCV with transferrin after 10 min (presumably in early 
endosomes), we could also observe colocalisation after 30 min, leaving some uncertainty 
as to what endosomal compartment this colocalisation was occurring in. To clarify this 
issue, we looked at the early endosomal protein, EEA1, and showed colocalisation with 
FCV after 10 and 15 min. Although complete colocalisation was not observed, this can 
be explained by the fact that FCV also uses macropinocytosis to enter these cells. As 
such, it is possible that the virus is trafficking from the membrane to a macropinosome 
and on to late or recycling endosomes, avoiding early endosomes (as reported in 
Racoosin & Swanson, 1993). The fact that there was still some colocalisation with EEA1 
visible after 30 min could indicate a slower pathway of internalisation; however, since 
these experiments were inconclusive, we made use of a DN form of Rab7, a GTPase 
involved in late endosomal trafficking. The DN Rab7 was transfected into cells, and 
showed no effect on FCV infection. In order to confirm this result, we moved on to 
analysing colocalisation of FCV with a late endosomal marker, LAMP1. As expected, 
FCV did not colocalise with LAMPI at any time point, clarifying earlier results with 
transferrin and EEA1 and confirming our results with Rab7. This suggested that FCV 
could be moving from directly early to recycling endosomes as is the case with FMDV 
(foot and mouth disease virus; Berryman et al., 2005). To explore this possibility, we 
transfected cells with a DN form of Rabi 1, a protein which is integral to recycling 
endosome transport (Ullrich et al., 1996). DN R a b ll inhibited FCV infection, suggesting 
that FCV is indeed travelling from early to recycling endosomes, bypassing late 
endosomes/lysosomes.
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As well as showing that FCV enters cells via clathrin-mediated entry, Stuart and Brown 
(2006) showed that FCV also depends on macropinocytosis for entry. We were 
interested in exploring this ability of the virus to use two different but very efficient 
pathways, and to do so we attempted colocalisation studies of FCV with dextran, a 
marker of fluid phase entry. After 15, 30 and 60 min, FCV was seen to colocalise with 
dextran, indicating that macropinocytosis plays a key role in FCV entry.
As well as exploring intracellular trafficking of FCV, we also analysed the signalling
pathways involved in FCV endocytosis. The first signalling molecules we investigated
were PI3-kinases which are involved in both clathrin and macropinocytic entry, as well as
many other functions within the cell (reviewed in Cantley, 2002). Treatment of cells with
the specific irreversible PI3-kinase inhibitor, wortmannin, revealed that FCV infection of
these cells is strongly dependent on PI3-kinase function, not only in cell entry, but also in
subsequent replication within the cell. PI3-kinases have been shown to be important in
the entry of many viruses, including Ebola virus (Saeed et al., 2008) and Nipah virus
where the virus was shown to enter cells via macropinocytosis (Pernet et al., 2009).
Using wortmannin, we again addressed the question of the capacity of FCV for entering
CRFK cells using both clathrin-mediated entry as well as macropinocytosis. Inhibition of
PI3-kinases almost completely inhibited dextran entry (a marker of macropinocytosis/fiuid
phase entry), as compared to transferrin (a marker of clathrin-mediated entry) where it
was merely accumulated in early endosomes, as seen previously (Spiro et al., 1996;
Brabec et al., 2006). When comparing the internalisation of these endocytic markers with
that of FCV, the pattern of internalisation more closely resembled that of dextran and
macropinocytosis. This again points to the possibility that FCV makes greater use of
macropinocytosis for entry into CRFK cells than the clathrin-mediated pathway. This
could also fit the model proposed above whereby virus is relocated from
macropinosomes directly to recycling endosomes (as seen in Racoosin & Swanson,
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1993). The inhibitory effect of wortmannin on FCV infection could also be due to 
inhibition of the PI3-kinase/Akt/mT0R pathway (mTOR is the Mammalian Target for 
Rapamycin). This pathway can be upregulated to enhance viral protein synthesis, as 
shown recently in hepatitis C virus (Bose et a/., 2012; Shrivastava et al., 2012). As it has 
been shown that norovirus is dependent on Akt for RdRp phosphorylation (Eden et a!., 
2011), these results could indicate a similar dependence on this pathway by FCV. 
Although the inhibition of tyrosine kinases by genistein might be expected to inhibit FCV 
entry to some degree (due to the usual role of tyrosine kinases in macropinocytosis), we 
saw no inhibition. This shows a similar effect to several other viruses such as W  EVs 
(Schmidt et a!., 2011) which are known to use macropinocytosis to enter cells but whose 
entry pathway is not affected by genistein inhibition of tyrosine kinases. This is thought to 
be due to a lack of specificity to some tyrosine kinases (such as RTKs) in different cells 
(Mercer & Helenius, 2012) which is backed up by our observation that genistein does not 
inhibit dextran entry into these cells. Similarly, the function of the ‘opposing’ molecular 
switches, protein phosphatases, in FCV entry was found not to be important. Although 
protein phosphatases have been previously shown to inhibit both clathrin-mediated entry 
as well as macropinocytosis, (Lucocq et a/., 1991; Radon et a!., 1994), this result does 
confirm that of Stuart and Brown (2006) that FCV infection is not dependent on Src 
tyrosine kinases (involved in macropinocytosis).
In summary, we have shown that entry of FCV into CRFK cells is dependent on PI3- 
kinases, not only for entry but also subsequent replication steps. As well as the expected 
role of dynamin in FCV entry, we also showed that dynamin plays a role in FCV 
replication, possibly in its trafficking through the cell to the recycling endosomes. When 
taking all data into account, macropinocytosis appears to be the major entry pathway for 
FCV, rather than clathrin-mediated entry. As will be seen from the next chapter, this entry
process can differ greatly between members of the same viral family.
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Chapter 4 
Early events and signalling in MNV infection
4.1 Introduction
As outlined previously, endocytosis is a fundamental cellular process to allow cells to 
internalise essential substances. Many pathogens, however, have found ways to hijack 
these pathways in order to gain entry to the host cell. These viral entry pathways are 
well-studied using many different tools specifically developed for studying endocytic 
pathways. These tools include the use of dominant negative forms of proteins involved in 
each pathway, inhibitor drugs that interfere with different pathways as well as 
colocalisation studies with markers of different endosomal compartments. All these 
methods were engaged in this study of MNV-1 entry.
Previous investigations into the entry mechanisms of MNV-1 were begun recently in our
laboratory (Gerondopoulos et al., 2010), as well as in Wobus’ laboratory (Perry et al.,
2009; Perry & Wobus, 2010). A related virus, FCV, had been shown to enter via clathrin-
mediated endocytosis (Stuart & Brown, 2006), so this entry pathway was investigated
first for MNV-1. Due to the abundance of adaptor accessory proteins involved in clathrin-
mediated entry (see Section 1.2.1) interference in this pathway was achieved by
interference with two adaptor proteins. The first of these, AP2 is a vital component,
central in the formation of clathrin-coated pits (Schmid et al., 2006), while eps15 is a
scaffolding protein for AP2 and other proteins in the clathrin-coat (Tebar et al., 1996).
Neither siRNA (small interfering RNA) to AP2 nor the ON form of eps15 had any effect
on MNV-1 entry, indicating the entry route is clathrin-independent. The next stage in
clathrin-mediated entry, the acidic early endosome, was blocked using the endosomal
acidification inhibitors, bafilomycin A and chloroquine. Again, there was no effect seen on
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MNV-1 infection, implying that entry to acidic compartments is not necessary for viral 
infection. These results were confirmed by Perry & Wobus by the use of hypotonic 
sucrose (an inhibitor of clathrin-coated pit formation), chlorpromazine (an inhibitor of 
clathrin lattice polymerisation) and siRNA knockdown of clathrin heavy chain. Since the 
clathrin-mediated pathway had been ruled out, the next entry pathway tested was lipid 
rafts, achieved using the cholesterol sequestering agents, M(3CD and nystatin (used by 
Perry & Wobus, 2010). The addition of both of these drugs inhibited infection, indicating 
that the virus could be using a cholesterol-dependent pathway. One such cholesterol- 
dependent pathway is caveolar entry, and to investigate this possibility, the presence of 
caveolin-1 proteins in RAW 264.7 cells was examined. Western blot analysis of RAW
264.7 cell extracts showed that these cells do no not express caveolin-1 proteins 
(Gerondopoulos et al., 2010). Further confirmation of the lack of dependence of MNV-1 
on caveolar entry was provided by Perry et al through the use of DN and siRNA 
constructs of cav1 which had no effect on MNV-1 infection. One of the properties of RAW
264.7 macrophage cells is their phagocytic nature, however, due to the similarity
between phagocytosis and macropinocytosis, inhibitors are used which affect both
pathways, such as the NaVH^ exchange inhibitor El PA. When cells were treated with
EIPA before infection with MNV-1, infection was unaffected, in fact in both studies there
was an increase of infection observed. However, when Perry & Wobus treated cells with
EIPA after infection, there was actually a decrease in infection observed, perhaps
indicating a role for NaVH^ exchangers later in infection. Following on from this, that
study also looked at the involvement of the GTPase R a d , which is involved in
phagocytosis as well as macropinocytosis. Transfection of RAW 264.7 cells with a DN
form of R a d  slightly decreased MNV-1 infection. As actin plays such a central role in
both phagocytosis and macropinocytosis, this was also investigated using the actin-
disrupting drug, cytochalasin D. Treatment with this drug showed the same effect as
EIPA, also increasing infection which indicates that actin plays no role in the entry of
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MNV-1. Following on from this, the role of dynamin proteins in the entry of MNV-1 was 
examined using the specific dynamin inhibitor, dynasore. Treatment of cells with 
dynasore prior to infection with MNV-1 had a dramatic effect on infection, reducing it by 
85% and indicating that entry relies on dynamin proteins (Gerondopoulos et al., 2010). 
Two relatively new endocytic pathways, the flotillin pathway and CLIC-GEEC, are both 
cholesterol dependent and in some cases have been found to be dependent on dynamin 
(similar to MNV-1 entry), and so these were also tested. siRNA against flotillin-1
(Gerondopoulos et al., 2010) or GRAF1 (a key component of the CLIC-GEEC pathway)
had no effect on MNV entry (Perry & Wobus, 2010), suggesting that neither of these 
pathways are used by this virus. As well as the pathways investigated, a preliminary 
investigation of trafficking within the cell was undertaken using the microtubule inhibitor, 
nocodazole. When intracellular trafficking mediated by microtubules was inhibited, MNV- 
1 infection was diminished by ~40%, indicating some reliance of the virus on 
microtubules for infection (Gerondopoulos et a i, 2010).
From previous results, it can be seen that MNV-1 infects RAW 264.7 cells using a 
cholesterol-, microtubule- and dynamin-dependent pathway. Although apparently not 
dependent on macropinocytosis, the entry of MNV-1 is affected somehow by 
macropinocytosis. Following on from this research, we looked further into the
intracellular trafficking and signalling involved in MNV-1 entry.
To begin this study, we sought to eliminate one of the last possible entry pathways this 
virus could be using, the Arf6  pathway (Radhakrishna & Donaldson, 1997). In order to 
investigate this pathway, we made use of dominant negative (DN) and constitutively 
active (CA) forms of Arf6 . Plasmids expressing these proteins were transfected into RAW
264.7 cells to observe their effect on MNV-1 infection. Although many pathways for this
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virus have been studied, there is not yet anything known about intracellular events or the 
signalling involved in MNV-1 entry.
It had already been established that MNV-1 does not traffic to early endosomes; 
however, it was unknown whether it trafficked to different endocytic compartments. In 
order to answer this question, we studied both Rab7 and R a b ll;  Rab7 is involved in 
transport from early to late endosomes (Bucci et al., 2000), and R a b ll in recycling 
endosomes (Ullrich et al., 1996; Green et al., 1997). Plasmids expressing DN forms of 
these proteins were transfected into cells to evaluate the effect on MNV-1 infection. The 
unanswered question over the relationship between MNV-1 and macropinocytosis was 
approached using purified and labelled MNV-1 and attempting colocalisation with a 
marker of fluid phase entry, dextran. As well as this, colocalisation with ChTxB, a marker 
of lipid-raft dependent entry was also undertaken.
The signalling involved in MNV-1 entry was the subject of the next stage of experiments. 
Cell signalling is vital in many cell processes, including endocytosis, where the role of 
signalling is heavily involved (reviewed in Sorkin & Von Zastrow, 2009; Platta & 
Stenmark, 2011). One of these signalling molecules is PI3-kinase, which is involved in 
many cellular processes, including endocytosis (reviewed in Cantley, 2002). The wide­
spread role of PI3-kinases in several pathways, but particularly in macropinocytosis led 
us to investigate the signalling involved in MNV-1 entry using wortmannin, a fungal 
metabolite which specifically inhibits PI3-kinases. Protein kinases and phosphatases are 
signalling molecules that work in opposing functions in the cell, acting as switches ‘on’ 
and ‘off’ for different protein functions. Tyrosine kinases are one of the protein kinases 
and are involved in signalling cascades, initiating several functions which are key to 
endocytosis (Gekle et al., 1997). Since entry of MNV-1 is dependent on cholesterol, we 
hypothesised that entry of the virus into cells would be dependent on tyrosine kinase
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signalling, and in order to investigate this further, we made use of a tyrosine kinase 
inhibitor, genistein.
The opposing signalling molecules to kinases, the phosphatases, are similarly involved in 
the regulation of many cellular processes, such as in endocytosis. While genistein is 
usually shown to inhibit lipid raft/caveolar entry, the phosphatase inhibitor, okadaic acid 
has often been shown to up-regulate internalisation of cargo through this pathway, 
resulting in accumulation in early endosomes (Parton et al., 1994). The action of okadaic 
acid has been suggested to be mediated by tyrosine kinase activation (Tarsounas et al.,
1999). Due to the implications of protein phosphatases in several pathways, but 
especially in cholesterol-dependent pathways, we sought to examine the implications of 
inhibiting this pathway, using the serine/threonine phosphatase inhibitor okadaic acid.
Using these methods, we examined further the intracellular trafficking and signalling 
used in MNV-1 infection of RAW 264.7 cells.
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Materials and Methods
4.2 Effect of DN and CA GTPases on MNV entry
The MOI (multiplicity of infection) of the virus was first determined empirically using 
confocal microscopy to calculate the percentage of infected cells as compared to the 
total number of cells.
RAW 264.7 cells were seeded onto coverslips in the wells of a 24 well plate (at -2 .7  x 
10"* for Arf6  or at -3 .5  x 10"^  cells/ml for Rab7 & 11) and incubated overnight at 37°C to 
reach -70%  confluency. For each well to be transfected, 100 pi of OptiMEM (GibcoBRL) 
was mixed with 1.5 or 1 pi Fugene HD (Roche Applied Science) and 0.5 pg DNA 
(plasmids expressing GFP-tagged wf Arf6 , DN Arf6  T27N CA Arf6  Q67L, wt R a b ll,  DN 
R a b ll or CA R a b ll from Michel Franco, Institut de Pharmacologie Moléculaire et 
Cellulaire, France; plasmids expressing GFP-tagged wt Rab7 and DN Rab7 from Prof. 
Stephen Ferguson, Roberts Research Institute, Ontario, Canada). The mixtures were 
incubated at RT for 15 min while the medium was removed from the cells and replaced 
with 300 pi of serum-free DMEM. lOOpI of the transfection mixture was added drop-by- 
drop to each well and the cells rocked to ensure even coverage. The cells were 
incubated at 37°C for 4 hours then the medium changed to 10% DMEM for the rest of the 
incubation (Arf6  until 16 h, Rab 7 & 11 until 18 h). After this time, cells were infected with 
MNV-1 at an MOI of 2 or 5 for 1 h. The cells were washed and incubated in serum free 
DMEM for a further 11 h. Cells were fixed in 800 pi 4% paraformaldehyde on ice for 45 
min, and maintained in PBS until staining for confocal analysis as in Section 4.5.
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4.3 Effect of signalling inhibitors on MNV entry
4.3.1 Analysis o f the effect o f drug treatm ent on M NV entry by confocal 
m icroscopy
RAW 264.7 cells were seeded at -4 x 1 0 ^  per well in 10% serum DMEM on coverslips in 
a 24 well plate and incubated at 37°C overnight to reach -70%  confluency. Inhibitors of 
different signalling pathways or DMSO were diluted to required concentration (seen in 
Table 2.1) in serum free DMEM. Overnight media was removed and 200pl of inhibitor 
dilution was added per well. Cells were returned to the incubator for 30 min while virus 
was diluted to an MOI of 2. After this time, 200pl of virus dilution was added to each well 
alongside the inhibitor and left to incubate for 1 h at 37°C. After an hour, cells were 
rinsed and replaced with serum-free DMEM, DMSO control or inhibitor for 11 h 
(reversible drugs were present throughout the 1 2  h incubation, irreversible drugs were 
replaced with serum-free DMEM for the remaining time). A transferrin, ChTxB, or dextran 
control was used as discussed in Section 4.4 Cells were rinsed and fixed in 4% 
paraformaldehyde for 45 min on ice. Cells were left in PBS until staining for confocal 
analysis as in Section 4.5 Analysis of drug effect on virus entry was calculated by 
counting at least 1 0 0  infected cells per experiment, (unless otherwise stated) and 
comparing the drug-treated to the mock-treated control.
4.3.2 Analysis of the effect o f drug treatm ent on M NV entry by TC ID 50 assay
RAW 264.7 cells were grown overnight in 24 well plates until -80%  confluent then 
treated with pharmacological inhibitors at 3 different times: i) prior to infection (drug 
treatment for 30 min followed by virus for 1 h, replaced with drug or media for the 
remaining infection time); ii) cells were infected for 1 h and after removing virus, drug 
was added for the rest of the infection time; iii) cells were infected for 1 h, and after
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removal of the virus, replaced with serum-free medium for 1.5 h followed by addition of 
the drug for the remaining incubation time. This aimed to find the point at which the drug 
was having an effect on virus infection: at entry, in early or in later events in infection. 
After incubation for a total of 12 h, cells were scraped from the wells, transferred to a 
microcentrifuge tube and centrifuged at 14 000 rpm for 15 min at 4°C. The supernatant 
was aliquoted and stored at -20°C until use in TCID5 0 assays (Section 2.3.2).
4.4 Internalisation of endocytic markers
As in Chapter 3, before evaluating the effect any inhibitor was showing on MNV-1 entry, 
the effect of that inhibitor on standard entry pathways of RAW 264.7 cells was first 
investigated. To do this, we utilised three endocytic markers as controls: transferrin, 
ChTxB and dextran.
4.4.1 Transferrin binding and internalisation
Transferrin is frequently used as a marker of receptor mediated endocytosis (Hinrichsen 
et al.] 2003) and in our study, was used to explore the effects that particular inhibitors 
have on clathrin-mediated entry. Transferrin enters the cell in clathrin-coated pits, travels 
to early endosomes, on to late endosomes then recycling endosomes. Cells were treated 
as in Section 4.3.1, the media removed and replaced with 200 pi of Transferrin 555 (80 
pg/pl. Molecular Probes, Invitrogen). Cells were incubated for 15 - 20 min following drug 
treatment, the transferrin rinsed off and cells fixed with 4% paraformaldehyde / 0.2% 
gluteraldehyde for 45 min on ice. This was replaced with PBS and kept at 4°C until 
staining for confocal microscopy. Cells were stained with nuclear stain as in Section 4.5 
and mounted on glass slides for analysis by confocal microscopy.
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4.4.2 Cholera Toxin B binding and internalisation
ChTxB is generally used as a marker for caveolar/lipid raft entry into cells. (Parton et al., 
1994; Sandvig & van Deurs, 2002) and in our studies was utilised to scrutinise the effect 
of specific inhibitors on lipid raft entry. 200 pi Alexa-Fluor® 594-linked ChTxB (20pg/ml; 
Molecular Probes, Invitrogen) was added to cells after treatment as in Section 4.3.1 
(without infection) for 30 min. ChTxB was rinsed off cells thoroughly with acid wash 
(Appendix) and the cells fixed in 4% paraformaldehyde for 45 min on ice. These 
samples were stained with nuclear stain as in Section 4.5 and mounted on glass slides 
for analysis using confocal microscopy.
4.4.3 Dextran binding and internalisation
Dextran is typically used as a control for macropinocytic/fluid phase entry 
(Dharmawardhane et al., 2000) and was used in our study to observe the effect of 
inhibiting macropinocytic entry into cells. Dextran was added to cells after treatment with 
inhibitor drugs as laid out in Section 4.3.1 200 pi Alexa-Fluor 555-linked Dextran (500 
pg/ml. Molecular Probes, Invitrogen) was added to the cells for 30 min, rinsed off and the 
cells fixed in 4% paraformaldehyde for 45 min on ice. The samples were stained with 
nuclear stain as in Section 4.5 and mounted on glass slides for visualisation by confocal 
microscopy.
4.5 Immunofluorescence labelling for confocal microscopy
RAW 264.7 cells were permeabilised in 0.1% Triton x 100 (Appendix) for 15 min. After 
rinsing in PBS, non-specific binding of antibody to the cells was prevented by incubating 
in 0.5% PBS/BSA (Appendix) for 30 min. 200 pi anti MNV 3D-polymerase primary 
antibody (1:1500; from Dr Ian Goodfellow, Imperial College, London) was added to each
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well and incubated for 1 h. After three 5 min washes in PBS, 200 pi Alexa-Fluor®- 
labelled anti-rabbit secondary antibody (1:400; Molecular Probes, Invitrogen) was applied 
for 1 h. After washing as before, 500 pi ToProS (Molecular Probes, Invitrogen) nuclear 
stain diluted 1:10 000 in PBS was applied to cells for 10 min. For experiments which 
used labelled endocytic markers or transfection of GFP-tagged plasmids only, ToProS 
staining alone was undertaken. The ToProS was replaced by PBS before the coverslips 
were removed, rinsed in MQ water and mounted on glass slides with a drop of 
Vectashield (Vector Laboratories). Coverslips were sealed onto glass slides with clear 
nail varnish and viewed using a Zeiss LSM 510 META confocal laser microscope. 
Infected cells were counted in the treated and mock treated samples to obtain 
percentage infection rates for each treatment.
4.6 Purification of MNV-1
A large amount of virus stock was made by infecting T175 tissue culture flasks (x20) of 
-80%  confluent RAW 264.7 cells with MNV-1 at an MOI of -0.1. After 24 h when ope 
was visible, this media was harvested, frozen at -80°C until completely frozen, thawed at 
RT and spun down at 4000 rpm for 30 min in a Beckman J2-21M/E centrifuge to pellet 
cellular debris. The supernatant was filtered through a 0.45pm vacuum filter unit 
(Nalgen). Whilst stirring at 4°C, NaCI (Fisher Scientific) was added to a final 
concentration of 0.2M PEG 3350 (Sigma Aldrich) was added to a concentration of 10% 
final volume and stirred at 4 X  overnight to allow for precipitation. The following day, the 
virus preparation was centrifuged at 14 000 rpm for 45 min at 4°C (Beckman J2-21M/E 
centrifuge, JA16 rotor) and all supernatant removed. Virus pellets were resuspended in 
boric acid buffer (Appendix) on ice using a blunt needle to avoid clumps. This boric acid 
suspension was centrifuged at 14 000 rpm for 25 min at 4°C (Beckman J2-21M/E 
centrifuge), the supernatant removed and kept aside on ice. The pellets were
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resuspended as before in boric acid buffer and centrifuged again at 14000 rpm for 20
min at 4°C (Beckman J2-21M/E centrifuge). The supernatant was pooled with the
previous supernatant and incubated on ice for several hours. A 30% sucrose solution
(Appendix) was placed in a tube suitable for SW28 rotor. This was carefully overlaid
with the virus solution and centrifuged at 25000 rpm overnight at 4°C (Beckman L8-70M
ultracentrifuge, SW28 rotor). The following day, the liquid was removed and the inside of
the tubes dried with tissue to remove all traces of sucrose. The pellets were resuspended
as before in boric acid buffer and incubated on ice for several hours before being
centrifuged at 15000 rpm for 10 min at 4°C (Hettich MIKRO 22R). The supernatant was
transferred to a microcentrifuge tube and set aside on ice while the pellet was
resuspended in boric acid buffer and spun down as before. The supernatant was
transferred to a separate microcentrifuge tube and incubated on ice while a 2 x caesium
chloride solution (Gibco BRL) was prepared in PBS (Appendix). An equal amount of
caesium chloride solution was added to each supernatant and mixed thoroughly before
transferring to 2 tubes suitable for use in an SW55Ti rotor. Samples were centrifuged at
40000 rpm at 4°C for 20 h in tubes suitable for a SW55Ti rotor (Beckman L8-70M,
SW55Ti rotor). The next day, the tubes were removed and placed in a clamp stand with
a narrow beam of light was used to visualise the band containing the virus preparation.
Using a needle, this band was removed from the gradient. The samples from separate
supernatants were pooled and dialysed overnight at 4°C against 2L of PBS using a
Slide-a-Lyser cassette (Pierce, Thermo Scientific, MWCO of 10 000). The samples were
centrifuged in a 30 000 MWCO vivaspin centrifugal concentrator following manufacturer’s
instructions (GE Healthcare; Hettich MIKRO 22R). This was transferred to a siliconised
tube, centrifuged at 15 000 rpm for 15 min at 4°C and the supernatant aliquoted to be
stored at -80°C. The purity of the resultant virus was analysed by SDS-PAGE as in
Section 2.8 and its concentration estimated using a BOA assay (Pierce). It was also
tested for infectivity by TCID50 as set out in Section 2.3.2
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4.7 Labelling of purified MNV-1 with DyLight-488
In order to visualise purified MNV effectively by confocal microscopy, direct labelling of 
the virus preparation was undertaken using a fluorophore. Purified virus (see Section 
4.6) was thawed and mixed with 20x borate buffer (Pierce, Thermo Scientific) and the 
fluorophore, DyLight 488 NHS Ester (Pierce, Thermo Scientific) was added to the virus 
mixture at -4  pg virus to 1 pi dye. This reaction was incubated in the dark at RT for 1 h 
and was centrifuged in Dye Removal Columns (Pierce, Thermo Scientific, Hettich 
MIKRO 22R; as per the manufacturer’s instructions) to remove unbound dye. This 
solution was stored at -80°C or used at once as set out in Section 4.8
4.8 Colocalisation studies
Labelled MNV-1 was mixed with serum-free DMEM to a concentration of -0 .7  pg/pl and 
added to RAW 264.7 cells grown on a coverslip in a 24 well plate. Virus and specific 
endosomal markers were incubated on cells for times as indicated in each experiment. 
These samples were rinsed before being fixed and stained with ToProS (as in Section 
4.5) in preparation for confocal microscopy.
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Results
4.9 Purification of MNV-1
For the most effective visualisation of MNV-1 entry by confocal microscopy, we sought to 
label virus directly with a fluorophore, DyLight. To do this, virus was propagated then 
purified, first with a sucrose cushion followed by purification through a caesium chloride 
gradient as described in Section 4.6 before concentrating. This virus was analysed, first 
by SDS-PAGE and Western blotting using anti-3D MNV polymerase antibodies. The 
result shown in Figure 4.1 indicated that the virus preparation was pure. As well as the 
purity of the virus preparation, the infectivity of the purified virus was also tested to 
ensure that by adding the flurophore (DyLight), the virus was not becoming inefficient at 
infecting cells. Purified virus was labelled, diluted to appropriate concentrations and the 
titre determined by TCID5 0 . The titre of the labelled virus was calculated to be 4.62 x 10® 
TDIC5 0 units/ml (compared to the original stock virus titre of 2  x 1 0  ^TDIC5 0 units/ml).
4.10 MNV-1 infection is not affected by a dominant negative Arf6
Arf6  is a GTPase protein involved in several cell processes, specifically those processes
affected by its role in affecting the actin cytoskeleton, such as in cell motility. It has a
well-established role in macropinocytosis, where it is responsible for membrane
trafficking, remodelling of the plasma membrane, inducing membrane curvature as well
as promoting Ras-mediated processes (reviewed in Mercer & Helenius, 2009). It is also
known to be involved in endosomal trafficking of the clathrin-mediated pathway
(Donaldson, 2003). More recently Arf6  has been characterised in an endocytic and
recycling pathway of its own (Radhakrishna & Donaldson, 1997), which has been found
to traffic HSV VP22 in a dynamin-dependent manner (Nishi & Saigo, 2007). The
components of this pathway are similar to MNV-1 entry (also dependent on dynamin and
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BFigure 4.1 Western blot analysis of the purified MNV-1 sample
A sample of purified virus (A) and the original stock virus solution (B) were analysed by SDS PAGE 
(10%), and Western blot membranes were probed with anti-3D polymerase (1:1000) followed by 
anti-rabbit HRP conjugated secondary antibody. Chemiluminescent substrate was added to the 
blot which was exposed to film and developed.
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cholesterol), leading us to hypothesise that this could be a pathway used by this virus. To 
investigate a possible role of Arf6 in MNV-1 entry, plasmids expressing GFP-tagged 
forms of either wt, DN or CA Arf6 were transfected into RAW 264.7 cells for 16 h, 
followed by infection with MNV-1 for 12 h. After this time, cells were fixed and stained for 
viral protein to be visualised by confocal microscopy (Figure 4.2). Results were 
calculated by counting the transfected cells and scoring them as infected or uninfected 
and comparing the DN and CA to wt. Neither the DN nor CA form of Arf6 had any effect 
on MNV-1 infection as compared to the infection of wf Arf6-expressing cells (Figure 4.3) 
This suggests that MNV-1 infection of RAW 264.7 cells does not require Arf6, implying 
that the Arf6-dependent pathway is not used for this virus to enter these cells.
4.11 MNV-1 infection is not affected by a dominant negative Rab7
The small GTPase protein, Rab7 plays an important role in cell transport from 
early/sorting endosomes to late endosomes. During endosomal maturation, Rab7 
proteins (late endosomal markers) gradually substitute early endosomal Rab5 proteins 
(markers of early endosomes) for traffic through the cell to form lysosomes (Bucci et al., 
2000; Rink et al., 2005). Several viruses have been found to be dependent on Rab7 late 
endosomal/ lysosomal traffic, such as SFV (Vonderheit & Helenius, 2005) and Echovirus 
7 (Kim & Bergelson, 2012), while others are independent of Rab7, such as Adenovirus 
Type 2 (Gastaldelli et al., 2008). It was unknown whether MNV-1 trafficked to late 
endosomes. Also, if indeed macropinocytosis is used for internalisation of MNV-1, it 
would be taken into macropinosomes, in which case it could also be trafficked from 
macropinosomes to late endosomes. This possibility was investigated by transfecting 
cells with GFP-tagged wt or DN forms of Rab7. Cells were transfected for 18 h, infected
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Figure 4.2 MNV-1 infection of RAW 264.7 ceils is independent of ArfB
RAW 264.7 cells were transfected with plasmids expressing GFP-tagged wt, DN or CA forms of 
ArfS for 18 h, then infected with MNV-1 for 12 h. Cells were fixed and stained for MNV-1 
infection using anti-3D pol antibody followed by Alexa-555 secondary antibody. ToPro3 stained 
nuclei are shown in blue. Cells were visualised using a ZEISS LSM META confocal laser 
microscope with 543 nm laser to detect the virus (red), 488 nm laser for transfected protein 
(green) and 633 nm laser to detect nuclei (blue). The bar indicates a size of 10 pm.
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Figure 4.3 MNV-1 entry into RAW 264.7 cells is independent of Arf6
RAW 264.7 cells were transfected with plasmids expressing GFP-tagged wt, DN or CA forms of 
Arf6 for 18 h and infected with MNV-1 for 12 h. Cells were fixed and stained for MNV-1 infection 
using anti-3D pol antibody followed by Alexa-555 secondary antibody. ToPro3 was used to stain 
the nuclei. Cells were visualised using a ZEISS LSM META confocal laser microscope and the 
transfected cells scored as infected or uninfected. Results shown are the numbers of cells 
infected in the DN and CA Arf6-expressing cells compared to the wt expressing cells, and are the 
mean of three independent experiments (+/-SE).
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for 12 h, fixed and stained in preparation for confocal microscopy (Figure 4.4). As seen 
in Figure 4.5, MNV-1 infection was not affected by the presence of DN Rab7, implying 
no role for Rab7 in MNV-1 infection in trafficking to late endosomes/lysosomes. This 
could indicate that instead of using the lysosomal pathway, MNV-1 could be trafficking 
via a recycling pathway.
4.12 MNV-1 infection is inhibited by mutant forms of R ab ll
R a b ll is a small GTPase protein used within the cell for trafficking between sorting 
endosomes and recycling endosomes, as well as between recycling endosomes and the 
plasma membrane (Ullrich et al., 1996; Green et al., 1997). In virus entry, R a b ll has 
been found to be required, along with microtubules, for effective infection by Influenza A 
virus, particularly in trafficking out of the cell (Amorim et al., 2011). As proved from the 
DN Rab7 experiments, MNV-1 was not following a classic degradative pathway; we 
therefore sought to explore whether it was following the recycling pathway by looking at 
R a b ll.  RAW 264.7 cells were transfected with plasmids expressing GFP-tagged wt, DN 
or CA forms of Rabi 1 for 18 h, followed by infection with MNV-1 for 12 h. Following fixing 
and staining for confocal microscopy, the results showed a significant decrease in 
infection in cells expressing the DN R a b ll and those expressing CA forms of R a b ll 
(Figure 4.6 and 4.7) This indicates that MNV-1 infection of RAW 264.7 cells depends on 
recycling compartments and the trafficking associated with them. However, it has been 
shown previously that overexpression of Rabi 1 results in accumulations of cholesterol 
within the cell, preventing it recycling back to the plasma membrane, interrupting 
cholesterol-dependent endocytosis (Hdltta-Vuori et al., 2002). Since MNV-1 entry is 
dependent on cholesterol, this could be causing the inhibition of MNV-1 infection. These 
results are discussed further in Section 4.17.
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Figure 4.4 Transfection of DN Rab? has no effect on MNV-1 infection
RAW 264.7 cells were transfected with plasmids expressing GFP-tagged w t or DN forms of Rab7 
for 18 h, then infected with MNV-1 for 12 h. Cells were fixed and stained for MNV-1 infection 
using anti-3D pol antibody followed by Alexa-555 secondary antibody. ToPro3 stained nuclei are 
shown in blue. Cells were visualised using a ZEISS LSM META confocal laser microscope with 543 
nm laser to detect the virus (red), 488 nm laser for transfected protein (green) and 633 nm laser 
to detect nuclei (blue). The bar indicates a size of 10 pm.
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Figure 4.5 MNV-1 infection of RAW 264.? cells is independent of Rab?
RAW 264.7 cells were transfected with plasmids expressing GFP-tagged w t or DN forms of Rab? 
for 18 h, then infected with MNV-1 for 12 h. Cells were fixed and stained for MNV-1 infection 
using anti-3D pol antibody followed by Alexa-555 secondary antibody. ToPro3 was used to stain 
the nuclei. Cells were visualised using a ZEISS LSM META confocal laser microscope and the 
transfected cells scored as infected or uninfected. Results shown are the numbers of cells 
infected in the DN Rab7-expressing cells compared to the w t expressing cells, and are the mean 
of three independent experiments (+/-SE).
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Figure 4.6 Mutant forms of Rabll proteins inhibit MNV-1 infection of RAW 264.7 cells
RAW 264.7 cells were transfected with plasmids expressing GFP-tagged wt, DN or CA forms of 
R ab ll for 18 h, then infected with MNV-1 for 12 h. Cells were fixed and stained for MNV-1 
infection using anti-3D pol antibody followed by Alexa-555 secondary antibody. ToPro3 stained 
nuclei are shown in blue. Cells were visualised using a ZEISS LSM META confocal laser 
microscope with 543 nm laser to detect the virus (red), 488 nm laser for transfected protein 
(green) and 633 nm laser to detect nuclei (blue). The bar indicates a size of 10 pm.
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Figure 4.7 MNV-1 infection of RAW 264.7 is dependent on Rabll
RAW 264.7 cells were transfected with plasmids expressing GFP-tagged wt, DN or CA forms of 
R ab ll for 18 h followed by infection with MNV-1 for 12 h. Cells were fixed and stained for MNV- 
1 infection using anti-3D pol antibody followed by Alexa-555 secondary antibody. ToPro3 was 
used to stain the nuclei. Cells were visualised using a ZEISS LSM META confocal laser microscope 
and the transfected cells scored as infected or uninfected. Results shown are the numbers of 
cells infected in the DN Rabll-expressing cells and CA Rabll-expressing cells compared to the 
w t expressing cells, and are the mean of three independent experiments (+/-SE; **  is P < 0.01).
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4.13 Colocalisation of MNV with endocytic markers
From previous investigations of MNV-1 entry, we knew that virus entry was cholesterol- 
dependent and possibly occurring via macropinocytosis (Gerondopoulos et al., 2010; 
Perry & Wobus, 2010). In order to clarify and expand these results further, we looked for 
any colocalisation of MNV-1 with two classic endocytic markers, ChTxB (a marker of lipid 
raft-dependent pathways) and dextran (a marker of fluid-phase entry). By using labelled 
virus (as prepared in Section 4.6), we examined colocalisation between the marker and 
virus at early time points during viral infection.
4.13.1 MNV-1 colocalises w ith dextran on entry
From previous studies into the entry of MNV-1, it was observed that inhibition of 
macropinocytosis resulted in increased infection of RAW 264.7 cells (Gerondopoulos et 
al., 2010; Perry & Wobus, 2010). We decided to investigate this unexplained association 
between MNV-1 entry and macropinocytosis using dextran, a well-established marker of 
fluid-phase entry (Kerr & Teasdale, 2009). Colocalisation of dextran has been used in 
several other studies investigating virus entry, such as BTV-1, where it was found that 
the virus was following the same path as dextran (Gold et al., 2010). In this study, 
dextran was used to track the pathway of labelled MNV-1 through the cell. Labelled 
MNV-1 was added to RAW 264.7 cells along with dextran for 15, 30 or 60 min. After this 
time, cells were fixed and stained for visualisation by confocal microscopy. As seen in 
Figure 4.8, 4.9 and 4.10, MNV colocalises with dextran at all time-points, implying that 
macropinocytosis could be acting as a main entry pathway for MNV-1. It also appears 
from this result that MNV-1 travels through macropinosomes, which could account for its 
absence from early endosomes (as seen in Kreutz & Seal, 1995; Stuart & Brown, 2006).
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Figure 4.8 Colocalisation of labelled MNV-1 and dextran 15 min post-infection
RAW 264.7 cells were incubated with labelled MNV-1 and Alexa-555 dextran for 15 min at 37°C, 
and fixed. ToPro3 stained nuclei are shown in blue. Cells were visualised using a ZEISS LSM META 
confocal laser microscope with 543 nm laser to detect dextran (red, A&D), 488 nm laser for 
labelled MNV-1 (green, B&E) and 633 nm laser to detect nuclei (blue). Shown are two replicates; 
panels C&F are overlays of A&B and D&E respectively. The bar indicates a size of 10 pm.
159
A: dextran
C: overlay A&B
■
■
W m
H
H
■
H
B
Bi
■
H
B
Figure 4.9 Colocalisation of labelled MNV-1 and dextran 30 min post-infection
RAW 264.7 cells were incubated with labelled MNV-1 and Alexa-555 dextran for 30 min at 37°C, 
and fixed. ToPro3 stained nuclei are shown in blue. Cells were visualised using a ZEISS LSM META 
confocal laser microscope with 543 nm laser to detect dextran (red, A&D), 488 nm laser for 
labelled MNV-1 (green, B&E) and 633 nm laser to detect nuclei (blue). Shown are two replicates; 
panels C&F are overlays of A&B and D&E respectively. The bar indicates a size of 10 pm.
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Figure 4.10 Colocalisation of labelled MNV-1 and dextran 60 min post-infection
RAW 264.7 cells were incubated with labelled MNV-1 and Alexa-555 dextran for 15 min at 37°C, 
and fixed. ToPro3 stained nuclei are shown in blue. Cells were visualised using a ZEISS LSM META 
confocal laser microscope with 543 nm laser to detect dextran (red, A&D), 488 nm laser for 
labelled MNV-1 (green, B&E) and 633 nm laser to detect nuclei (blue). Shown are two replicates; 
panels C&F are overlays of A&B and D&E respectively. The bar indicates a size of 10 pm.
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4.13.2 MNV-1 partially colocalises with ChTxB on entry
From previous studies into the entry of MNV-1, it was known that MNV-1 entry into RAW
264.7 cells was dependent on cholesterol, but independent of caveolae (Gerondopoulos 
et al., 2010; Perry & Wobus, 2010). Due to lipid rafts frequently being found as the 
source for newly discovered pathways, we sought to further characterise this pathway. In 
order to do so, we used ChTxB , a well-established marker of lipid raft/caveolar entry 
(Pelkmans et a/., 2001). Colocalisation of ChTxB has been used in several other studies 
investigating virus entry, such as in the entry of HIV 1 into brain endothelial cells, where 
the virus was found to colocalise strongly with ChTxB (Liu et a/., 2002). In our study, we 
used ChTxB to determine whether the pathway of MNV-1 through the cell followed the 
classic lipid raft-dependent pathway displayed by ChTxB. Labelled MNV-1 was added to 
RAW 264.7 cells alongside ChTxB for 15, 30 or 60 min. After this time, cells were fixed 
and stained for visualisation by confocal microscopy. As seen in Figure 4.11, after 15 
min, ChTxB and MNV-1 were partially colocalised on the plasma membrane. However, 
after 30 min (Figure 4.12) the internalised virus appears less colocalised with ChTxB, 
although virus bound at the membrane still colocalises with ChTxB. It appears that after 
60 min (Figure 4.13); the internalised MNV-1 is once again colocalised with ChTxB. This 
could fit with a model where virus is partially internalised via macropinocytosis as well as 
by an alternative pathway, which subsequently follows the recycling pathway. However, 
as discussed further in Section 4.17, these studies showed a lack of ChTxB 
internalisation into some cells, making this result inconclusive.
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Figure 4.11 Co-internalisation of labelled MNV-1 and ChTxB 15 min post-infection
RAW 264.7 cells were incubated with labelled MNV-1 and Alexa-555 ChTxB for 15 min at 37°C, 
and fixed. ToPro3 stained nuclei are shown in blue. Cells were visualised using a ZEISS LSM META 
confocal laser microscope with 543 nm laser to detect ChTxB (red, A&D), 488 nm laser for 
labelled MNV-1 (green, B&E) and 633 nm laser to detect nuclei (blue). Shown are two replicates; 
panels C&F are overlays of A&B and D&E respectively. The bar indicates a size of 10 pm.
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Figure 4.12 Co-internalisation of labelled MNV-1 and ChTxB 30 min post-infection
RAW 264.7 cells were incubated with labelled MNV-1 and Alexa-555 ChTxB for 30 min at 37°C, 
and fixed. ToPro3 stained nuclei are shown in blue. Cells were visualised using a ZEISS LSM META 
confocal laser microscope with 543 nm laser to detect ChTxB (red, A&D), 488 nm laser for 
labelled MNV-1 (green, B&E) and 633 nm laser to detect nuclei (blue). Shown are two replicates; 
panels C&F are overlays of A&B and D&E respectively. The bar indicates a size of 10 pm.
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Figure 4.13 Co-internalisation of labelled MNV-1 and ChTxB 60 min post-infection
RAW 264.7 cells were incubated with labelled MNV-1 and Alexa-555 ChTxB for 60 min at 37°C, 
and fixed. ToPro3 stained nuclei are shown in blue. Cells were visualised using a ZEISS LSM META 
confocal laser microscope with 543 nm laser to detect ChTxB (red, A&D), 488 nm laser for 
labelled MNV-1 (green, B&E) and 633 nm laser to detect nuclei (blue). Shown are two replicates; 
panels C&F are overlays of A&B and D&E respectively. The bar indicates a size of 10 pm.
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4.14 MNV-1 infection is not dependent on PI3-kinases
PI3-kinases are a group of enzymes implicated in several cellular processes, such as cell 
migration, growth and survival and in several endocytic pathways, the function we were 
interested in exploring. The role of PI3-kinases in clathrin-mediated entry is mainly in the 
trafficking of the endosome where, through activation of Rab5, it aids in the transition 
from early to late endosomes. As well as this role in clathrin-mediated entry, PI3-kinases 
are also essential in macropinocytosis and phagocytosis, where in both cases, 
membrane ruffling is able to proceed, but cannot result in the closure of the 
macropinosome or phagosome when activity is inhibited (Araki et al., 1996). The specific 
PI3-kinase inhibitor wortmannin inhibits specific classes of PI3-kinases: I, II (3 and y, and 
III (Okada et al., 1994). The effect of this inhibition is not exhibited in clathrin-mediated 
entry itself, having no effect on the assembly of the clathrin-coat, but rather the trafficking 
from the early to late endosome (Shpetner et al., 1996) for example, through inactivation 
of Rab5 (Li et al., 1995), which is thought to interfere with the fusion of endosomes 
(Jones et al., 1998). Inhibition of PI3-kinases using wortmannin has also been shown to 
inhibit the membrane ruffling associated with macropinocytosis (Dharmawardhane et al.,
2000). Wortmannin has been used in the study of several virus endocytosis pathways, 
such as with W  where PI3-kinases are required for blebbing to internalise the virus 
(Mercer & Helenius, 2008), in HSV infection where it prevented virus cycling to the 
perinuclear region (Nicola & Straus, 2004), and Nipah Virus infection where it aided the 
authors' conclusion that the virus uses macropinocytosis for entry (Pernet et al., 2009). 
Wortmannin has been shown to irreversibly inhibit PI3-kinases at lower concentrations 
(Jones et al., 1998). However, there are off-target effects of wortmannin, such as the 
inhibition of PI4-kinases, at higher concentrations, generally accepted to be at 
concentrations of -10  pM and higher (Nakanishi et al., 1995; Shpetner et al., 1996; 
Etkovitz et al., 2007), which is far higher than the concentrations used in this study. In
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order to confirm this in these cells, the entry of several labelled endocytic markers was 
observed, and evaluated as below.
4.14.1 W ortm annin is not cytotoxic to RAW  264.7 ceils
Due to the role of PI3-kinases in so many aspects of cellular survival, inhibition of these 
kinases could lead to cell death. To ensure cellular cytotoxicity would not affect any 
results obtained, RAW 264.7 cells were treated with wortmannin, the supernatant 
collected and tested for LDH activity to indicate cell death. As seen in Figure 4.14, 
wortmannin, even at its highest concentration used in our studies only resulted in -8%  
cell death so these concentrations were deemed suitable for further experiments.
4.14.2 MNV-1 entry is independent o f PI3-kinases
Before infection of wortmannin-treated cells, the entry of well-characterised endocytic 
markers into cells was assessed. RAW 264.7 cells were treated with wortmannin for 30 
min before the addition of transferrin, dextran or ChTxB, then fixed and stained in 
preparation for confocal microscopy. Transferrin is known to enter cells via a clathrin- 
mediated pathway (Dautry-Varsat et al., 1983), and was used as a control for the effect 
of wortmannin on this pathway. The entry of transferrin into wortmannin-treated RAW
264.7 cells appeared similar at both 100 nM or 500 nM wortmannin (Figure 4.15 A&B 
and 4.16 A&B), with typical accumulations of transferrin in early endosomes (Spiro et al., 
1996). PI3-kinases have been shown to be involved in the completion of 
macropinocytosis (Araki et al., 1996). As expected, the entry of the fluid-phase marker, 
dextran was significantly decreased in wortmannin-treated cells (Figure 4.15 C&D and 
4.16 C&D). Again, the effects of 500 nM and 100 nM wortmannin on dextran entry are 
very similar.
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Figure 4.14 Effect of increasing concentrations of wortmannin on RAW 264.7 cell viability
RAW 264.7 cells were treated with increasing concentrations of wortmannin and incubated for 
12 h. After this time, the supernatant was removed from the cells and tested for LDH activity as 
an indication of cell death. A high control (Triton X-100 treated cells) and low control (media 
only) are included. Results show the mean +/- SE of 3 replicates, as a percentage of the high 
control as calculated in Section 2.7.
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As expected, entry of the lipid raft marker, ChTxB was not affected by wortmannin 
treatment in these cells (Figure 4.15 E&F and 4.16 E&F) due to a lack of involvement of 
PI3-kinases in lipid raft entry. The similarity of the effect between 500 nM and 100 nM 
could indicate that although the higher concentration of wortmannin may inhibit PI4- 
kinases in other cells, it appears not to affect these cells any differently from the lower 
concentrations.
Subsequent to the control studies, the role of PI3-kinases in MNV-1 entry was 
investigated. RAW 264.7 cells were treated with wortmannin for 30 min before infection 
with MNV-1 for 12 h, fixed and stained (as in Section 4.5) to be viewed by confocal 
microscopy. The results as seen in Figure 4.17 show that entry of MNV-1 is not affected 
by inhibition of PI3-kinases; although there was a slight (but insignificant) increase in 
infection observed in 500 nM wortmannin-treated cells. This increase in infection is 
consistent with previous results that showed when macropinocytosis was inhibited, MNV- 
1 infection was increased (Gerondopoulos et al., 2010; Perry & Wobus, 2010). This 
result is considered further in Section 4.17.
4.14.3 P I3-kinases are not required for MNV-1 replication
Due to the involvement of PI3-kinases in intracellular trafficking, we sought to examine 
the effects of PI3-kinase inhibition on virus replication by adding wortmannin at different 
stages of infection. RAW 264.7 cells were treated with wortmannin at various times 
before and after infection; the supernatant was collected and virus titres analysed by 
TCIDso. The results (Figure 4.18) show that when cells were treated with wortmannin 
before, concurrently with, or after infection with MNV-1, there was generally no effect on 
virus replication, suggesting that PI3-kinases are not required for MNV-1 replication in 
RAW 264.7 cells. The increase in infection seen in pre-treatment with 500 nM 
wortmannin prior to infection is consistent with previous results seen (that inhibition of
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Figure 4.15 Effect of lOOnM wortmannin treatment on endocytic pathways of RAW 264.7 cells
RAW 264.7 cells were mock-treated (A,C&E) or treated with lOOnM wortmannin (B,D&F) for 30 
min then incubated with Alexa-555 transferrin (A&B) for 15 min, Alexa-555 dextran (C&D) or 
Alexa-555 ChTxB (E&F) for 30 min at 37°C. ToPro3 stained nuclei are shown in blue. Cells were 
visualised using a ZEISS LSM META confocal laser microscope with 543 nm laser to detect the 
markers (red) and 633 nm laser to detect nuclei (blue). The bar indicates a size of 10 pm.
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Figure 4.16 Effect of 500nM wortmannin treatment on endocytic pathways of RAW 264.7 cells
Raw 264.7 cells were mock-treated (A,C&E) or treated with 500nM wortmannin (B,D&F) for 30 
min then incubated with Alexa-555 transferrin (A&B) for 15 min, Alexa-555 dextran (C&D) or 
Alexa-555 ChTxB (E&F) for 30 min at 37°C. ToPro3 stained nuclei are shown in blue. Cells were 
visualised using a ZEISS LSM META confocal laser microscope with 543 nm laser to detect the 
markers (red) and 633 nm laser to detect nuclei (blue). The bar indicates a size of 10 pm.
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Figure 4.17 Wortmannin does not affect MNV-1 entry into RAW 264.7 cells
RAW 264.7 cells were treated with increasing concentrations of wortmannin for 30 min before 
infection for 12 h, control cells were treated with DMSO-containing DMEM. Cells were fixed and 
stained using anti-MNV 3D-pol antibody followed by Alexa-555 secondary antibody. ToPro3 was 
used to stain nuclei and cells were visualised using a ZEISS LSM META confocal laser microscope. 
Results shown are the numbers of cells infected in each treatment compared to the control, and 
are the mean of three independent experiments (+/-SE).
172
150-
100
(Q
S. 50
Wortmannin
control 
S  50nM 
B 3 lOOnM 
^  500nM
early simultaneous 
Time drug added
late
Figure 4.18 Entry, early or later events in MNV-1 replication are not dependent on PI3-kinases
RAW 264.7 cells were treated with wortmannin either i) 30 min before infection (early), ii) 
simultaneously with infection (simultaneous) or iii) 90 min after infection (late). Control cells 
were treated with DMSO-containing DMEM. Infection was carried out for 12 h at 37°C, the cells 
lysed and the viral titre of the supernatant analysed by TCID50 assay. The results were calculated 
as a percentage of the untreated control and are the mean of three independent experiments 
(+/- SE; * is P <0.05).
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macropinocytosis results in an increase in infection (Gerondopoulos et al., 2010; Perry & 
Wobus, 2010). Discussed further in Section 4.17, it may be that MNV-1 is usually taken 
up into cells by a PI3-kinase-dependent pathway targeted for degradation, and is then 
inactivated. When this PI3-kinase-dependent mechanism is inhibited by wortmannin, 
MNV-1 could freely replicate in the cell, leading to increased infection.
4.14.4 MNV-1 enters cells via pathways alternative to m acropinocytosis  
follow ing treatm ent w ith w ortm annin
Due to the varying effect on MNV-1 infection seen when cells were treated with 
wortmannin at different times, we sought to investigate whether the entry of MNV-1 
infection after wortmannin treatment more closely resembled macropinocytosis or 
clathrin-mediated pathways. Cells were pretreated with wortmannin for 30 min, followed 
by incubation with labelled MNV-1 and either transferrin for 15 min or dextran for 30 min, 
fixed and stained for observation by confocal microscopy. As shown in Figure 4.19, 
transferrin is able to enter cells, but forms typical accumulations in the cytoplasm. In 
Figure 4.20, entry of dextran is shown to be decreased after wortmannin treatment, but 
not completely inhibited indicating the possibility of another fluid-phase pathway 
independent of PI3-kinases. When comparing Figure 4.19 and 4.20, the appearance of 
MNV-1 following wortmannin treatment is more analogous to transferrin, (displaying 
accumulations in the cytoplasm), rather than dextran (which shows very little entry into 
wortmannin-treated cells). The fact that when macropinocytosis is inhibited by 
wortmannin, some MNV-1 is still able to enter the cell indicates it could enter via multiple 
pathways. As seen in the partial colocalisation between transferrin and the reduced 
amount of MNV-1 that enters the cells (Figure 4.19), it appears that MNV-1 is also able 
to enter by an alternative pathway under certain conditions, and accumulates in 
endosomes such as those containing transferrin.
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Figure 4.19 Wortmannin affects the internalisation of both transferrin and MNV
RAW 264.7 cells were treated with wortmannin (D,E&F) or mock-treated (A,B&C) for 30 min 
followed by incubation with Alexa-555 transferrin (red, A&D) and labelled FCV (green, B&E) for 
15 min at 37°C. ToPro3 stained nuclei are shown in blue. Panels C&F are overlays of A&B and 
D&E respectively. Cells were visualised using a ZEISS LSM META confocal laser microscope with a 
488 nm laser to detect the virus, 543 nm laser to detect transferrin and 633 nm laser to detect 
nuclei. The bar indicates a size of 10 pm.
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Figure 4.20 Wortmannin affects the entry of both dextran and MNV
RAW 264.7 cells were treated with wortmannin (D,E&F) or mock-treated (A,B&C) for 30 min 
followed by incubation with Alexa-555 dextran (red, A&D) and labelled FCV (green, B&E) for 30 
min at 37°C. ToPro3 stained nuclei are shown in blue. Panels C&F are overlays of A&B and D&E 
respectively. Cells were visualised using a ZEISS LSM META confocal laser microscope with a 488 
nm laser to detect the virus, 543 nm laser to detect dextran and 633 nm laser to detect nuclei. 
The bar indicates a size of 10 pm.
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4.15 MNV-1 infection is tyrosine kinase-dependent
Tyrosine kinases are vital signalling enzymes in many processes within the cell, involved 
in several endocytic pathways. They have been implicated in lipid raft/caveolar entry 
(Pike, 2003) as well as in macropinocytosis where their role in macropinosome trafficking 
is crucial (Ridley, 1994; Kasahara et al., 2007). Receptor tyrosine kinases activate Ras 
and initiate the PI3-kinase signalling pathway which is required particularly for the 
closure of macropinosomes. The isoflavone genistein is a well-established drug used in 
the treatment of cancer (Barnes, 1995). However, at a cellular level, its main activity is to 
inhibit the action of tyrosine kinases (Akiyama et al., 1987), which are often out of control 
in cancer. Therefore genistein is also commonly used to investigate signalling pathways 
implicated in endocytosis, particularly in pathogen entry. One of the best characterised 
viruses to be studied using genistein, is SV40, which was found to require tyrosine 
kinases to induce the signalling required for internalisation (Chen & Norkin, 1999). 
Different W  strains were also found to be dependent or independent of tyrosine kinases 
for entry (Mercer et al., 2010). Due to the dependence of MNV-1 entry on cholesterol and 
its association with macropinocytosis (Gerondopoulos et al., 2010), we hypothesised it 
might also rely on the signalling-induced processes of tyrosine kinases. To investigate 
this possibility, we used genistein to inhibit tyrosine kinases in RAW 264.7 cells.
4.15.1 Genistein is not cytotoxic to RAW  264.7 cells
Given that genistein is used as a cancer treatment (Barnes, 1995), it is known to be 
potent at the concentrations used; therefore, lower concentrations were tested on these 
cells to avoid cytotoxic effects. RAW 264.7 cells were treated with genistein for 6 h, the 
supernatant harvested and tested for LDH activity to give an indication of cell toxicity. 
The concentrations of genistein to be used in later experiments resulted in minimal cell 
death as seen in Figure 4.21
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Figure 4.21 Genistein does not affect RAW 264.7 cell viability
RAW 264.7 cells were treated with different concentrations of genistein for 12 h, the 
supernatant was collected and tested for LDH activity to give an indication of cell death. A high 
control (Triton X-100 treated cells) and low control (media only) are included. Results are 
presented as cell death for each treatment as a percentage of the high control (as calculated in 
Section 2.7), showing the mean +/-SE of 3 replicates.
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4.15.2 G enistein treatm ent increases MNV-1 entry
Prior to testing the effect of tyrosine kinase inhibition on MNV-1 entry, the effect of the 
inhibitor on the entry of several endocytic markers was investigated using confocal 
microscopy. RAW 264.7 cells were treated with genistein for 30 min, followed by the 
addition of transferrin, dextran or ChTxB. Cells were then fixed and stained in 
preparation for analysis by confocal microscopy. From Figure 4.22 A&B, it can be seen 
that inhibiting tyrosine kinases does not affect clathrin-mediated entry characterised by 
transferrin. Genistein caused a decrease in entry of the fluid phase marker, dextran, into 
RAW 264.7 cells (Figure 4.22 C&D). This was expected due to the reliance of 
macropinocytosis on tyrosine kinases. Although genistein would be expected to inhibit 
ChTxB entry, ChTxB entry into RAW 264.7 cells was observed to be only slightly 
decreased in genistein-treated cells (as shown in Figure 4.22 E&F). These results imply 
that the main point of action for genistein in these cells are the tyrosine kinases involved 
in macropinocytic entry, rather than those in lipid raft entry.
Following the control studies, the effect of genistein on the entry of MNV-1 was 
scrutinised to discover whether MNV-1 entry required tyrosine kinases. RAW 264.7 cells 
were pre-treated with genistein, infected for 6 h, fixed and stained for confocal 
microscopy (Figure 4.23) An increase in MNV-1 entry into RAW 264.7 cells was seen at 
a higher concentration, which is consistent with previous results showing an increase in 
MNV-1 entry when macropinocytosis was inhibited (Gerondopoulos et a/., 2010; Perry & 
Wobus, 2010).
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Figure 4.22 Effect of genistein on the entry of classic endocytic markers into RAW 264.7 cells
Raw 264.7 cells were mock-treated (A,C&E) or treated with genistein (B,D&F) for 30 min then 
incubated with Alexa-555 transferrin (A&B) for 15 min, Alexa-555 dextran (C&D) or Alexa-555 
ChTxB (E&F) for 30 min at 37°C. ToPro3 stained nuclei are shown in blue. Cells were visualised 
using a ZEISS LSM META confocal laser microscope with 543 nm laser to detect the markers and 
633 nm laser to detect nuclei. The bar indicates a size of 10 pm.
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Figure 4.23 Genistein increases MNV-1 entry into RAW 264.7 cells
RAW 264.7 cells were treated with two concentrations of wortmannin for 30 min and infected 
for 12 h, while control cells were treated with DMSO-containing DMEM. Cells were fixed, then 
stained using anti-MNV 3D-pol antibody followed by Alexa-555 secondary antibody and ToPro3 
to stain nuclei for confocal microscopy. Results shown are the numbers of cells counted as 
infected in each treatment compared to the control, and are the mean of three independent 
experiments (4-/-SE; **  is P <0.01).
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4.15.3 Tyrosine kinases are required at d ifferent stages o f MNV-1 infection
Due to the involvement of tyrosine kinases not only in endocytosis, but also in 
intracellular signalling events, we sought to investigate the effect of tyrosine kinase 
inhibition on viral replication by adding genistein at different stages of infection. RAW
264.7 cells were treated with genistein at different times before and after infection; the 
supernatant was harvested and virus titres analysed by TCID5 0 . An unusual effect was 
seen in Figure 4.24 (similar to that in Figure 4.23); pre-treatment of cells with genistein 
resulted in an increase in MNV-1 replication. However, when genistein was added 
simultaneously with or 1 h after infection, there was a significant inhibition of viral 
replication. The observed increase in virus infection when cells were pre-treated with 
genistein is consistent with previous results that showed an increase in infection when 
macropinocytosis was inhibited (Gerondopoulos et al., 2010; Perry & Wobus, 2010). 
However, the decrease in MNV-1 infection seen when genistein was added post- 
infection points to a role of tyrosine kinases late in MNV-1 infection, possibly in 
intracellular trafficking. This result points to a requirement of MNV-1 infection for tyrosine 
kinases once within the cell, possibly in macropinosome trafficking or in replication 
(discussed further in Section 4.17).
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Figure 4.24 Entry, early and late events in MNV-1 replication are tyrosine kinase-dependent
RAW 264.7 cells were treated with genistein either i) 30 min before infection (early), ii) 
concurrently with infection (simultaneous) or iii) 90 min after infection (late). Control cells were 
treated with DMEM containing DMSO. Infection was carried out for 12 h at 37°C, following 
which, the cells were lysed and the viral titre of the supernatant analysed by TCID50. The results 
were calculated as a percentage of the untreated control and are the mean of three 
independent experiments (+/- SE; * is P ^0.05; **  is P < 0.01).
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4.16 MNV-1 entry is dependent on protein phosphatases
Protein phosphatases are used in the cell as a sort of ‘switch’, important in the signalling 
of several endocytic pathways. They are classically associated with lipid raft/caveolar 
entry (Parton et al., 1994) where they often act to switch ‘o ff a signalling cascade. 
Interference in the function of these molecules is commonly achieved by the 
serine/threonine phosphatase inhibitor okadaic acid which specifically inhibits the 1 and 
2a phosphatases (Cohen et al., 1990). Okadaic acid-mediated inhibition of protein 
phosphatases affects not only lipid raft entry, but macropinocytosis and clathrin-mediated 
entry, often by interference with endosomal fusion (Woodman et al., 1992). In the case of 
SV40 entry, treatment of cells with okadaic acid resulted in an increase in SV40 binding 
and internalisation (Pelkmans et al., 2002); however, inhibition of tyrosine phosphatases 
has been shown to inhibit poliovirus entry (Coyne et al., 2007), indicating cell- and virus- 
specific effects. Although okadaic acid has also been shown to interfere with clathrin- 
mediated entry as well as fluid-phase entry, its major effect is on lipid raft mediated 
endocytosis (Lucocq et al., 1991; Parton et al., 1994). Due to the dependence of MNV-1 
entry on cholesterol, and therefore a potential role for protein phosphatases in its entry, 
we assessed the effect of okadaic acid on MNV-1 entry.
4.16.1 O kadaic acid is not cytotoxic to RAW  264.7 cells
Owing to the widespread roles of protein phosphatases in cell function, the effect of 
okadaic acid on cell viability was tested. RAW 264.7 cells were treated with okadaic acid 
for 12 h, the supernatant collected from the cells and tested for LDH activity which gives 
an indication of cell death. As seen in Figure 4.25, okadaic acid results in no loss to cell 
viability at the concentrations of drug used in these studies. Therefore, 50 and 100 nM 
concentrations were considered to be appropriate for use in further experiments.
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Figure 4.25 Okadaic acid treatment of RAW 264.7 cells has no effect on cell viability
RAW 264.7 cells were treated with varying concentrations of okadaic acid for 12 h, and the 
supernatant harvested to be tested for LDH activity as an indicator of cell death. A high control 
(Triton X-100 treated cells) and low control (media only) are included. Results are presented as 
cell death for each treatment as a percentage of the high control as calculated in Section 2.7, 
with the mean +/- SE of 3 replicates shown.
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4.16.2 Okadaic acid inhibits MNV-1 entry
Before exploring the effect of protein phosphatase inhibition on MNV-1 infection, the 
effect of okadaic acid treatment on endocytic pathways of the cell was tested using 
classic markers of endocytic pathways. RAW 264.7 cells were treated with okadaic acid 
for 30 min before the addition of transferrin, dextran or ChTxB. The cells were then fixed 
and stained in preparation for confocal microscopy. Okadaic acid treatment of cells has 
previously been shown to inhibit clathrin-mediated entry (Parton et al., 1994). Similarly, 
entry of transferrin into RAW 264.7 cells was slightly decreased after okadaic acid 
treatment (shown in Figure 4.26 A&B). Although macropinocytosis has been shown to 
be inhibited by okadaic acid treatment, its principal effect is on lipid raft endocytosis 
(Lucocq et a!., 1991). The entry of dextran into RAW 264.7 cells is unaffected by okadaic 
acid treatment as shown in Figure 4.26 C&D. Treatment with okadaic acid has 
previously been shown to increase entry via caveolae/lipid raft pathway (Parton et a!., 
1994). However, the entry of ChTxB into okadaic acid-treated RAW 264.7 cells is 
unaffected (Figure 4.26 E&F). This could be indicative of the fact that these cells do not 
possess caveolae (Gerondopoulos et a!., 2010) or suggests that ChTxB enters these 
cells via another pathway.
Following on from control studies, the function of protein phosphatases in MNV-1 entry 
was explored. RAW 264.7 cells were treated with okadaic acid for 30 min, infected with 
MNV-1 for 12 h, fixed and stained for confocal microscopy. Due to okadaic acid only 
affecting clathrin-mediated entry in control studies; we expected to see no effect on 
MNV-1 infection. However, as shown in Figure 4.27 a decrease was observed, which 
was significant at 100 nM concentration. This indicates that entry of MNV-1 into RAW
264.7 cells is dependent on the action of protein phosphatases within these cells, 
possibly in the role of endosome trafficking which has been shown to be inhibited with 
okadaic acid treatment (Lucocq et a/., 1991).
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Figure 4.26 Effect of okadaic acid treatment on entry of endocytic markers into RAW264.7 cells
RAW 264.7 cells were mock-treated (A,C&E) or treated with okadaic acid (B,D&F) for 30 min 
then incubated with Alexa-555 transferrin (A&B) for 15 min, Alexa-555 dextran (C&D) or Alexa- 
555 ChTxB (E&F) for 30 min at 37°C. ToPro3 stained nuclei are shown in blue. Cells were 
visualised using a ZEISS LSM META confocal laser microscope with 543 nm laser to detect the 
markers (red) and 633 nm laser to detect nuclei (blue).The bar indicates a size of 10 pm.
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Figure 4.27 Okadaic acid inhibits MNV-1 entry into RAW 264.7 cells
RAW 264.7 cells were treated with different concentrations of okadaic acid for 30 min then 
infected for 12 h, control cells were treated with DMSO-containing DMEM. Cells were fixed and 
stained using anti-MNV 3D-pol antibody followed by Alexa-555 secondary antibody and ToPro3 
to stain nuclei for confocal microscopy. Results shown are the numbers of cells infected in each 
treatment compared to the control, and are the mean of three independent experiments (+/-SE; 
* is P< 0.05).
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4.16.3 Protein phosphatases affect d ifferent stages o f MNV-1 infection
Owing to protein phosphatase involvement in several stages of endocytosis, the effect of 
okadaic acid on viral replication at different times was tested. RAW 264.7 cells were 
treated with okadaic acid at different times before and after infection; the supernatant 
removed from the cells and virus titres analysed by TCID50. Similarly to previous results 
(Section 4.16.2), early treatment with okadaic acid resulted in a significant inhibition of 
MNV-1 infection (Figure 4.28). However, treatment with okadaic acid after infection with 
MNV-1 showed an increase in infection. A similar effect on virus infection was seen in 
Amphotropic Murine Leukaemia Virus (A-MLV) infection where pre-treatment with 
okadaic acid inhibited infection whereas treatment post-entry stimulated infection (Beer 
et al., 2005). Because okadaic acid stimulates caveolar internalisation, in A-MLV 
infection this increase in infection (when okadaic acid is added post-entry) can be 
accounted for by A-MLV’s dependence on caveolar endocytosis. The results of our 
experiments could be indicative of MNV’s dependence on an, as yet undefined, lipid raft- 
dependent pathway which is dependent on protein phosphatases, or that protein 
phosphatases play a role in MNV-1 replication.
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Figure 4.28 Entry and early events in MNV-1 replication are protein phosphatase-dependent
RAW 264.7 cells were treated with okadaic acid either i) 30 min before infection (early), ii) at the 
same time as infection (simultaneous) or iii) 90 min after infection (late). Control cells were 
treated with DMSO-containing DMEM. Infection was carried out for 12 h at 37°C, the cells lysed 
and the viral titre of the supernatant analysed by TCID50. The results were calculated as a 
percentage of the untreated control and are the mean of three independent experiments (+/- 
SE; * is P <0.05; **  is P < 0.01).
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4.17 Discussion
Cellular endocytosis pathways are highly complex, as demonstrated by the number of 
pathways that viruses are able to hijack to enter cells. Following binding to the cell, 
viruses are able to initiate cellular signals and endocytic pathways to gain entry into the 
cell. The work in this chapter is focussed on the entry mechanism of MNV-1.
Following on from previous work on MNV-1 entry mechanisms, this study sought to 
further explore the trafficking and begin investigating the signalling involved in infection.
It was previously reported that MNV-1 used a cholesterol-, microtubule- and dynamin- 
dependent pathway (Gerondopoulos et al., 2010; Perry & Wobus, 2010).
Although these studies eliminated many other possible pathways of entry for MNV-1, 
they did not examine the possibility of MNV-1 using an Arf6-dependent pathway as HSV 
VP22 does (Nishi & Saigo, 2007). We investigated the role of Arf6 in MNV-1 infection 
and found that MNV-1 entry into RAW 264.7 cells was independent of Arf6.
Previous investigations into MNV-1 trafficking showed that it did not traffic to early 
endosomes, however no further trafficking was investigated (Gerondopoulos et al., 2010; 
Perry & Wobus, 2010). We sought to answer this question by looking at the role of Rab7 
in MNV-1 infection using a DN form of the protein. Our results showed that MNV-1 does 
not traffic to late endosomes. However further investigations into MNV-1 trafficking in 
RAW 264.7 cells showed that MNV-1 could be trafficking to recycling endosomes. MNV- 
1 infection was inhibited in cells expressing both the DN and CA forms of R a b ll 
indicating that MNV-1 infection in these cells requires functional R a b ll.  As mentioned in 
Section 4.12, the transfection of CA R a b ll into cells could be affecting cholesterol 
availability on the plasma membrane, (as seen previously; Holtta-Vuori et al., 2002; 
Takahashi et al., 2007). Due to the dependence of MNV-1 entry on cholesterol 
(Gerondopoulos et al., 2010), a decrease in cholesterol availability could result in an
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inhibition of infection as seen here. An alternative explanation is the finding that the CA 
form of Rab11 localises to the recycling endosome while the DN Rab11 localises to the 
TON (Chen et al., 1998; Rowe et al., 2008). If this is the case in these cells, MNV-1 could 
require Rabi 1-dependent trafficking from the recycling endosomes and from the TGN. 
Overall, the reduction of infection caused by DN R a b ll does indicate a role for recycling 
compartments in MNV-1 entry.
Previous investigations of MNV-1 entry showed an increase in infection when 
macropinocytosis was inhibited. It was suggested that this was either as a result of up- 
regulation of another pathway; or that MNV-1 was usually taken up into the degradative 
macropinocytosis pathway thus inhibiting it resulted in a more productive infection 
(Gerondopoulos et al., 2010). It has been found (in macrophages) that macropinosomes 
swiftly gain markers of late endosomes, such as Rab7 and subsequently fuse with 
lysosomal compartments (Racoosin & Swanson, 1993). If this is the case in our 
macrophage cell line, this would explain why a virus that normally enters cells via 
macropinocytosis can yield such a productive infection when macropinocytosis is 
inhibited. We sought to answer this question using colocalisation studies with the fluid 
phase marker dextran, which showed partial colocalisation with labelled MNV-1 and 
dextran during entry. This indicated that some MNV-1 enters RAW 264.7 cells via 
macropinocytosis; however since there is not complete colocalisation, the remaining 
virus could be entering via another pathway. This alternative pathway could be the 
pathway ChTxB is using for entry into RAW 264.7 cells. ChTxB has long been 
considered as a marker for lipid raft entry, however it has previously been shown to enter 
via other pathways (Torgersen et al., 2001). As well as this, in this study, we have shown 
that entry of ChTxB into RAW 264.7 cells does not appear to be via a classic lipid raft 
pathway. The results of these colocalisation studies are therefore inconclusive until the
pathway of ChTxB entry into these cells is further clarified.
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The involvement of endocytic regulators, such as kinases and phosphatases had not 
been investigated in MNV-1 entry. We used the PI3-kinase inhibitor wortmannin which 
affected macropinocytic entry more than it did clathrin-mediated entry in RAW 264.7 
cells. The significant increase in MNV-1 infection after pre-treatment with wortmannin 
supports previous results showing that when macropinocytosis is inhibited, MNV-1 entry 
is increased. An alternative explanation for this effect could also be the involvement of 
PI3-kinase in cellular defence mechanisms. When a cell is under stress (such as during 
viral infection) the PI3-kinase/Akt/mT0R pathway is down-regulated which in turn 
decreases protein synthesis in the cell, by inactivating the translation initiation protein, 
elF4E (Proud, 2004). This mechanism of cell protection has been found to reduce VSV 
infection in mouse embryo fibroblast cells (Minami et a/., 2007). Similarly, wortmannin 
may be inhibiting this pathway in these cells, and in so doing allowing the virus to 
replicate freely, causing an increase in infection. As well as this, the VPg of MNV-1 has 
been shown to interact with elF4E (Daughenbaugh et al., 2006), indicating that the 
observed increase in MNV-1 infection could be due to inhibition of the PI3- 
kinase/Akt/mTOR pathway. Confocal analysis of MNV-1 entry with transferrin or dextran 
after wortmannin treatment showed that when macropinocytosis is inhibited, some MNV- 
1 is able to enter via an alternative pathway that may traffic to early endosomes.
The role of tyrosine kinases in caveolar/lipid raft entry is well-established; as is the 
inhibitory effect on this pathway by genistein (Parton et al., 1994). However, genistein is 
also able to inhibit RTKs which are involved in several receptor-induced endocytic 
pathways, such as macropinocytosis. The significant increase in MNV-1 entry supports 
previous results showing that by inhibiting macropinocytosis, MNV-1 infection is 
increased. When cells were treated with genistein post-infection, there was a decrease in 
MNV-1 replication. Replication of influenza virus was shown to be inhibited by specific 
RTK inhibitors (Kumar et al., 2011), and the results of our experiments could indicate a
similar effect, implicating RTKs in the replication of MNV-1.
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The protein phosphatase inhibitor, okadaic acid, has previously been shown to up- 
regulate the caveolae-dependent pathway (Parton et al., 1994), however in RAW 264.7 
cells, entry of the classic lipid raft marker, ChTxB was unaffected. The subsequent 
decrease observed in MNV-1 infection could be accounted for by a general decrease in 
intracellular trafficking seen in okadaic acid treatment (Lucocq et al., 1991). The result 
observed when treating cells with okadaic acid at different stages of infection (pre­
treatment inhibiting entry, treatment post-infection increasing entry) mirrors that of A-MLV 
(Beer et al., 2005) which enters cells via a caveolae-dependent pathway. Since there are 
no caveolae present in these cells, this effect could be indicative of virus entry by lipid- 
raft mediated entry, or a cell-specific pathway not yet characterised.
Due to the phagocytic nature of these macrophage cells, it seems likely that under 
normal conditions, a proportion of virus particles are internalised and broken down in the 
cell, while some virus enters via a different pathway. This theory is supported by two 
findings; the first is the observed increase in infection when macropinocytosis is inhibited 
(Gerondopoulos et al., 2010; Perry & Wobus, 2010) -  compared to normal conditions, 
MNV-1 infection is more productive when entering via other, non-degradative pathways. 
The second finding is the colocalisation seen between the fluid phase marker, dextran 
and labelled MNV-1. The ability of the virus to cause infection even when 
macropinocytosis is functional and possibly degrading the virus supports the hypothesis 
of alternative pathways.
Taken together, these results show that MNV-1 entry into RAW 264.7 cells could be 
occurring via multiple pathways which include macropinocytosis. The fact that these 
results do not match any model pathway could reflect the difference between typical cell 
lines and these macrophage cells. However, these results do indicate the presence of an
uncharacterised endocytic pathway in these cells.
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Chapter 5 
Effect of FCV infection on CRFK cell metabolism
5.1 Introduction
Metabolism is required for the survival of all organisms, in producing molecules required 
for survival, such as proteins and genetic material, and for energy production necessary 
for all cellular processes (Berg et al., 2012). Some metabolic pathways are well 
conserved even across different organisms, such as the Krebs cycle, used for large 
amounts of ATP production and found both in mammalian cells (Krebs & Johnson, 1937) 
and in bacterial cells (Krebs, 1937). Metabolism has been found to be affected in several 
different cell states, such as in cancer, where an increase in glucose uptake and 
glycolysis is observed, as well as one of the most commonly-known aberrations of 
metabolism, the Warburg effect. Here, the tumour cells metabolise glucose to pyruvate, 
but instead of direct transport to the mitochondria for the Krebs cycle the pyruvate is 
converted to lactate, even when oxygen levels are high, hence the process being called 
“aerobic glycolysis" (Vander Heiden et al., 2009). However, cancer is not the only 
condition under which a cells’ metabolism can be affected.
Viruses rely on host cells to provide the metabolic resources required for their replication
and therefore can affect the normal metabolic activity of the cell (Koppelman & Evans,
1959). The process of viral replication depends on the synthesis of large quantities of
macromolecules, which in turn is reliant on a generous source of molecular components
and energy with which to assemble them. Investigations into the metabolism of virally-
infected cells have been underway since the 1950s (Koppelman & Evans, 1959), and
since then several viruses have been shown to have a significant influence on the
metabolism of the host cell. For example, HCMV (Munger et al., 2008), Paramyxoviridae
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viruses (Mumps virus and Newcastle disease virus; Green et al., 1958), Dengue 2 virus 
(El-Bacha et al., 2007) and influenza virus (Ritter et al., 2010) all influence the host cell 
metabolism in different ways depending on their requirements. These effects on cell 
metabolism are not only a result of the need for more energy required for the enforced 
production of viral proteins and genetic material, but in some cases when viral infection 
causes apoptosis (such as in Influenza virus infection; Ritter et al., 2010). In addition to 
this, when enveloped viruses leave the cell by budding, they force the cell to produce 
membrane lipids which are used in forming a new viral envelope (Munger et al., 2008). 
Most recent investigations into the metabolic effects of viral infection on cells have been 
performed using HPLC (High-Performance Liquid Chromatography) mass spectrometry- 
based metabolomics to analyse metabolites (El-Bacha et al., 2007; Munger et al., 2008).
The Biolog system was originally developed to study the metabolism of bacteria 
(Bochner et al., 2001). However, more recently it has been further developed for use in 
the study of the metabolism of mammalian cells (Bochner et al., 2011). Here, we have 
attempted to use the Biolog system to investigate the influence of FCV-F9 infection on 
the metabolism of CRFK cells. Due to the relative novelty of the technology, these 
experiments were only performed as initial investigations, with an aim to develop a 
suitable method for these experiments and attain preliminary data, looking to further 
investigations in the future.
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Materials and Methods
5.2 Effect of FCV-F9 infection on CRFK cell metabolism
FCV-infected and uninfected CRFK cells were analysed using the Biolog Phenotype 
Microarray™ (PM) technology (Bochner et al., 2001; Bochner et al., 2011). Initial studies 
focussed on the high-throughput screening of carbon-based substrate utilisation. All 
plates and reagents used were supplied by Biolog Inc (Hayward, CA), and used 
according to the manufacturer’s instructions.
5.2.1 O ptim isation of m ethod
Tests were undertaken to optimise the number of cells required in each well, the best 
media to use, which dye was most suitable and which MCI of FCV to use.
For optimisation experiments, blank (no substrate) Biolog plates were utilised. First, 
different numbers of cells were tested. 2.5 x 10"^ , 5 x 10"^  and 1 x10 ^  cells per well were 
tested along with different MOIs of 0.1, 1 and 10. The two dyes for mammalian cells (MA 
and MB) were also tested. The medium on the cells in a T75 flask was changed to MC-0 
media (Appendix) 24 h before the start of the experiment and compared to cells where 
the medium was not changed before the experiment. Two different media were 
compared; the Biolog MC-0 media and ‘blank’ DMEM media (Appendix). It was ensured 
for continuity that all subsequent experiments would be undertaken on cells of low 
passage number (under 10 passages).
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5.2.2 Final method
For the investigation of carbon substrate utilisation, we used the Biolog PM-M1 plates 
which contain 90 carbon substrates for analysis. 24 h prior to setting up the Biolog 
plates; -70%  confluent CRFK cells in a T75 tissue culture flask were washed twice in 
pre-warmed PBS and the medium replaced with MC-0 media for -24  h. After 24 h, the 
cells were detached from the flask using Versene, centrifuged at 2500 rpm for 4 min and 
resuspended in MC-0 media then seeded at approximately 2.5 x10^ cells per well (50 pi) 
in a PM-M1 plate. For the infection studies, virus was mixed in MC-0 media to an MOI of 
1, alongside an uninfected control made up of 10% MEM diluted to the same 
concentration as the virus, and 33 pi was added to each well. Substrate utilisation was 
measured according to the rate of reduction of a tétrazolium dye (MA; 16 pI/well) to 
formazan, providing an indication of the rate of cellular respiration. The plates were 
placed in the OmniLog plate reader at 37°C in order to monitor respiration at 15 min 
intervals over a 24 h period. Three individual experiments were carried out and the 
kinetic data was analysed, and the substrates where a significant difference between 
infected and uninfected was seen were identified using the OmniLog-PM software. Due 
to the replication cycle of FCV taking -6  h, the results are presented in 6 h periods of 
time, the results averaged over each time period. GraphPad Prism was used for 
statistical testing for each time point, using two-way AN OVA with a Bonferroni post test.
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Results
5.3 Results of optimisation experiments
Due to the novelty of using this technology for use in viral studies, optimisation 
experiments were first undertaken. This involved the use of blank Biolog plates into 
which different cell numbers, virus MOIs and types of dyes were dispensed.
The results of optimisation studies showed that, as expected, when increasing cell 
numbers, the cells metabolised at a faster rate. This led to the use of a relatively low 
number of cells per well (2.5 x 10"^ ). Testing of different MOIs did not dramatically affect 
the cells, so the intermediate MOI (1) was used in subsequent studies. The use of one of 
the dyes (MB) showed a much faster conversion rate of the dye, and resulted in the use 
of the alternative dye (MA) for successive studies. Changing the medium on the cells 24 
h prior to the experiment proved more effective in slowing down the conversion rate of 
the dye, as did the reduction in serum levels (2.5%), and thus these conditions were 
deemed more suitable for use in subsequent experiments.
5.4 Analysis of the effect of FCV Infection on CRFK cell 
metabolism
The metabolism of FCV-infected and uninfected CRFK cells over a 24 h period was
investigated using the Biolog technology. Cells were dispensed into Biolog plates and
either infected or mock-infected; dye was added to each well and the plates incubated for
24 h. In these assays, a total of 91 carbon compounds (listed in Appendix) were
assessed. Of those compounds tested, and analysed using the OmniLog-PM software,
nine showed a difference in metabolism between infected and uninfected samples. In
two cases infected cells metabolised significantly better than uninfected cells. The
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remaining seven substrates showed increased metabolism in uninfected cells compared
to the infected cells.
The two substrates which caused increased metabolism in FCV-infected cells were 
a-D-glucose and D, L- a-glycerol phosphate, described as follows.
5.4.1 a-D -glucose
There are two forms of glucose, D- and L-glucose, and although they are mirror-images 
of each other, cells are only able to metabolise D-glucose. This is also evident by the fact 
that L-glucose is not metabolised in these experiments (data not shown), whereas D- 
glucose is. In these experiments, there was more a-D-glucose metabolised in FCV- 
infected cells than uninfected cells, beginning to be used from 0 h while uninfected cells 
are delayed by -1 h in starting to metabolise this substrate (Figure 5.1) Over the 24 h 
time-course, infected cells metabolised more a-D-glucose than the uninfected cells, 
which indicated a higher overall level of activity and requirement for energy in these cells.
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Figure 5.1 Metabolism of a-D-glucose by FCV-infected and uninfected CRFK cells
CRFK cells were incubated in the wells of a 96 well plate containing different carbon sources for 
24 h at 37°C using the rate of tétrazolium dye conversion to indicate the rate of metabolism. The 
resultant graphs show the metabolism of a-D-glucose in infected (red) or uninfected cells (green) 
as an average of three individual experiments (mean +/- SE).
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5.4.2 D, L-a-glycerol-phosphate
There was an increase in the metabolism of D,L-a-glycerol phosphate in FCV-infected 
cells (Figure 5.2), which could be feeding into the glycerol-phosphate pathway and into 
glycolysis. However, from the delay of -12  h observed in cells beginning to metabolise 
this substrate, it is clear that it is not an optimal carbon source for these cells, and so 
could be being directed through another pathway. Glycerol phosphate also serves as a 
precursor to the glycerol portion of triglycerides, diacylglycerols and phospholipids which 
could indicate an increase in membrane synthesis. Although an increase in fatty acid 
synthesis is usually seen in enveloped viruses (such as HCMV; Yu et al., 2011a) for the 
creation of envelope for viruses exiting the cell, the increase in fatty acid production here 
could be explained by an increase in membrane rearrangements. Most single-stranded 
RNA viruses replicate on membranous vesicles in the cytoplasm of cells, which is how 
FCV has been shown to replicate (Green et al., 2002). Since D,L- a-glycerol phosphate 
can be metabolised into building blocks of cell membranes, the need for vesicles on 
which to replicate could be driving the increased metabolism of this compound in FCV- 
infected cells.
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Figure 5.2 Metabolism of D,L-a glycerol phosphate by FCV-infected and uninfected CRFK cells
CRFK cells were incubated in the wells of a 96 well plate containing different carbon sources for 
24 h at 37°C using the rate of tétrazolium dye conversion to indicate the rate of metabolism. The 
resultant graphs show the metabolism of D,L-a glycerol phosphate in infected (red) or 
uninfected cells (green) as an average of three individual experiments (mean +/-  SE; * is P < 
0.05).
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The seven substrates that resulted in higher metabolism in uninfected cells than in
FCV-infected cells were as follows.
5.4.3 D-turanose
D-turanose is a dissacharide, a sucrose analogue, which can be broken down into 
glucose and fructose for metabolism in the cell. D-turanose is also able to be used as a 
carbon source by some organisms (Sinha et a/., 2002). In these experiments, FCV- 
infected cells showed decreased metabolism of D-turanose as compared to uninfected 
cells (Figure 5.3). This indicates lower overall metabolism in infected cells.
5.4.4 Palatinose
Also referred to as Isomaltulose, Palatinose is widely used as a sugar substitute, or as a 
sucrose replacement (Lina et al., 2002). Similarly to D-turanose, this disaccharide is 
broken down into glucose and fructose to be absorbed into cells and metabolised. As 
seen in Figure 5.4, uninfected cells are able to metabolise better than infected cells with 
palatinose as a substrate. Metabolic activity of infected and uninfected cells is also 
higher overall in palatinose than in D-turanose, showing it is a preferred carbon source 
for these cells.
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Figure 5.3 Metabolism of D-turanose by FCV-infected and uninfected CRFK cells
CRFK cells were incubated in the wells of a 96 well plate containing different carbon sources for 
24 h at 37°C using the rate of tétrazolium dye conversion to indicate the rate of metabolism. The 
resultant graphs show the metabolism of D-turanose in infected (red) or uninfected cells (green) 
as an average of three individual experiments (mean +/- SE).
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Figure 5.4 Metabolism of Palatinose by FCV-infected and uninfected CRFK cells
CRFK cells were incubated in the wells of a 96 well plate containing different carbon sources for 
24 h at 37°C using the rate of tétrazolium dye conversion to indicate the rate of metabolism. The 
resultant graphs show the metabolism of Palatinose in infected (red) or uninfected cells (green) 
as an average of three individual experiments (mean +/- SE).
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5.4.5 L-sorbose
L-sorbose is a ketohexose sugar which can be utilised in the fructose and mannose 
metabolism pathway, which then feeds into glycolysis. As shown in Figure 5.5, 
uninfected cells show increased metabolism of L-sorbose compared to infected cells. 
Since L-sorbose feeds into the glycolysis pathway, this result indicates that there is less 
glycolysis occurring in infected cells than in uninfected cells. The delay in metabolism 
starting could indicate this is not a preferable substrate for these cells.
5.4.6 D -tagatose
Similarly to L-sorbose, D-tagatose is a ketohexose sugar (also commonly used as a 
sweetener) could be metabolised in the tagatose-6-phosphate pathway - a branch of 
galactose metabolism - feeding into glycolysis. Although it is unknown how D-tagatose is 
metabolised when it is the only carbon source (Kim, 2004), it is apparent that CRFK cells 
are capable of metabolising this substrate (Figure 5.6). Uninfected cells show increased 
metabolism of D-tagatose compared to infected cells.
5.4.7 D -glucuronic acid
Although an analogue of glucose, D-glucuronic acid can only feed into the halfway point 
of the PPP, and could continue in that pathway or after several further steps feed into 
glycolysis. The delay of ~7 h seen before establishment of metabolism of this substrate 
(Figure 5.7) could either be indicative of the fact that it needs to undergo several 
chemical alterations before being used in glycolysis, or the cell may not be able to 
internalise it efficiently.
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Figure 5.5 Metabolism of L-sorbose by FCV-infected and uninfected CRFK cells
CRFK cells were incubated in the wells of a 96 well plate containing different carbon sources for 
24 h at 37°C using the rate of tétrazolium dye conversion to indicate the rate of metabolism. The 
resultant graphs show the metabolism of L-sorbose in infected (red) or uninfected cells (green) 
as an average of three individual experiments (mean +/- SE).
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Figure 5.6 Metabolism of D-tagatose by FCV-infected and uninfected CRFK cells
CRFK cells were incubated in the wells of a 96 well plate containing different carbon sources for 
24 h at 37°C using the rate of tétrazolium dye conversion to indicate the rate of metabolism. The 
resultant graphs show the metabolism of D-tagatose in infected (red) or uninfected cells (green) 
as an average of three individual experiments (mean +/- SE).
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Figure 5.7 Metabolism of D-glucuronlc acid by FCV-lnfected and uninfected CRFK cells
CRFK cells were incubated in the wells of a 96 well plate containing different carbon sources for 
24 h at 37°C using the rate of tétrazolium dye conversion to indicate the rate of metabolism. The 
resultant graphs show the metabolism of D-glucuronic acid in infected (red) or uninfected cells 
(green) as an average of three individual experiments (mean +/- SE; * is P < 0.05).
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5.4.8 D-glucose-6-phosphate
The main point of metabolism where glucose-6-phosphate is used is in the initial stages 
of both glycolysis and PPP, where it is broken down further. During normal cell function, 
glucose is converted to glucose-6-phosphate, the addition of the phosphate group is a 
mechanism employed by the cell to keep the glucose within the cell, as diffusion across 
the membrane is not as easily achieved. The fact that D-glucose-6-phosphate is only 
observed to be metabolised after -6  h (Figure 5.8) could be indicative of the cell 
struggling to internalise the glucose-6-phosphate. D-glucose-6-phosphate causes 
increased metabolism in uninfected cells; possibly indicating that metabolism in infected 
cells is less dependent on glycolysis or PPP than uninfected cells, as this pathway is not 
as productive as others in the cell.
5.4.9 D -fructose-6-phosphate
Fructose-6-phosphate is downstream of glucose-6-phosphate in the glycolysis pathway 
of metabolism, converted by the enzyme phosphoglucose isomerase. Interestingly in 
these experiments, although glucose-6-phosphate (the upstream chemical in glycolysis) 
is not utilised by the cells until ~6 h, fructose-6-phosphate was used by the cells from the 
beginning of the time-course studies (Figure 5.9). As well as this, CRFK cells also show 
overall higher metabolic activity when fructose-6-phosphate is the sole carbon source 
than when glucose-6-phosphate is, indicating that the cells are better able to take up and 
use D-fructose-6-phosphate. Again, the increased metabolism in uninfected cells as 
compared to infected cells indicates a higher level of metabolism through the glycolysis 
pathway in uninfected cells.
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Figure 5.8 Metabolism of D-glucose-6-phosphate by FCV-lnfected and uninfected CRFK cells
CRFK cells were incubated in the wells of a 96 well plate containing different carbon sources for 
24 h at 37°C using the rate of tétrazolium dye conversion to indicate the rate of metabolism. The 
resultant graphs show the metabolism of D-glucose-6-phosphate in infected (red) or uninfected 
cells (green) as an average of three individual experiments (mean +/-  SE).
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Figure 5.9 Metabolism of D-fructose-6-phosphate by FCV-infected and uninfected CRFK cells
CRFK cells were incubated in the wells of a 96 well plate containing different carbon sources for 
24 h at 37°C using the rate of tétrazolium dye conversion to indicate the rate of metabolism. The 
resultant graphs show the metabolism of D-fructose-6-phosphate in infected (red) or uninfected 
cells (green) as an average of three individual experiments (mean +/- SE).
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5.5 Discussion
Cell metabolism is a process which is required for the normal functioning of cells, 
providing energy and building blocks for macromolecules. The pathways of metabolism 
are highly complex and under tight control in order to maintain cellular homeostasis 
(Berg et al., 2012). When a cell is infected or cancerous, these metabolic pathways have 
been shown to be adversely affected. This is seen in cancerous cells as the Warburg 
effect (Vander Heiden at a!., 2009) where increased lactate is synthesised, or in HCMV- 
infected cells where an increase in fatty acid synthesis is observed (Munger et a/., 2006). 
The limited study of the effects of virus infection on host cells has been developed over 
many years, and this chapter focuses on the possible use of newer technology to 
investigate these effects. We explored the effect of FCV infection on the metabolism of 
CRFK cells using the Biolog technology, a technology not yet used for this purpose. 
Consequently, before any usable results were acquired, there was extensive optimisation 
of the conditions required. Of the conditions tested, it was found that lower cells 
numbers, lower serum levels. Biolog tétrazolium MA dye and a longer incubation in the 
Biolog media prior to FCV infection produced better results.
Investigation of the effect of FCV-F9 infection on the metabolism of CRFK cells has 
demonstrated that infected cells metabolise more a-D-glucose than uninfected cells, as 
well as more D,L-a-glycerol phosphate (but only after -12h indicating that this is not a 
preferable carbon source) which could point to increased fatty acid synthesis.
The decreased metabolism of D-turanose, Palatinose, L-sorbose, D-tagatose, D- 
glucuronic acid, D-glucose-6-phosphate and D-fructose-6-phopshate in infected cells all 
point to a decrease in metabolism by glycolysis and PPP when CRFK cells are infected 
with FCV. Overall, this suggests that when infected, CRFK cells undergo less glycolysis
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and possibly less PPP too which could indicate the virus is slowing down normal 
metabolic pathways to enable the establishment of its own metabolic schedule.
The increase in metabolism of a-D-glucose in FCV-infected cells is as yet, unexplained. 
An increase in glucose metabolism is observed in several viral infections, such as Rous 
Sarcoma virus (Singh et al., 1974), HIV type 1 (Sorbara et al., 1996) and in HCMV 
infection where the induced metabolic changes are very similar to the Warburg effect 
(Landini, 1984). The increase in glucose uptake is attributed to the virus directing 
metabolism for increased synthesis of fatty acids (Munger et al., 2006); inhibiting the 
uptake of glucose into cells inhibits productive infection of HCMV (Yu et al., 2011b). The 
increase in glucose uptake seen in FCV-infected CRFK cells could be similar to that 
seen in the Warburg effect (Vander Heiden et al., 2009) and HCMV infection. However, 
further investigation is required before this could be related to the effect observed here.
The increase in D,L-a-glycerol phosphate metabolism in FCV-infected could be indicative 
of an increase in membrane synthesis. Glycerol phosphate can be used to synthesise 
the fatty acids which make up membranes. Due to FCV requiring membranous vesicle 
for replication (Green et al., 2002), this increase in D,L-a-giycerol phosphate metabolism 
could be evidence of FCV directing cellular metabolism to form more membranous 
material on which to replicate.
Further work is required to optimise the system further particularly with regard to 
improving the condition of the cells in order to attain results that perhaps better reflect in 
vivo cell conditions. For example, we know that FCV induces apoptosis in CRFK cells 
-6-8 h post-infection which is not reflected in these results. As well as this, further 
analyses using sealed plates could improve the condition of the cells by maintaining the 
level of CO2 in the cellular environment for longer. These experiments could also be
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undertaken in FEA (Feline Embryonic Airway) cells to confirm the results seen in CRFK 
cells and investigate whether different cell types might react differently in this system.
In time, it might be possible to develop a ‘biochemical fingerprint’ to identify viruses, as 
has been suggested for several microbes such as Enterobacter sakazakii isolates 
(Bochner, 2006; Restaino et al., 2006). It has more recently been used in attempting to 
develop a method of rapid identification for metabolic signatures of prostate cancer 
(Putluri et al., 2011). Since the use of this technology would involve simply dispensing 
samples into Biolog plates, this could similarly present a method for rapid identification of 
causative viral agents of disease.
At the present time, our understanding of the FCV-induced changes in metabolism of 
CRFK cells is very limited and needs further targeted investigation. By understanding the 
metabolic changes of cells during infection with FCV, we can gain further insight into 
infection in these cells and the cellular processes FCV requires for productive infection.
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Chapter 6 General discussion
6.1 Early events and signalling in FCV infection
Internalisation into a host cell is a critical step in the virus replication cycle, and viruses 
have developed many different strategies to gain entry into host cells. As described in 
Section 1.3, there are several pathways available for a virus to use, with some better 
characterised than others and more being discovered all the time. Previous studies on 
FCV entry into CRFK cells showed that the virus entered cells via clathrin-mediated 
endocytosis or macropinocytosis and travelled to early endosomes (Stuart & Brown, 
2006). We further advanced this work and have shown that entry and replication of FCV 
requires dynamin and PI3-kinases, and that the virus travels from early endosomes to 
recycling endosomes. We also suggest that FCV shows a greater dependence on 
macropinocytosis than was originally thought, based on colocalisation studies. In Figure 
6.1, I have presented a model for the proposed entry pathways of FCV into CRFK cells. 
FCV enters cells by macropinocytosis or clathrin-mediated endocytosis, traffics via 
macropinosomes (Figure 6.1 A) or early endosomes (B) to recycling endosomes.
Our studies using wortmannin to inhibit the action of PI3-kinases showed that FCV 
requires PI3-kinases for entry into CRFK cells and for effective replication. To discover at 
which point in the replication cycle PI3-kinases are required (e.g. whether it’s for traffic 
beyond early endosomes or for replication), we should attempt colocalisation studies with 
early endosomal marker EEA1 and labelled virus when wortmannin is added at different 
timepoints before and after FCV. This would show whether PI3-kinase inhibition was 
interfering with trafficking to replication sites within the cell, or whether it is interfering 
with replication, possibly by the mTOR pathway. The possibility that FCV-F9 upregulates 
the mTOR pathway is supported by the fact that a different strain of FCV (Urbana)
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upregulates this pathway early in infection (Abdul Wahab, personal communication). 
These results should also be confirmed using a different PI3-kinase inhibitor, such as the 
signalling-specific LY294002 compound, used in several investigations of viral 
endocytosis, such as in influenza A virus (Shin et al., 2007).
Our cell trafficking investigations indicated that FCV traffics from either macropinosomes 
or early endosomes to recycling endosomes. In order to confirm these results the use of 
synchronised entry of labelled virus with endocytic markers should be optimised. This 
would give a clearer indication of rate of traffic to the different endosomal compartments. 
As well as this, different macropinocytosis markers should be used in conjunction with 
labelled virus, such as Lucifer Yellow and horse radish peroxidase (HRP) which are also 
macropinosmal markers. In order to confirm the trafficking of FCV via macropinosomes 
colocalisation of FCV with a macropinosome-specific marker such as Sorting Nexin-5 
(used in the study of Ebola virus infection; Nanbo at a/., 2010) should be undertaken. To 
confirm the trafficking of FCV to recycling endosomes, colocalisation studies with FCV 
and a Rabi 1 antibody to label recycling endosomes should also be undertaken (Ullrich 
at a/., 1996). As well as this, investigation of the point at which the viral RNA escapes 
into the cytoplasm should be undertaken, perhaps through direct RNA labelling as was 
achieved in the study of Poliovirus (Brandenburg at a/., 2007).
Taking such studies a step further, the use of thin section electron microscopy could also 
aid in determining the endosomes used for trafficking of FCV, as used in the study of 
HPV type 16 (Schelhaas at a/., 2012). For complete analysis of all proteins involved in 
FCV entry and infection, an siRNA screen could be completed to give an indication of 
proteins involved in those processes (Quenneville & Conibear, 2006) as employed in 
studies on respiratory syncytial virus (Kolokoltsov at a/., 2007).
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6.2 Early events and signalling in MNV-1 infection
As mentioned previously, viruses are able to use any of the diverse entry pathways (see 
Section 1.3) into cells to produce infection, and these early entry events in viral infection 
are investigated by many researchers. Earlier research into MNV-1 entry indicated the 
use of a cholesterol-, dynamin-, microtubule dependent pathway (Gerondopoulos et al., 
2010; Perry & Wobus, 2010), and we have continued this investigation further.
In this study, we have shown using colocalisation studies that some MNV-1 is entering 
cells by macropinocytosis. Entry of MNV-1 is also dependent on Rabi 1, possibly for 
trafficking from recycling endosomes, or from the TON to the plasma membrane, based 
on its dependence on both forms of Rabi 1(CA and DN). MNV-1 infection is dependent 
on tyrosine kinases and protein phosphatases at different stages of entry and 
trafficking/replication. Figure 6.2 shows the putative pathway MNV-1 could be using to 
enter and traffic in RAW 264.7 cells. Some MNV-1 enters cells via macropinocytosis and 
could traffic via the macropinosome to recycling endosomes (Figure 6.2 A). MNV-1 also 
appears to enter via another pathway, proposed to be a lipid-dependent pathway which 
potentially traffics to recycling endosomes (B). Either of these pathways might traffic 
MNV-1 to the TGN, however the role of the TGN in MNV-1 infection is not clear as yet. 
The observed increase in infection when inhibiting tyrosine kinases (regulators of 
macropinocytosis) is consistent with previous results observed when inhibiting 
macropinocytosis (Gerondopoulos et al., 2010; Perry & Wobus, 2010). In order to 
confirm the role of macropinocytosis in MNV-1 entry, colocalisation studies with labelled 
virus and specific macropinosomal markers such as horse radish peroxidase (HRP) or 
Lucifer Yellow could be undertaken. The role of late endosomes should also be 
confirmed using colocalisation with markers of late endosomes such as LAMP1 to 
confirm the Rab7 transfection results.
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The observed increase early in virus infection when PI3-kinases were inhibited could be 
attributed to inhibition of the mTOR pathway cellular defences by wortmannin (Proud, 
2004), or it could be showing a similar effect to that seen previously in inhibition of 
macropinocytosis (Gerondopoulos et al., 2010). This relationship between PI3-kinases 
and MNV-1 infection could be further investigated by addition of wortmannin at different 
times pre- and post-infection and analysing the effect on MNV-1 trafficking by 
colocalisation between the virus and endosomal markers.
The role of protein phosphatases in MNV-1 entry and infection also requires further 
investigation, as it shows similarity to the caveolae-dependent entry of A-MLV. When 
protein phosphatases were inhibited prior to viral entry, a decrease in infection was seen, 
however inhibition of the protein phosphatases post-infection showed an increase in 
infection (Beer et a/., 2005). Since protein phosphatases play a role in lipid raft/caveolae 
entry, the inhibitor okadaic acid should be used further to assess the cholesterol- 
dependent pathway MNV-1 is using, to determine whether it is indeed using lipid raft 
entry, or an uncharacterised pathway available in these cells in place of caveolae. By 
adding okadaic acid at specific times before and after infection with labelled virus and 
markers of endosomal compartments, the point at which protein phosphatases are 
involved in infection could be found. A similar approach could be used in the further 
investigation of tyrosine kinases, which are required later in infection.
The results of the investigations into Rabi 1 in MNV-1 infection showed a possibility of 
trafficking between the recycling endosome or the TGN, based on the virus’ dependence 
on both forms of Rabi 1. To confirm the role of recycling endosomes and the possible 
transport of MNV-1 to the TGN, colocalisation studies with labelled MNV-1 and a 
recycling endosomal marker such as Rabi 1 should be performed (Ullrich et a!., 1996).
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Taking this work another step forward, the entry of MNV-1 into microglial or dendritic 
cells should be investigated to compare entry pathways in different cell types. To analyse 
all the proteins involved in the entry and infection of MNV-1, an siRNA screen should be 
undertaken (Quenneville & Conibear, 2006). Again, the use of thin section electron 
microscopy would allow the visualisation of viral particles, and whether or not the 
protrusions which are characteristic of macropinocytosis are induced for entry of MNV-1 
into these cells. However, it could be the case, as in a recent study of HPV type 16 
(Schelhaas et a/., 2012) that entry of MNV-1 is by an uncharacterised pathway perhaps 
bearing some resemblance to macropinocytosis,, or is perhaps a form of virus-induced 
endocytosis.
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6.3 Effect of FCV infection on CRFK cell metabolism
Infection of a host cell supplies a virus with everything required to produce progeny virus 
and continue its infection. One of the mechanisms a virus is able to control during 
infection is the host cell metabolism, the series of chemical reactions tightly controlled in 
normal cell function to maintain homeostasis. During infection and in tumour cells, 
metabolism is adversely affected, diverting the normal metabolism pathways for 
alternative functions such as increased energy production (Koppelman & Evans, 1959; 
Vander Heiden et al., 2009).
Initial exploration into the effect of FCV infection on the metabolism of CRFK cells by 
measuring substrate metabolism demonstrated that there is an increase in the 
metabolism of glucose, but an apparent decrease in glycolysis and use of the pentose 
phosphate pathway.
Although it has been previously reported that there is an increase in glucose metabolism 
during HCMV infection (Landini, 1984), the increase in glucose metabolism in FCV 
infection is not explained by any other results from these experiments as no other 
pathway appears to be up-regulated. This result requires more investigation, possibly 
through microarray analysis of gene expression to indicate the specific metabolic 
enzymes affected in infection. The knowledge of the enzymes which are switched on 
gives another indication of which metabolism pathway or alteration of a pathway is being 
used. Specifically, the enzymes involved in metabolising glucose, such as hexokinase 
which breaks down a-D-glucose into a-D-glucose-6-phosphate (Singh et al., 1974) could 
be investigated. This could aid in answering why there is an increase in glucose uptake, 
but no concurrent increase in glycolysis or use of the PPP. These results also need to be 
validated after further optimisation work to improve the conditions for infection of cells.
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Similarly, the decrease in metabolism of substrates associated with glycolysis and the 
PPP should be investigated further by studying the enzymes affected by FCV infection 
using microarray analysis. Further analysis of the metabolic products should also be 
undertaken, as in several studies using mass spectrometry and RT-PCR to measure 
gene expression (Munger et al., 2006; Marin-Valencia et al., 2012). To further investigate 
the effect of FCV on CRFK cells, additional Biolog plates could be used (specifically PM- 
M5 -  M8 which are 96 well plates coated with different hormones, ions and other 
metabolic effectors). Investigation of the effect on cell metabolism in later stages of FCV 
infection could be achieved by longer infection times.
To conclude, we have made advances in the study of FCV and MNV-1 entry which could 
prove useful in the design of antiviral therapies against these important viruses.
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Appendices
Transformations 
LB Broth
10 g tryptone (Oxoid Ltd)
5 9  yeast extract (Oxoid Ltd)
10 9  NaCI (Fischer Scientific)
Dissolve in RO
Adjust pH to 7.5
Make up to 1 L with RO water
Autoclave
LB agar
1.5 9  bacterial agar (Oxoid Ltd)
100 ml LB Broth
Autoclave
C aC l2/Tris solution
1.5 9  CaCl2 (Sigma Aldrich)
1 ml 1M Tris-HCL (pH 7.5; Fisher Chemicals)
Fill up to 100 ml with sterile MQ water 
Filter sterilised through a 0.2 pm syringe
Sodium  Acetate (NaAc) 2M
19.63 9  Sodium Acetate (Fischer Scientific)
80 ml MQ water
pH to 5.2 with glacial acetic acid (Fischer Scientific)
Fill up to 100ml with water
Autoclave
SDS-PAGE & Western blot solutions 
AX2 buffer
45.3 g Tris (Fisher Chemicals)
Fill up to 500 ml with MQ water 
pH to 8.8
BX2 buffer
15.12 g Tris (Fisher Chemicals)
Fill up to 500 ml with MQ water 
pH to 6.8
10% resolving gel
4.5 ml MQ water 
10 ml Ax2
5ml Bis acrylamide (Biorad)
200 pi 10% SDS (Sigma Aldrich)
200 pi Ammonium Persulphate (0.3%; Sigma Aldrich) 
100 pi TEMED (Sigma Aldrich)
4%  stacking gel
3.7 ml MQ water 
5 ml Bx2
1 ml Bis acrylamide (Biorad)
100 pi 10% SDS (Sigma Aldrich)
100 pi Ammonium Persulphate (0.3%; Sigma Aldrich) 
50 pi TEMED (Sigma Aldrich)
Running buffer
3g Tris base (Fisher Chemicals)
14.4g glycine (Sigma Aldrich)
5ml 20% SDS (Sigma Aldrich)
Fill up to 1L with MQ water
Transfer buffer
3g Tris base (Fisher Chemicals) 
14.4g glycine (Sigma Aldrich)
200ml methanol (Fisher Chemicals) 
Fill up to 1L with MQ water
10 X TBS -  0.1%  Tween
24.2 g Tris (Fisher Chemicals)
80 g NaCI (Fisher Scientific) 
Dissolved in 800 ml MQ water 
pH to 7.6 
10 ml Tween-20 
Fill up to 1 L
5% blocking buffer
5 g powdered milk (Marvel)
Fill up to 100 ml with 1x TBS TWEEN
Cell treatment 
PBS
1 PBS tablet (Oxoid Ltd) 
100 ml MQ water 
Autoclaved
4% Paraform aldehyde 0.2%  gluteraldehyde
8 g paraformaldehyde (Sigma Aldrich)
200 ml sterile PBS; stirred at 80°C 
20 pi MgCLz 
20 pi CaCLz
400 pi gluteraldehyde (Sigma Aldrich)
Cooled and filtered through a 0.45 pm filter
Acid wash
0.1 M NaCI (Fisher Scientific) 
0.1 M Glycine (Sigma Aldrich) 
Fill up to 100 ml with MQ water 
pH to 3 
Autoclaved
Virus purification
Boric acid buffer
1.24 g Boric acid (Fisher Scientific)
2.92 g NaCI (Fisher Scientific)
Fill up to 100 ml MQ water 
pH to 7.4
30%  sucrose solution
30% sucrose (Fisher Chemicals) in PBS
2x caesium  chloride in PBS
8.39 g CsCI (Life Technologies)
Fill up to 10 ml MQ water
Plaque assay
2x m aintenance m edium  for plaque assay
31 ml sterile MQ water
10ml lOx Eagles MEM with Earles salts
1ml Penicillin and Streptomycin
1ml Glutamine
2ml Foetal calf serum
4ml Sodium Bicarbonate
1ml Non-essential amino acids
IV
0.8%  agarose for plaque assay
0.8g Sigma cell-culture grade agarose 
100ml MQ water
Autoclaved, melted in the microwave then cooled to 42°C before mixing with 2x media 
Form ol Saline
10 ml formaldehyde (Sigma Aldrich)
90 ml 0.89% saline
Crystal v io let stain
0.1% crystal violet in 20% ethanol
Immunofluorescence staining
0.1%  Tritonx-100
100 pi Triton X-100 (BDH Ltd)
100 ml autoclaved MQ water
0.5%  PBS/BSA (B locking buffer)
1 g Bovine Serum Albumin (Sigma Aldrich) 
200 ml sterile PBS
Stirred then filtered through a 0.45 pm filter 
0.5%  Saponin
0.5% saponin (Sigma Aldrich) in PBS
BiOLOG solutions 
MC-0 m edia
1 ml Penicillin/Streptomycin (Gibco BRL)
1 ml L-Glutamine (Gibco BRL)
2 ml Foetal Bovine Serum (Gibco BRL)
Fill up to 100 ml with IF-M1 media (BiOLOG Inc)
‘B lank’ DMEM media
1 ml Penicillin/Streptomycin (Gibco BRL)
1 ml L-Glutamine (Gibco BRL)
2 ml Foetal Bovine Serum (Gibco BRL
Fill up to 100 ml with ‘blank’ DMEM media (Sigma Aldrich)
BiOLOG substrates in PM-M1 plate
a-cyclodextrin
Dextrin
Glycogen
Maltitol
Maltotriose
D-maltose
D-trehalose
D-cellobiose
(3-gentiobiose
D-glucose-6-phosphate
a-D-glucose-1 -phosphate
L-glucose
a-D-glucose
3-0-methyl-D-glucose
a-methyl-D-glucoside
(3-methyl-D-glucoside
D-salicin
D-sorbitol
N-acetyl-D-glucosamine 
D-glucosaminic acid
vi
D-glucuronic acid
Chondroitin-6-sulfate
Mannan
D-mannose
a-methyl-D-mannoside
D-mannitol
N-acetyl-{3-D-mannosamine
D-melezitose
Sucrose
Palatinose
D-turanose
D-tagatose
L-sorbose
L-rhamnose
L-fucose
D-fucose
D-fructose-6-phosphate
D-fructose
Stachyose
D-raffinose
D-lacitol
Lactuiose
a-D-lactose
Melibionic acid
D-melibiose
D-galactose
a-methyl-D-galactoside
(3-methyl-D-galactoside
N-acetyl-neuraminic acid
Pectin
Sedoheptulosan
Thymadine
Uridine
Adenosine
Inosine
Adonitol
VII
L-arabinose
D-arabinose
(3-methyl-D-xylopyranoside
Xylitol
Myo-inositol 
Meso-erythritol 
Propylene glycol 
Ethanolamine 
D,L-a-glycerol-phosphate 
Glycerol 
Citric acid 
Tricarballylic acid 
D,L-lactic acid 
Methyl D-lactate 
Methyl pyruvate 
Pyruvic acid 
a-keto-glutaric acid 
Succinamic acid 
Succinic acid 
Mono-methyl succinate 
L-malic acid 
D-malic acid 
Meso-tataric acid 
Acetoacetic acid (a) 
y-amino-N-butyric acid 
a-keto-butyric acid 
a-hydroxy-butyric acid 
D,L-(3-hydroxy-butyric acid 
y-hydroxy-butyric acid 
Butyric acid 
2,3-butanediol 
3-hydroxy-2-butanone 
Propionic acid 
Acetic acid 
Hexanoic acid
VIII
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